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ABSTRACT 
Primary open angle glaucoma (POAG) is characterized by progressive degeneration of the 
retinal ganglion cells, resulting in optic nerve atrophy with visual field defects. The 
biological basis of POAG is not fully understood.  
This thesis covers two studies. The aims for Study 1 were to investigate the risk factors of 
glaucoma in a population aged 18 years to 40 years. These were investigated by a 
retrospective study of intraocular pressure measurements and optic nerve assessments (cup 
to disc ratio) in two groups. One group had a family history of glaucoma and a second group 
was without a family history of glaucoma. The aims for Study 2 were to investigate whether 
the risk factors for primary open angle glaucoma were present many years before glaucoma 
develops. These were investigated with a retrospective review of intraocular pressure 
measurements and optic nerve measurements in participants who subsequently developed 
primary open angle glaucoma.  
Each study collected anonymised retrospective data from community optometry clinics for 
extraction and analysis of data on intraocular pressure measurements and optic nerve 
assessments. Study 1 collected one data entry per case. Study 2 collected ten years of 
historical data from each clinical visit from clinical records of participants prior to their 
diagnosis/treatment of glaucoma. This data spanned 33 years. For each glaucoma record, 
data for a similar period were obtained from a case-matched control record.  
The results for Study 1 are that mean intraocular pressure measurements and optic nerve 
head assessments in young adults aged between 18 years and 40 years did not differ 
significantly in cases with a family history of glaucoma compared with a group without.  
For Study 2, the correlations of intraocular pressure and optic nerve cup to disc ratio indicate 
an increase in values over a 10-year duration for cases that subsequently developed 
glaucoma as compared to case-matched controls. Analyses conducted at 5 and 10-year time 
points for mean intraocular pressure and median optic nerve cup to disc ratios prior to 
POAG diagnosis were statistically significantly different (p<0.05). Visual field data were 
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collected for all the cases and descriptive data showed that pre-diagnosed cases had more 
reported suspicious visual field defects. 
The principle findings of this thesis are that there are pre-glaucomatous changes up to ten 
years before glaucoma diagnosis and that this may have considerable relevance for models 
of glaucoma aetiology. It also highlights the important role that community optometrists 
play in guarding the borders between pre-glaucoma and glaucoma. 
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LIST OF TERMS 
Anterior Chamber Angle  
The anterior chamber angle is the junction formed by the scleral-
corneal junction, the ciliary body and the peripheral iris (Leung & 
Weinreb 2011).  
Aqueous Humour 
Clear, colourless fluid that fills the anterior and posterior chambers of 
the eye. It contributes to the maintenance of the intraocular pressure. 
It is formed in the ciliary processes, flows into the posterior chamber, 
then through the pupil into the anterior chamber and leaves the eye 
through the trabecular meshwork passing to the canal of Schlemm 
(Millodot & Laby 2002). 
Angle Closure Glaucoma See Glaucoma. 
Glaucoma 
“The term glaucoma encompasses a number of diseases in which 
there is a progressive loss of retinal ganglion cells (RGC) with 
corresponding visual field loss that results in a characteristic 
“cupped” appearance in the optic nerve head. Glaucoma results in an 
irreversible loss of visual field, usually starting in the periphery, and 
sometimes affecting the central visual field first, but leading to 
varying degrees of visual disability and, in a small but significant 
proportion of patients, blindness” (Barton & Hitchings 2013).  
Hypermetropia 
Hypermetropia is a refractive condition in which images of distant 
objects are focused in behind the retina; thus, vision is blurred 
(Millodot & Laby 2002).  
Intraocular Pressure 
The internal pressure of the fluid contained within the eye (NICE 
2017). 
Lamina Cribrosa 
Where axons of retinal nerve cells exit to form the optic nerve (Tan et 
al. 2018). 
Myopia 
Myopia is a refractive condition in which images of distant objects 
are focused in front of the retina; thus, distance vision is blurred 
(Millodot & Laby 2002).  
Normal Tension Glaucoma 
(NTG) 
In NTG, IOP is below 21.0mmHg, yet has an open anterior chamber 
and there are glaucomatous optic nerve changes and visual field 
defects. (Shields 2008).  
Ocular Hypertension (OHT) 
Elevated IOP (greater than 21.0mmHg) in one or both eyes in the 
absence of clinical evidence of optic nerve damage, visual field defect 
or other pathology (College of Optometrists 2016).  
Open Angle Glaucoma 
(OAG) 
See Glaucoma. 
Ophthalmologist 
A medical doctor with specialist qualification in conditions that affect 
the eye and orbit, including diagnosis, management and surgery. 
Ophthalmoscopy 
A technique to describe examination of the optic nerve, retinal, ocular 
media using an ophthalmoscope or with slit lamp bio-microscopy.  
Optical Coherence 
Tomography 
Device that uses the principle of low-coherence interferometry to 
produce cross sectional images of ocular tissues (Fujimoto et al. 
1995). 
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Optometrist 
A healthcare professional with specialist training and expertise in 
conditions of the eye, especially measurement of vision and refractive 
error, prescription and dispensing of spectacles and contact lenses. 
Pre-Perimetric Glaucoma 
Glaucomatous optic nerve changes and/or nerve fibre layer defect, 
with no visual field defect caused by glaucoma. (Sawada et al. 2017) 
Primary Closed Angle 
Glaucoma  
 
Primary closed angle glaucoma is defined as an occludable drainage 
angle and features indicating that trabecular obstruction by the 
peripheral iris has occurred (European Glaucoma Society 2017). 
Primary Open-Angle 
Glaucomas  
 
Primary open-angle glaucoma (POAG) is a chronic progressive optic 
neuropathy with characteristic morphological changes at the optic 
nerve head and retinal nerve fibre layer in the absence of other ocular 
disease or congenital anomalies. Progressive retinal ganglion cell 
death and visual field loss are associated with these changes 
(European Glaucoma Society 2017). 
Secondary Glaucoma 
Secondary glaucomas are a heterogeneous group of conditions, in 
which elevated IOP is the leading pathological factor causing 
glaucomatous optic neuropathy. Most forms of secondary glaucoma 
like uveitic or traumatic glaucoma have complex pathomechanisms 
including both an open or closed angle (European Glaucoma Society 
2017) 
Slit Lamp Bio-Microscope 
A microscope that projects a narrow beam of light that allows 
examination of the structures of the eye (Walters 2006). 
Tonometry 
A test to measure intraocular pressure using an instrument called a 
tonometer (NICE 2017). 
Van Herick Method 
A non-contact approach for estimating angle width using the slit-lamp 
beam to compare the depth of the peripheral anterior chamber depth 
to the thickness of the cornea (Van Herick et al. 1969). 
Visual Field 
The extent of space in which objects are visible to an eye in a given 
position (Millodot & Laby 2002).  
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ACA Anterior Chamber Angle 
AH Aqueous Humour 
BMC Slit lamp biomicroscopy 
CC Case-matched control 
CI Confidence Interval 
COAG Chronic Open Angle Glaucoma 
CVF Computerised Visual Field 
GAT Goldmann Applanation Tonometry 
HES Hospital Eye Services 
ICO Information Commissioner’s Office 
INSTRUM Instrument 
IOP Intraocular Pressure 
L IOP AV Left Intraocular Pressure Average 
L SER Left Spherical Equivalent Refraction 
LVA  Left Visual Acuity 
NICE National Institute for Health and Care Excellence 
NHS National Health Service 
NTG Normal Tension Glaucoma 
OCT Optical Coherence Tomography 
OHT Ocular Hypertension 
ONH Optic Nerve Head 
ONHVL Optic Nerve Head Vertical Left 
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OR Odds Ratio 
PG Pre-diagnosis glaucoma  
PPG Pre-perimetric Glaucoma 
POAG Primary Open-Angle Glaucoma 
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 INTRODUCTION 
 BACKGROUND 
Primary open angle glaucoma (POAG) is characterized by progressive degeneration of the 
retinal ganglion cells, resulting in characteristic visual field defects, that reflect optic nerve 
atrophy, with a distinctive clinical appearance (Gemenetzi et al. 2012). A typical 
glaucomatous optic nerve will have localised nerve loss and generalised enlargement of the 
optic cup (European Glaucoma Society 2017). A diagnosis of POAG is a life-changing 
commitment for the patient and health service, and POAG has profound public health 
implications. It is a condition that contributes globally to severe visual impairment and 
blindness (Murray & Lopez 2013; WHO 2017).  
The biological basis of POAG is not fully understood (Weinreb et al. 2014). Numerous studies 
have investigated the risk factors (Prum et al. 2016), which include elevated intraocular 
pressure, increasing age, family history, race and myopia (Hirani et al. 2012).  
Guidelines on glaucoma diagnosis and management were introduced in 2009 and were re-
issued in November 2017 by the National Institute of Clinical Excellence. (NICE 2017). The 
introduction of the NICE guidelines increased the absolute number of patients detected with 
glaucoma and has resulted in more patients being diagnosed with early disease (de Silva et al. 
2013). Case-finding and referral for glaucoma is conducted mostly by optometrists 
(Lawrenson 2013).  
The aims for this thesis are to provide information about intraocular pressure and optic disc 
cupping by comparing with control groups (a) a population at risk of glaucoma owing to 
family history (Study 1); and (b) a population who subsequently went on to develop glaucoma 
(Study 2). 
This chapter will introduce the function of the eye and the structures of the eye which are 
pertinent to glaucoma. Following this, the chapter will review glaucoma, concentrating on 
POAG and the assessments which are used for its detection and management.  
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 STRUCTURE AND FUNCTION OF THE EYE 
A schematic diagram of the eye is shown in Figure 1.2-1. The diagram presents the structures 
of the eye that will be referred to in this thesis. A simple description of the function of the eye 
is to convert light to an electrical signal and all the preliminary image analysis in the retina 
(Tovee 1996). After light is captured by the eye, it is refracted (partially focussed) by the 
cornea and passes through an aperture called the pupil. There are chambers positioned anterior 
and posterior to the pupil. Each of these chambers contain aqueous humour (AH) (Section 
1.2.4).  
 
 
FIGURE 1.2-1 Illustration of the human eye (sagittal view). 
 
The anterior chamber is the space between the iris and the cornea. The posterior chamber is 
the anatomical portion of the eye posterior to the iris and anterior to the lens and vitreous face. 
The largest component of the eye is the vitreous chamber, which makes up more than two-
thirds of the volume of the eye (5-6 ml) and contains the vitreous gel (Murthy et al. 2014; 
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Stamer et al. 2008). Light passes through the vitreous before reaching the back of the eye. It 
is then transformed into a neural signal by specialised receptor cells at the retina. The retina is 
the photosensitive layer that contains neural elements that are involved in processing visual 
information (Field & Chichilnisky 2007). The neural signal is modified in the retina, before 
travelling onto the brain via the optic nerve (Tovee 1996; Nuschke et al. 2015; Heitmancik & 
Nickerson 2015).  
The eyeball is composed of three concentric layers. The outermost layer consists anteriorly of 
the transparent cornea and the opaque sclera posteriorly. The cornea meets the sclera at a 
region known as the limbus or corneoscleral junction (Forrester et al. 2015). The cornea, 
together with the sclera forms a tough fibrous envelope that protects the ocular tissues 
(Forrester et al. 2015). The sclera becomes thin and sieve-like at an area called the lamina 
cribrosa. This is where the axons of retinal nerve cells exit to form the optic nerve (Tan et al. 
2018). 
The middle layer of the globe is called the uvea; it consists of the choroid, ciliary body and 
iris. The uvea is highly vascular and serves a nutritive and supportive function. The inner layer 
of the globe is the retina.  
 
1.2.1 CORNEA 
The cornea constitutes the main refractive element of the eye (Kamma-Lorger et al. 2010) and 
covers the anterior one sixth of the total surface area of the globe (Dawson et al. 2009). The 
sclera covers the remaining five sixths (Dawson et al. 2009). The cornea is composed of six 
layers: corneal epithelium, anterior limiting lamina, corneal stromal (substantia propia), Dua’s 
layer, posterior limiting lamina (Descemet’s membrane) and the corneal endothelium (Dua et 
al. 2013). The thickness of the central part of the cornea (central corneal thickness/CCT) has 
mean values between 427 to 620μm, with a maximal difference between eyes of 42μm (Wolfs 
et al. 1997).  
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1.2.2 LIMBUS 
The limbus is the zone between the cornea and the sclera. This area contains the pathways for 
aqueous humour outflow (Section 1.2.4). The limbus also functions to maintain nourishment 
of the peripheral cornea and is a repository of stem cells (Michael Van Buskirk 1989).  
 
1.2.3 ANTERIOR CHAMBER & ANTERIOR CHAMBER ANGLE 
(ACA)  
In this section, the anterior chamber, the anterior chamber angle (ACA) and intraocular 
pressure will be described. These three components work in conjunction. Physical viewing of 
the anterior chamber will allow for its angle to be viewed simultaneously. The anterior 
chamber is anterior to the cornea and posterior to the iris diaphragm and the pupil (Figure 
1.2-2). The anterior chamber angle consists of Schwalbe’s line, Schlemm’s canal and 
trabecular meshwork, scleral spur, anterior border of the ciliary body and the iris (Liu et al. 
2011). The depth of the ACA can vary; it is deeper in those who do not have a natural lens 
(aphakia) or a replacement intraocular lens (pseudophakia). There is a relationship between 
refractive error and the depth of the ACA; being greater in those with eyes with a longer axial 
length of the eye (myopia) and shallower in those who have a smaller axial length 
(hypermetropia) (Liu 2008). 
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FIGURE 1.2-2 Positioning of the anterior chamber: it is situated anterior to the cornea and posterior to the 
iris diaphragm and the pupil. 
 
1.2.4 AQUEOUS HUMOUR 
Aqueous humour is a transparent fluid that circulates from the posterior to the anterior 
chamber of the eye. Its transparency allows for optical clarity (Stamer et al. 2008). The major 
components of AH are organic and inorganic ions, carbohydrates, glutathione, urea, amino 
acids and proteins, oxygen, carbon dioxide and water (Goel et al. 2010). The anterior and 
posterior chamber fluids are similar in chemical composition (Kinsey 1953).  
The circulation of AH supplies nutrients and oxygen and removes metabolic wastes from the 
anterior intraocular tissues such as cornea, crystalline lens and trabecular meshwork. AH also 
facilitates the local immune responses during inflammation and infection (To et al. 2002; Wax 
et al. 2014). AH inflates the globe and creates an intraocular pressure (IOP) for normal optical 
functioning of the eye.  
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1.2.4.1 CILIARY  EPITHELIUM 
AH is secreted by the ciliary epithelium; this covers the surface of the ciliary body and has a 
non- pigmented side and a pigmented side (To et al. 2002). The inner layer abuts to the 
aqueous side or vitreous body (To et al. 2002).  
Ion transporters are most commonly concerned with epithelial secretion and have been found 
to be more numerous at the anterior region (pars plicata) than the posterior region (pars plana) 
of the ciliary body (To et al. 2002). This suggests that the pars plicata is the primary site of 
AH formation (Ghosh et al. 1991).   
Transport from the posterior chamber to the anterior chamber is uni-directional and achieved 
by three inter-dependent mechanisms (Civan & Macknight 2004). These processes are 
diffusion, ultrafiltration and active transport.  
 
1.2.4.2  DIURNAL VARIATION 
Diurnal variations have been observed with AH turnover rates, reflecting the pattern known 
as circadian rhythm. AH flow is normally about 3.0μl/min in the morning, 2.4μl/min in the 
afternoon, and drops to 1.5 μl/min at night (Wilensky 1991). The fluid volume of the anterior 
chamber can be completely changed over a period of 100 min (Pascale et al. 2012).   
 
1.2.4.3 AQUEOUS HUMOUR ABSORPTION/OUTFLOW 
There are two outflows for AH from the eye: the conventional and non-conventional outflows 
(Figure 1.2-3). Each of these has a different physiological mechanism (Goel et al. 2010) and 
each shall be described in turn.  
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FIGURE 1.2-3 Aqueous humour is secreted by the ciliary body and moves through the pupil, around the 
iris. a pressure gradient directs it toward the SC lumen (red arrow). This is termed the conventional pathway 
(C). The non-conventional pathway (NC) involves the drainage of aqueous through the fibres of the ciliary 
body into the supraciliary and suprachoroidal spaces. 
 
1.2.4.3.1 CONVENTIONAL ROUTE OF AQUEOUS HUMOUR OUTFLOW 
The conventional route for AH outflow is pressure dependent and utilises the trabecular 
meshwork. The trabecular meshwork is an area of connective tissue located at the anterior 
chamber angle. It contains endothelium-lined spaces (intertrabecular spaces) through which 
AH passes to the Schlemm’s canal (Millodot & Laby 2002). Schlemm’s canal is in the form 
of a circular duct, in the deep part of the limbus (Dvorak-Theobald 1934) (Figure 1.2-3). 
Outflow from the trabecular meshwork has been described as a series of linear springs that 
allow Schlemm’s canal to change with the proportion of AH filtering through (Johnson & 
Kamm 1983; Acott et al. 2014). 
1.2.4.3.2 NON-CONVENTIONAL  ROUTE OF AQUEOUS HUMOUR OUTFLOW 
The non-conventional route is not pressure dependent but has been reported to be pressure 
insensitive rather than pressure independent (Johnson et al. 2017). This process uses 
uveoscleral outflow (Figure 1.2-3) (Alwaird & Longmuir 2008). Approximately 10% of AH 
outflow is thought to be via a non-conventional route, although this is an unclear determination 
(Pederson & Toris 1987). AH is said to enter connective tissue between the muscle bundles, 
through the suprachoroidal space, and out through the sclera (Ascher 1954; Bill & Hellsing 
1965; Alm & Nilsson 2009).  
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 INTRAOCULAR PRESSURE 
The integrity of the eye and the structures that mediate vision are dependent on intraocular 
pressure (IOP) (Kelly & Farrell 2017). IOP is maintained primarily by change in the aqueous 
humour outflow resistance, which is located within the connective tissue (cribiform 
meshwork) of the trabecular meshwork and the inner wall of Schlemm’s canal (Acott & Kelley 
2008; Johnson 2006). Maepae and Bill (1992) showed that in monkey eyes, nearly 90% of the 
outflow resistance was in the subendothelial region of Schlemm’s canal. There is stable inflow 
for aqueous humour, unless high pressures are achieved (Brubacker 1991). As discussed in 
Section 1.2.4.3, AH outflow is primarily through the conventional route but also occurs 
through the non-conventional route.  
Several population studies have collectively shown that IOP measurements differ little 
between genders (Armaly 1965; Hollows & Graham 1966; Bankes et al. 1968; Kahn et al. 
1977; Klein et al. 1992). Each study found some indication of increasing pressure with age 
and that this age effect was lost or at least weakened at the oldest ages (Armaly 1965; Hollows 
& Graham 1966; Bankes et al.1968; Kahn et al. 1977; Klein et al. 1992). Table 1.3-1-1 shows 
that between the ages of 40 years and 86 years, mean IOP values have been measured between 
14.7mmHg and 17.5mmHg for females and between 15.0mmHg and 17.4mmHg for males.  
Epidemiologic studies have shown the mean measurement of IOP to be approximately 
16.0mmHg, with a standard deviation of 3.0mmHg (Colton & Ederer 1980). More recent 
research from a UK bio data bank, states that the mean IOP in a majority Caucasian population 
with a mean age of 57 years, to be 15.7mmHg (Chan et al. 2016). There is limited normative 
data on the range of IOP in people under the age of 40 years.   
An estimated 50% of people with glaucoma present with IOP below 21.0mmHg (Chan et al. 
2016) suggesting that there is no value of IOP that can used to differentiate is as safe or unsafe 
(Liu & Allingham 2017).  
IOP is a dynamic variable that follows a circadian rhythm (Liu et al. 2011). Animal studies 
have shown IOP can fluctuate as much as 10.0mmHg day to day and hour to hour (Crawford-
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Downs et al. 2011). The time at which IOP peaks, appears to be usually in the morning hours 
(Liu et al. 2011). The diurnal fluctuation is an important consideration in glaucoma but very 
little is known how the eye responds to these fluctuations (Downs 2015). IOP can have a wide 
variability throughout a 24-hour period due to activity, nocturnal elevation, physiologic body 
position, and individual variability of response to topical medications (Sit & Liu 2009; 
Orzalesi et al. 1999; Khawaja et al. 2014).  
 
TABLE 1.3-1-1 Summary of (IOP) intraocular pressure from population studies. Age measured in years. 
IOP measured in mmHg. S.D.=standard deviation  
Study Gender Age range/years IOP mmHg S.D 
Armaly 1965 Female 50-59 16.0 3.1 
Female 80-86 14.7 3.3 
Male 43-49 15.0 2.9 
Male 80-86 15.5 3.3 
Hollows and Graham 1966 UK Study Female 40-74 16.6 2.9 
Male 40-74 15.9 2.9 
Bankes et al. 1968 
Bedford Glaucoma Study 
Female Under 40 14.9 2.9 
Female 40-49 15.5 2.4 
Female 50-59 15.7 2.4 
Female 60-69 15.9 2.5 
Female 70-79 16.0 2.5 
Female 80+ 15.4 2.6 
Male Under 40 15.3 2.5 
Male 40-49 15.4 2.5 
Male 50-59 15.7 2.6 
Male 60-69 15.6 2.6 
Male 70-79 15.4 2.6 
Male 80+ 15.1 3.2 
Kahn et al. 1977 
Framingham Study 
Female 52-64 16.8 3.4 
Female 64-74 17.5 4.4 
Female 75-85 17.3 5.3 
Male 52-64 16.6 3.4 
Male 64-74 17.4 4.4 
Male 75-85 17.4 4.9 
Klein et al. 1992 
Beaver Dam Study 
Female 43-86 15.5 3.3 
Male 43-86 15.3 3.4 
Chan et al. 2016 
Norfolk 
Female 48-92 16.3 3.6 
Male 48-92 16.2 3.6 
 
 
 
10 
 RETINA  
1.4.1 RETINAL STRUCTURE 
The retina is the innermost lining of the eye and becomes part of the central nervous system.  
It is a thin, transparent structure that during embryo development, originates from the inner 
and outer layers of the optic cup. The layers of the retina from outer to inner retina are: retinal 
pigment epithelium (RPE) and its basal lamina, rod and cone inner and outer segments, 
external limiting membrane, outer nuclear layer (nuclei of the photoreceptors), outer 
plexiform layer, inner nuclear layer, inner plexiform layer, ganglion cell layer, nerve fibre 
layer (axons of the ganglion cells) and the internal limiting membrane (Cheng et al. 2006). 
There are key areas of the retina which provide orientation for observing the retina. The 
posterior pole or central retina (area centralis) is a 5-6mm diameter circular zone of retina 
situated between the superior and inferior temporal arteries. The macula lutea is a 1.5mm 
diameter area in the posterior pole and is positioned 3mm lateral to the optic disc. The fovea 
centralis (fovea) is a central 0.35 mm wide zone in the macula, consisting of a depression 
surrounded by slightly thickened margins (Sundaram et al. 2016). This is where cone receptors 
are concentrated at maximum density to the exclusion of rods (Hendrickson & Drucker 1992). 
The optic disc lies 3mm medial to the centre of the macula (fovea). There are no normal retinal 
layers at the optic disc and it is the area where ganglion cell axons from the retina pierce the 
sclera to enter the optic nerve. The central retinal vessels emerge at the centre of the optic disc 
and radiate out to supply the retina. The peripheral retina is the remainder of the retina outside 
the posterior pole and it is rich in rods. The ora serrata is the anterior margin of the sensory 
retina (Sundaram et al. 2016).  
For descriptive purposes, the retina is divided into nasal and temporal halves by a vertical line 
through the fovea. The optic nerve head (ONH) is often used as the central point to describe 
the retina as having supero- and infero-nasal and supero- and infero-temporal quadrants.  
Figure 1.4-1 presents a direct observation of the human retina as would be seen by an 
optometrist or ophthalmologist or on a direct photograph.  
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FIGURE 1.4-1 Retinal photographs of right eye (left image) and left eye (right image). showing healthy 
physiological optic nerve, retinal arteries and veins and macula. 
 
1.4.2 RETINAL FUNCTION 
Light striking the retina initiates a cascade of chemical and electrical events that ultimately 
trigger nerve impulses. The retina utilises five types of retinal nerve cells to carry out this 
process; these are shown in Figure 1.4-2. These nerve cells are the photoreceptors which detect 
light; the interneurons (horizontal, bipolar and amacrine cells) process the output of the 
photoreceptors and the retinal ganglion cells (RGC) axons convey visual information to the 
rest of the brain through the optic nerve (Purves et al. 2001; Sanes & Masland 2015).  
 
1.4.2.1  PHOTORECEPTORS 
The receptor layer (which lies underneath the retinal pigment epithelial layer) (Figure 1.4-2) 
holds two types of light-sensitive photoreceptors; the rods and cones. Cones are centred at the 
fovea and mediate vision under typical daytime bright (photopic) conditions and provide high-
acuity colour vision (Curcio et al. 1990). Rods mediate vision under dark (scotopic) conditions 
and provide only low-acuity monochrome vision (Tovee 1996). There are on average 91 
million rods in the human retina and 4.5 million cones. The density of the rods is much greater 
than the cones throughout most of the retina, except for the fovea. The fovea is a highly 
specialised region of the central retina where cone density increases almost 200-fold (Purves 
et al. 2001). The extreme centre 300 µm of the fovea (the foveola), is cone saturated and rod-
free (Purves et al. 2001). The layers of cell bodies and retinal blood vessels that overlie the 
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photoreceptors in other areas of the retina are displaced around the fovea which allows for less 
light scatter and superior acuity (Purves et al. 2001).   
The ONH is the channel connecting the neurosensory retina to the visual cortex (Calkins et al. 
2017). Travelling from the eye, the ONH travels through the orbit and the optic canal to then 
form the optic chiasm. Topographically, this is divided into the intraocular part and the 
retrobulbar portion. The retinal ganglion cell layer, the retinal nerve fibre layer, and the ONH 
make up the intraocular portion (Wilczek 1947; Minckler 1986; Gala 2015). 
 
 
FIGURE 1.4-2 Schematic diagram to show the course of retinal ganglion cells to the optic nerve. (Adapted 
from Carreras et al. 2014). 
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1.4.2.2 RETINAL GANGLION CELL LAYER 
Retinal neurons are stacked in five alternating layers (Figure 1.4-2). The cell bodies of the 
retinal neurons are in the inner nuclear, outer nuclear, and ganglion cell layers, and the 
processes and synaptic contacts of them are in the inner plexiform and outer plexiform layers 
(Purves et al. 2001; Sanes & Masland 2015). The retinal ganglion cells represent the final 
output neurons of the retina (Pascale et al. 2012).  
 
1.4.2.3  RETINAL NERVE FIBRE LAYER 
The retinal nerve fibre layer (RNFL) comprises ganglion cell axons, astrocytes, retinal vessels 
and Müller cell processes (Jonas & Schiro 1993). Within the nerve fibre layer, ganglion cell 
axons complete a 90% turn and proceed toward the optic nerve head, where they ultimately 
exit the eye (Radius 1987). The axons of the ganglion cells nasal to the ONH run directly 
towards it, while those of the ganglion cells in the temporal fundus describe an arcuate course 
around the fovea (Vrabect 1966; Jonas & Schiro 1993). This region is called the temporal 
raphe (Huang et al. 2015). At the fovea, the ganglion cells divide into a superior temporal and 
an inferior temporal group. The course of the RGC axons are demonstrated in Figure 1.4-3.  
RNFL thickness has been reported to be on average 100 µm (Alasil et al. 2013; Budenz et al. 
2007). The RNFL thickness increases from the fundus periphery to the optic disc (Jonas et al. 
1993). The arrangement of the thickness of the RNFL corresponds to the arrangement of the 
intrapapillary neuro-retinal rim (Dichtl et al. 1999; Jonas et al. 1993; Varma et al. 1996) 
(Section 1.4.2.3). RNFL thickness values starting from the thickest quadrant inferiorly to the 
thinnest quadrant temporally: inferior quadrant (~126µm), superior quadrant (120 µm), nasal 
quadrant (80 µm), and temporal quadrant (~70 µm SD 10.8) (Alasil et al. 2013; Budenz et al. 
2007). In healthy eyes, thinner RNFL measurements were associated with older age; being 
Caucasian, versus being either Hispanic or Asian; or being more myopic (Alasil et al. 2013). 
For every decade of increased age, mean RNFL thickness reduces by approximately 1.5 µm 
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(95% CI 0.24-0.07) (Alasil et al. 2013). There has been no relationship found between gender 
and RNFL thickness or right versus left (Mwanza et al. 2012; Budenz et al. 2007).  
 
FIGURE 1.4-3 Schematic diagram of the optic nerve fibres of the right eye seen from the front (M, macula; 
P, optic disc; R, retinal raphe; PM, papillomacular fibres; AF, arcuate fibres; T,temporal side; N, nasal 
side). (Adapted from Millodot 2009). 
 
1.4.3 OPTIC NERVE HEAD   
The retinal ganglion cell axons leave the eye through an area called the posterior scleral 
foramen, which is like a funnel (Jonas et al. 1993). With ophthalmoscopy view, the internal 
surface of the posterior scleral opening is the optic nerve head (ONH) (Jonas et al. 1993). The 
ONH is surrounded by the peripapillary scleral ring of Elschnig as shown in Figure 1.4-5.  
 
1.4.3.1  PERIPAPILLARY  SCLERAL RING OF ELSCHING 
The intrapapillary region of the ONH is delineated by a white, often circular band surrounding 
the optic disc and separating the intrapapillary optic disc region from the para-papillary area. 
This is called the peripapillary scleral ring of Elschnig; its size can range from 0.68 to 4.42mm2 
(Iester et al. 2005).   
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FIGURE 1.4-4 Schematic diagram of the optic nerve head. the disc rim is the area contained between the 
disc edge and the cup edge. the cup edge is where the surface of the nerve fibre layer intersects the imaginary 
plane established by the inner margin of the scleral ring. (Adapted from Moya et al. 1999). 
 
1.4.3.2 OPTIC DISC SHAPE AND SIZE 
The optic disc is slightly vertically oval with the vertical diameter having been shown to be 
on average about 9 % larger than the horizontal diameter (Jonas et al. 1988; Quigley et al. 
1990). The interindividual variability of the ONH size is influenced by the size of the 
peripapillary scleral ring of Elschnig; the ONH size can range in area from 1.15 to 4.94 mm2 
(Iester et al. 2005). The area of the ONH, as well as its vertical diameter, is on average 12 % 
larger in individuals of Black race than those of White race (Radius et al. 1981; Quigley et al. 
1990; Oliveira et al. 2007). On average, optic nerve size in females has been shown to be 
smaller than those in males (Quigley at al. 1990). Larger ONH and optic discs have more optic 
nerve fibres than do smaller discs (Quigley et al. 1990).  
 
1.4.3.3 OPTIC CUP 
The intrapapillary ring (the area inside the peripapillary scleral ring), consists of the neuro-
retinal rim (Section 1.4.3.5) and the optic cup (Section 1.4.3.3) (Jonas & Naumann 1993). 
Measurement of the optic cup can be achieved with imaging systems but is more commonly 
estimated with observation. The estimation is made by comparison of the cup with the size of 
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the disc and given as the ratio of the vertical diameter of the cup to the vertical diameter of the 
disc (vertical cup/disc ratio or CDR) (Weismann et al. 1973; Hitchings & Spaeth 1976; Tielsch 
et al. 1988; Varma et al. 1992). There is a wide variation in the size of the cup in the normal 
population due to a physiological relation between optic disc size and cup size (Zangwill et 
al. 1995; Teal et al. 1972; Bengtsson & Krakau 1992). Larger cup size is associated with large 
optic discs with the opposite being said for smaller optic nerve and cupping (Nixon et al. 2017; 
Garway-Heath et al. 1998). In healthy eyes, cupping between the two eyes is mostly 
symmetrical in over 96% of normal subjects (European Glaucoma Society 2017).   
 
1.4.3.4  CUP-DISC RATIOS 
The cup to disc ratio (CDR) in normal eyes is significantly larger horizontally than vertically 
(Jonas et al.1988; Samarawickrama et al. 2012). CDR have been shown to have a mean of 
0.39 horizontally and 0.34 vertically with normal healthy adults (Jonas et al. 1988). On 
average, CDR measurements have been reported to be larger in patients with African descent 
compared to Indian, Asian and Caucasian (Samarawickrama et al. 2012).  
 
1.4.3.5  NEURO-RETINAL RIM 
The neuro-retinal rim is the intrapapillary equivalent of the retinal nerve fibres and optic nerve 
fibres; it is one of the main targets for clinical assessment of the optic nerve (Jonas et al. 1999; 
European Glaucoma Society 2017). On direct observation, the neuro-retinal rim is the area 
resulting from subtraction of the cup from the disc area (Jonas et al. 1988). The neuro-retinal 
rim width follows the pattern of inferior, superior, nasal and temporal in order of thickness  
(I > S > N > T) (Poon et al. 2017). This is in line of the RNFL thickness (Section 1.4.2.3). 
There is high correlation for interocular symmetry for neuro-retinal rim width and RNFL 
thickness (Li et al. 2013). 
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1.4.3.6 LAMINA CRIBROSA 
The lamina cribrosa is a mesh-like structure in the scleral canal of the optic nerve head; it is 
composed of overlapping and branching collagenous beams (Wilczek 1947; Anderson 1969; 
Emery et al. 1973). The collagenous beams form pores through which the retinal ganglion cell 
(RGC) axons and retinal blood vessels pass. Part of the laminar cribrosa can be visible at the 
base of the optic cup when viewed by a direct ophthalmoscope (Figure 1.4-5) (Park & Ritch 
2011). Girkin et al. (2017) report that the lamina cribrosa has conflicting functions as it also 
needs to provide structural support to the ONH by withstanding IOP related mechanical strain 
but also having to provide an open pathway for retinal ganglion cell axons to leave the eye. 
The retrobulbar portion of the optic nerve starts at the posterior end of the lamina cribrosa. 
 
1.4.3.7 RETROBULBAR OPTIC NERVE 
The retrobulbar portion of the optic nerve is subdivided into three parts. These are the 
intraorbital part, the intracanalicular portion and the prechiasmatic intracranial portion. The 
retrobulbar section joins the contralateral optic nerve to form the optic chiasma, where the 
nasal fibres from each optic nerve decussate and temporal fibres do not decussate (Wilczek 
1947; Gala 2015). 
 
1.4.4 BLOOD SUPPLY TO THE RETINA AND OPTIC NERVE  
The central retinal artery arises from the ophthalmic artery in the optic canal.  It passes forward 
in the centre of the optic nerve accompanied by the central retinal vein. The large retinal 
arterial branches travel in the RNFL beneath the inner limiting membrane. Each of its four 
major branches supplies a sector of the retina (Forrester et al. 2015). The central retinal artery 
supplies all the retina apart from the photoreceptors. On occasion, a cilioretinal artery is also 
observed on the retina; this is a small artery from the choroid which can follow from the edge 
of the optic disc onto the retina (Hayreh 2015). The photoreceptors receive their metabolic 
supply from the choroid (Foulds 1990). 
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The vasculature system of the optic nerve is supplied from branches of both the central retinal 
artery and posterior ciliary arteries (Yu et al. 2017). The most anterior part of the ONH is said 
to be supplied by the retinal arterioles; in some cases, the temporal region is supplied by the 
posterior ciliary artery (Hayreh 2001). The circle of Haller and Zinn is formed by short 
posterior ciliary arteries and the lamina cribrosa is supplied either directly or from this circle. 
The optic nerve behind the lamina cribrosa (the retrolaminar region) is supplied from branches 
of the circle of Haller and Zinn and branches from the central retinal artery (Hayreh 1985; 
Hayreh 2001). 
There are individual variations in the blood supply of the optic nerve head due the anatomical 
pattern of blood supply, the pattern of posterior ciliary artery circulation and blood flow 
(Hayreh 1985). One suggested reason for the variation in the blood flow in the eye is change 
in intraocular pressure (Hayreh 1985). Acute IOP spikes can reduce blood flow to the retina, 
choroid and optic nerve in healthy volunteers (Findl et al. 2000) with suggestion that there can 
also be interference with delivery of chemicals from the brain to the retina (Quigley et al. 
2000).  
 
1.4.5 VISUAL FIELD 
One approach to assessing visual function is to measure the visual field (Fontenot Chair et al. 
2017). The visual field is that portion of space in which objects are visible at the same moment 
during steady fixation of gaze in one direction (Grill-Spector 2003). The visual field holds a 
historic definition given by Harry Moss Traquair (1875-1954) of “an island of vision in a sea 
of darkness”(Grzybowski 2009). Figure 1.4-5 presents this description diagrammatically and 
shows how the shores represent the extent of the visual field and the height of the island above 
sea level denotes sensitivity (Johnson et al. 2000). The normal extent of the visual field for a 
bright stimulus is furthest temporally measuring 100 degrees, followed by 75 degrees 
inferiorly and 60 degrees both superior and nasal.  
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FIGURE 1.4-5 Schematic representation of an island of vision in a sea of darkness. (Adapted from 
www.ssc.education.ed.ac.uk/resources). 
 
The first part of the introduction has described structures of the eye and described visual 
function. The main structures of the eye described in the anterior segment were the cornea and 
anterior chamber which lead to an understanding of intraocular pressure. The posterior 
segment of the eye reviewed the retina, optic nerve and visual field have also been described. 
Understanding these structures will aid understanding processes of development of glaucoma. 
The following section will introduce glaucoma and its classification and then continue to 
discuss glaucoma classification, diagnosis and treatments.   
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 GLAUCOMAS  
This section will provide an overview of primary open angle glaucoma. It will review the 
definition and classification of glaucoma. Its prevalence and incidence will be considered, 
followed by the criteria used for primary open angle case finding in the UK. Current literature 
on the pathogenesis of POAG will be reviewed as will treatment strategies.   
The glaucomas refers to a group of conditions with heterogeneous causes that result in damage 
to the optic nerve head and loss of visual field (NICE 2017; Kansal et al. 2018). Their uniting 
clinical feature is optic neuropathy (Casson et al. 2012). All glaucomas have clinically visible 
changes at the ONH which include focal or generalised thinning of the neuro-retinal rim, 
excavation and enlargement of the optic cup, neurodegeneration of retinal ganglion cell axons 
and deformation of the lamina cribrosa (European Glaucoma Society 2017; Casson et al. 
2012). These changes lead to a corresponding diffuse and localised retinal nerve-fibre bundle 
pattern visual field loss. Change in visual field and visual acuity may not be detectable in early 
stages but progression can lead to irreparable loss of vision (Casson et al. 2012). 
 CLASSIFICATION OF GLAUCOMAS 
Glaucoma is classified as open or closed with this differentiation being directed from the 
structure and function of the anterior chamber angle. An open anterior chamber angle will 
allow drainage of aqueous humour; a closed angle will create a forced block. (Figure 1.6-1). 
Open and closed angle glaucomas are further classified by being either primary or secondary.   
 
The most important characteristic of the glaucomatous process is change in the appearance of 
the disc from its former state. Spaeth (1993) 
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FIGURE 1.6-1 Schematic diagram to show an (A) open anterior chamber and (B) closed anterior chamber 
angle. (Adapted from Glaucoma Research Foundation 2010). 
 
Primary open angle glaucomas are usually bilateral and are caused by increased resistance to 
the outflow of aqueous humour or to the closure of the anterior chamber with no known ocular 
or systemic association. Primary closed angle closure glaucomas are usually unilateral and 
caused by disorders of the iris, the lens, and retro-lenticular structures. Pupillary block is the 
most common mechanism of angle closure and is caused by resistance to aqueous humour 
flow from the posterior to anterior chambers at the pupil (Weinreb et al. 2014). Primary closed 
angle glaucoma may be chronic or acute but these are beyond the scope of this thesis and will 
not be reviewed. 
Secondary glaucomas are asymmetric or unilateral and associated with disorders that cause 
decreased aqueous humour outflow. Combined-mechanism glaucoma can appear in a patient 
with open-angle glaucoma who develops secondary angle closure from other causes but is 
uncommon (Lee & Fantes 2003). Open-angle glaucoma is classified as primary when no 
anatomically identifiable underlying cause of the events that led to outflow obstruction and 
IOP elevation can be found.  
A B 
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FIGURE 1.6-2 Classifications for open and closed angle glaucoma 
 
 PRIMARY OPEN ANGLE GLAUCOMA 
There is a lack of consistency in epidemiology research concerning a precise definition of 
POAG and criteria for its diagnosis (Kroese & Burton 2003; Bathija et al. 1998). This thesis 
will use the term POAG but consider literature which has used the terms chronic open angle 
glaucoma (COAG) and open angle glaucoma (OAG). The literature reviewed in this thesis 
will aim to use research which defines its criteria for POAG and COAG and if using the term 
OAG will have excluded any cases with secondary causes.  
 
GLAUCOMAS
OPEN ANGLE
PRIMARY/CHRONIC
PRIMARY OPEN 
ANGLE GLAUCOMA
NORMAL TENSION 
GLAUCOMA
JUVENILE
SECONDARY
PIGMENT DISPERSION 
SYNDROME
PSEUDOEXFOLIATON
UVEITIC
OTHERS
CLOSED ANGLE
PRIMARY
PRIMARY CLOSED 
ANGLE GLACOMA
SECONDARY
RUBEIOTIC
UVEITIC
OTHERS
 
23 
1.7.1 PRE-PERIMETRIC GLAUCOMA 
The term ‘pre-perimetric glaucoma’ (PPG) has been used to describe glaucomatous eyes that 
have glaucomatous optic nerve changes and/ or nerve fibre layer defect, yet have a no visual 
field defect caused by glaucoma. (Sawada et al. 2017). 
 
1.7.2 NORMAL TENSION GLAUCOMA 
Normal tension glaucoma (NTG) and (POAG) differ in IOP measurements. In NTG, IOP is 
consistently at or below 21.0mmHg yet as with POAG, the anterior chamber is open and there 
are glaucomatous optic nerve changes and a visual field defect (Shields 2008).  
 
1.7.3 OCULAR HYPERTENSION 
Ocular hypertension (OHT) is defined as consistently elevated intraocular pressure (IOP) 
(greater than 21.0mmHg in one or both eyes in the absence of clinical evidence of optic nerve 
damage, visual field defect or other pathology that could explain high IOP (College of 
Optometrists 2016). 
 
1.7.4 CLINICAL DIAGNOSIS 
Allocco et al. (2017) have suggested a critical pathway for the diagnosis and treatment of 
POAG. This pathway is useful for understanding how ocular hypertension, normal tension or 
open angle glaucoma may be diagnosed. The pathway has been adapted to reflect current 
NICE guidelines (2017) of referral for glaucoma suspects at 24.0mmHg and shown in Figure 
1.7-1.  
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FIGURE 1.7-1 Critical pathway for glaucoma diagnosis. (Adapted from Alloco et al. 2017) 
 
 EPIDEMIOLOGY 
Glaucoma was reported to be one of the top three causes of blindness in 2015 (Flaxman et al. 
2017). Quigley and Broman (2006) estimated that by 2020, 11.1 million people will be 
bilaterally blind from primary glaucoma. A systematic review affirms that Black populations 
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have the highest POAG prevalence from early middle life; (Friedman et al. 2004; Rudnicka et 
al. 2006). Age-specific increase in POAG prevalence is highest among White populations and 
Hispanic populations, followed by Asians and is lowered in Black populations (Kapetanakis 
et al. 2016). Although most people in the UK with a diagnosis of POAG do not go blind (Crabb 
2015), 1 in 20 treated people in the UK have a real lifetime risk of serious visual impairment 
(Saunders et al. 2014; Goh et al. 2011). 
 
1.8.1 PREVALENCE 
The prevalence of glaucoma can be defined as the proportion of people in a specified 
population who have the condition in a defined period (Rudnicka & Owen 2007). Tham et al 
(2014) predict that by 2040, there will be an increase of 75% in the number of people with 
glaucoma worldwide (aged 40 years to 80 years) The most current UK population study was 
set in Norfolk where the prevalence of glaucoma from all causes in those aged 48-92 year was 
4.2% (95% CI 3.8 - 4.6) (Chan et al. 2016). Specifically, for POAG, the prevalence found was 
3.7% (95% CI 3.3 - 4.0). This echoed findings from the meta-analysis by Tham et al. (2014), 
in which the prevalence of glaucoma (POAG and PACG) for Europeans aged 40-80years was 
2.93% (95% CI 1.85 - 4.40) and the prevalence of primary open angle glaucoma was 2.51% 
(95% CI 1.54 - 3.89). In another meta-analysis, published in 2006, the pooled prevalence of 
POAG in White people was 2.1% (95% CI 1.6 - 2.7) (Rudnicka et al. 2006).  
The Beaver Dam study considered the prevalence of OAG in the United States (Klein et 
al.1992). With no significant effect of gender, the overall prevalence of definite open-angle 
glaucoma was reported to be 2.1%.; the prevalence increased with age from 0.9% in people 
43 to 54 years of age to 4.7% in people 75 years of age or older (Klein et al. 1992). The studies 
mentioned highlight that glaucoma is a condition prevalent in an older population; however, 
research has not considered what age the earliest changes begin to occur.  
The Blue Mountains Eye study found a prevalence of 3.0% (95% CI 2.5 -3.6) of OAG with 
also an exponential rise in prevalence with increasing age (Mitchell et al. 1996). Ocular 
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hypertension was present in 3.7% (95% CI 3.1–4.3) of the population but with no significant 
age-related increase in prevalence. The age range was described as under 60 years to 80 years 
and over. There was no difference found between genders in the prevalence of ocular 
hypertension.  
 
1.8.2 RACE 
Prevalence increases proportionately with age for each racial group. Estimated prevalence in 
those older than 70 years of age was 6% in White populations, 16% in Black populations, and 
3% in Asian populations (Rudnicka et al. 2006). Black populations had the highest POAG 
prevalence at all ages but the increase in prevalence with age for POAG is steeper for White 
populations; increases with age in Black and Asian populations are similar (Rudnicka et al. 
2006; Cedrone et al. 2008). Friedman et al. (2004a) also reported that those in Black 
populations had almost three times the age-adjusted prevalence of glaucoma than those in 
White populations. 
 
1.8.3 INCIDENCE 
The incidence of glaucoma can be defined as the number of new cases occurring in a defined 
population over a specified period (Rudnicka & Owen 2007). Between 2008 and 2012, 
glaucoma/OHT prescriptions increased by approximately 3000 per 100,000 in England for 
patients aged above 40 years (Heng et al. 2016). This variation was reported to be due to age, 
western African diaspora ethnicity and male gender (Heng et al. 2016).  
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 RISK FACTORS OF PRIMARY OPEN ANGLE 
GLAUCOMA 
A ‘‘risk factor’’ describes features that may be causal in disease, as they are statistically 
associated with the disease, and were present before its occurrence, and could conceivably 
have played an ‘‘essential role’’ along with other factors in incident disease (Boland & 
Quigley 2007). Boland and Quigley (2007) categorise risk factors of POAG into individual 
characteristics such as age, gender, race and family history. Raised IOP, increased diurnal IOP 
variation, myopia and increased disc diameter are listed under ocular anatomy and physiology. 
Systemic conditions include thyroid conditions, sleep apnoea and migraine. Cortico-steroids 
also increase risk of POAG.  
 
 PATHOPHYSIOLOGY OF PRIMARY OPEN ANGLE 
GLAUCOMA 
The pathogenesis of glaucoma is not fully understood, but it is recognised that the level of 
intraocular pressure is related to retinal ganglion cell death (Weinreb et al. 2014). In 1990, 
Hernandez et al. described alterations in the extracellular matrix of glaucomatous human optic 
nerve heads, including the deposition of collagen IV and other molecules within the laminar 
pores. A similar deposition of collagen was noted in monkey eyes with experimental IOP 
elevation suggesting that IOP plays a causative role in producing the optic neuropathy of 
human glaucoma (Morrison et al. 1990; Burgoyne & Morrison 2001). Section 1.2.4 discussed 
the balance between secretion and drainage of AH that determines the intraocular pressure. In 
patients with OHT and OAG, there is much research to suggest that increased resistance to 
aqueous outflow through the trabecular meshwork may result in an impaired flow, but the 
underlying link remains unclear (Alvarado et al. 1984; Wang et al. 2017; Carreon et al. 2017). 
POAG patients have been shown to have structural differences in Schlemm’s canal diameter 
and trabecular meshwork than normal patients; this also being negatively correlated with 
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intraocular pressure (Yan et al. 2016). It is not known if there are congenital differences in 
intraocular pressure for those who develop glaucoma or if it has a process of change which is 
different from normal eyes from an early age. 
Intraocular pressure may cause mechanical stress and strain on the posterior structures of the 
eye; the lamina cribrosa is proposed to be the initial site of injury (Voorhees et al. 2017). The 
sclera is perforated at the lamina where the optic nerve fibres (retinal ganglion cell axons) exit 
the eye (Weinreb et al. 2014). Stress and strain to the lamina cribrosa is thought to result in 
compression, deformation, and remodelling leading to consequential mechanical axonal 
damage and disruption of axonal transport (Fechtner & Weinreb 1994; Burgoyne et al. 2005). 
Axonal transport damage interrupts delivery of essential trophic factors to retinal ganglion 
cells from their brainstem target (relay neurons of the lateral geniculate nucleus) (Weinreb et 
al. 2014). The time between IOP change being manifest to optic nerve alteration is not known. 
There is little information on glaucomatous eyes many years before diagnosis. Therefore, it is 
not known if slightly higher than average IOP over many years may cause constant mechanical 
stress on the optic nerve, thereby causing alterations. 
The blood flow of the optic nerve head is tightly controlled so that it can efficiently meet the 
demands of the retina, including the retinal ganglion cells (Chan et al. 2017). Studies have 
found that there may be narrowing of retinal vessel diameters in glaucoma (Mitchell et al. 
2005). The reasons for this has been proposed to be thinning of the RNFL (Kim et al. 2014). 
However, it has also been demonstrated that narrowing of retinal vessels may be a risk factor 
for development of POAG (Kawasaki et al. 2013).  
The biomechanical properties of the cornea may provide information regarding the 
development of glaucoma as they reflect how the eye responds to physical stress. Corneal 
hysteresis is a term used to describe measurement of the viscoelastic damping of the cornea. 
It is estimated by analysing corneal responses to deformation induced by an air pulse 
(Medeiros et al. 2013). This response of the cornea has been suggested to replicate how the 
optic nerve may also behave under certain stressors (Murphy et al.2017). The response of the 
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cornea to deformation may reflect the behaviour of the extracellular matrix, which may also 
reflect the composition of the lamina cribrosa and sclera and therefore be more affected by 
IOP damage (Medeiros et al. 2013).  
Normal tension ranges can also lead to glaucomatous optic neuropathy. In such patients, there 
are thoughts that there may be an abnormally low cerebrospinal fluid pressure in the optic 
nerve subarachnoid space resulting in a large pressure gradient across the lamina (Ren et al. 
2011). Other thoughts for the pathogenesis of glaucoma are impaired microcirculation, altered 
immunity, excitotoxicity, and oxidative stress (Weinreb et al. 2014).  
 
 GENETIC RISK FACTORS OF PRIMARY OPEN 
ANGLE GLAUCOMA 
There have been genes identified to have a role in POAG (Allingham et al. 2009; van Koolwijk 
et al. 2013; Weinreb et al. 2014). These are myocilin, optineurin and TANK-binding kinase 1 
(Monemi et al. 2005; Rezaie et al. 2002; Stone et al. 1997; Fingert 2011; Liu & Allingham 
2017). The genes listed are said to account for 5 to 10% of POAG cases in the general 
population (Kwon et al. 2009; Alward et al. 2003; Fingert et al. 1999; Hauser et al. 2006; 
Hewitt et al. 2006). Genetic effects have also been shown to account for a significant 
proportion of the variance in IOP, with heritability estimates ranging from 0.29 to 0.67 
(Carbonaro et al. 2008; Chang et al. 2009; Klein et al. 2004; Zheng et al. 2009).  
Disease-associated mutations of myocilin generally occur in the juvenile or early adult form 
of POAG, usually characterised by very high levels of intraocular pressure (Weinreb et al. 
2014). In populations of adults with POAG, the prevalence of myocilin mutations varies from 
3 to 5% (Kwon et al. 2009; Weinreb et al. 2014). Carriers of disease-associated mutations 
develop the glaucoma phenotype in approximately 90% of cases (Kwon et al. 2009; Weinreb 
et al. 2014). Although the mechanism of myocilin-related glaucoma is not fully known (Kwon 
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et al. 2009), it is said that mutations alter the myocilin protein in a way that disrupts normal 
regulation of intraocular pressure (Weinreb et al. 2014).    
In contrast to individuals with the myocilin gene, those with the optineurin gene have normal 
levels of intraocular pressure (Rezaie et al. 2002). There is evidence suggesting that optineurin 
may have a neuroprotective role by reducing the susceptibility of retinal ganglion cells to 
apoptotic stimuli (Weinreb et al. 2014).   
The genetic basis of POAG and IOP has been considered through genetic studies. These 
studies are beyond the remit of this thesis but suffice to say that as POAG is a complex disease, 
gene-finding studies give an ambiguous conclusion (van Koolwijk et al. 2013 Normative 
values of IOP have been reviewed in Section 1.3. However, we do not know if average IOP is 
different to those that have a family history of glaucoma.  
This chapter has covered the structure of the eye and these sections have aided in an 
understanding of glaucoma and its classification. The diagnosis of glaucoma in the UK will 
now be reviewed through current NICE guidelines with an overview of treatments. Following 
this, the assessments used for glaucoma screening and case-finding will be reviewed.  
 
 DIAGNOSTIC CRITERIA FOR PRIMARY OPEN 
ANGLE GLAUCOMA 
Current NICE guidelines (NICE 2017), advise that health professionals involved in case-
finding or diagnoses of POAG should be able to perform and interpret the following:  
• central visual field assessment using standard automated perimetry (full threshold or 
supra-threshold) (repeated on different occasions) 
• optic nerve assessment and fundus examination using stereoscopic slit lamp 
biomicroscopy (with pupil dilatation if necessary), and optical coherence tomography 
(OCT) or optic nerve head image if available 
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• intraocular pressure measurement using Goldmann-type applanation tonometry 
(repeated on different occasions) 
• peripheral anterior chamber configuration and depth assessments using gonioscopy 
or, if not available or the patient prefers, the van Herick test or OCT.  
Referral for further investigation and diagnosis of COAG and related conditions (after 
considering repeat measures) is made if: 
• there is optic nerve head damage on stereoscopic slit lamp biomicroscopy or 
• there is a visual field defect consistent with glaucoma or 
• IOP is 24.0mmHg or more using Goldmann-type applanation tonometry.  
The World Glaucoma Association (Weinreb 2016) have issued a preliminary report of the 
diagnosis of POAG  
Consensus statements taken from this report conclude that: 
• Clinical diagnosis of glaucoma is predicated on the detection of thinning of the retinal 
nerve fibre layer (RNFL), narrowing of the neuro-retinal rim, and deformation of the 
optic nerve head (ONH) (cupping).  
• Detecting progressive glaucomatous RNFL thinning and neuro-retinal rim narrowing 
are the best currently available good standards for glaucoma diagnosis. However, it is 
important to differentiate between age-related ONH change and disease-related 
damage. 
• The diagnosis of glaucoma does not require the detection of visual field defects with 
perimetry although perimetry is indispensable for documentation and monitoring of 
functional decline in glaucoma. 
• Assessment of the colour and the configuration (size and shape) of the neuro-retinal 
rim is important to differentiate glaucomatous from non-glaucomatous optic 
neuropathies.  
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• Optic nerve head (ONH) biomechanics, which are the physical manifestations of the 
IOP force distribution in the tissues, are important to glaucoma pathophysiology. 
Studies in patients and animal models of glaucoma have linked elevated IOP exposure 
and/or glaucoma to morphological changes in the lamina cribrosa and peripapillary 
sclera, and these changes are associated with axonal loss and/or visual field damage.  
 
 TREATMENT STRATEGIES  
Lowering intraocular pressure is the only modifiable treatment for glaucoma. Treatment is 
recommended in patients who are deemed at risk of progression of POAG within their lifetime 
(NICE 2017). Suggested reduction of IOP is approximately 30% for preservation of retinal 
ganglion cells and visual function (van der Valk et al. 2005; Garway-Heath et al. 2015; 
Karaskiewicz et al. 2017). This is achieved in the main through pharmacology treatments. The 
progressive nature of the pathology of POAG, offers an opportunity for therapeutic 
intervention (Pascale et al. 2012). Table 1.13-1 presents the groups of drug therapies that are 
used for lowering IOP.  
NICE recommends that treatment for OHT, suspect and COAG with a generic prostaglandin 
analogue. OHT and suspect COAG patients are offered beta-blocker and carbonic anhydrase 
inhibitor therapies if the initial line of treatment is unsuccessful. COAG patients are also 
offered a surgical treatment intervention prior to a different course of therapy (NICE 2017).   
A systematic review and meta-analysis (Li et al. 2016) found that all active first-line drugs 
were effective compared with placebo and that prostaglandins were more efficacious in 
lowering IOP at three months than beta-blockers, alpha-agonists, or carbonic anhydrase. 
Bimatoprost, latanoprost, and travoprost were among the most efficacious drugs. Li et al 
(2016) also reported that most trials did not measure or report visual field or other patient-
centred outcomes, such as visual function and blindness.  
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Selective laser trabeculoplasty (SLT) is a technique used to target pigmented trabecular 
meshwork cells with a laser (Latina & Park 1995). It is used as an alternative or in combination 
with medication and has been reported to have successful results in reducing IOP (Li et al. 
2015). As there are cost, compliance and adverse reactions involved with regular medication 
use, laser therapy has suggestion of improving quality of life (De Keyser et al. 2017). 
 
TABLE 1.13-1 Drug treatments for intraocular pressure reduction (Adapted from European Glaucoma 
Society 2017) 
CLASS COMPOUND MODE OF 
ACTION 
IOP REDUCTION 
Prostaglandin 
analogues 
Latanoprost  
Tafluprost  
Travoprost  
Increase in uveo-
scleral outflow 
25-35% 
Prostamide Bimatoprost  
Bimatoprost  
Increase in uveo-
scleral outflow 
25-35% 
Beta-receptor 
antagonists.  
Non-selective 
Timolol  
Levobunolol  
Metipranolol  
Carteolol  
Befunolol  
Decreases aqueous 
humour production 
20-25 % 
Beta-receptor 
antagonists.  
selective 
Betaxolol  Decreases aqueous 
humour production 
±20% 
Carbonic anhydrase 
inhibitors - topical 
Brinzolamide 
Dorzolamide  
Decreases aqueous 
humour production 
20% 
Carbonic anhydrase 
inhibitors - selective 
Acetozolamide  
Methozolamide  
Dichlorphenamide 
Decreases aqueous 
humour production 
 
30-40% 
Alpha-2 Selective 
Adrenergic Agonists 
Brimonidine 
Apraclonidine 
 
Decreases aqueous 
humour production 
and increases uveo-
scleral outflow 
25-35% 
 
 CLINICAL ASSESSMENTS FOR GLAUCOMA 
1.14.1 ANTERIOR CHAMBER ASSESSMENTS 
1.14.1.1 GONIOSCOPY 
Gonioscopy is a technique used to visualise the structures of the iridocorneal angle and 
observe any outflow obstruction (Scheie 1957). Gonioscopy is used readily as a tool in 
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glaucoma diagnosis as the anterior chamber can be examined but anterior segment imaging is 
also being used (Chansangpetch et al. 2018). 
The normal adult iridocorneal angle consists of five anatomical landmarks, from anterior to 
posterior. These are: Schwalbe’s line, anterior (nonpigmented) trabecular meshwork, 
trabecular meshwork, posterior (pigmented) trabecular meshwork, scleral spur and ciliary 
body band (Sundaram et al. 2016).  
Direct visualisation of the angle by changing the corneal refractive surface with a viewing lens 
(Koeppe’s lens) is a technique that is primarily used in the operating room as the patient is 
supine. Most commonly in a clinical setting, indirect visualisation is used and is accomplished 
using a mirrored lens and a slit lamp biomicroscope (Sundaram et al. 2016).  
1.14.1.2 LIMBAL ANTERIOR CHAMBER DEPTH 
Whilst gonioscopy remains the gold standard for evaluating the anterior chamber angle, it can 
also be evaluated using the van Herick method (or limbal anterior chamber depth – LACD) 
(Saeedi et al. 2014; Dabasia et al.2013). Van Herick described how LACD can be estimated 
at the slit lamp by directing a slit beam at the temporal limbus with the light source offset at 
60 degrees from the axis of the microscope and comparing the depth of the anterior chamber 
to the thickness of the cornea (Van Herick et al. 1969) (Figure 1.14-1). 
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FIGURE 1.14-1 Schematic diagram illustrating practitioner’s view during van Herick assessment. Diagram 
A presents a light directed at 60 degrees. Diagram B shows the cornea and iris. The depth of the gap in 
between these structures is compared to the width of the cornea. 
 
1.14.2  INTRAOCULAR PRESSURE ASSESSMENT 
In a clinical setting, measurement of intraocular pressure is achieved with a technique called 
tonometry. Tonometry has been used in eyecare practice since 1885 with first assessment 
being through indentation of the eye (Maklakoff 1885; Schiotz 1905). Applanation tonometry 
was first introduced in 1955 (Goldmann & Schmidt. 1957). Goldmann and Schmidt (1957) 
reported that in a “normal” eye, applanation tonometry with a diameter of flattened cornea 
between 3.0mm and 3.5mm would result in measurement of undisturbed intraocular pressure. 
At these diameters meniscus forces due to the tear film are vitiated by forces due to thickness 
and elasticity of the cornea (Stuckey 2004). This principle is based on the Imbert-Fick 
principle. The Imbert-Fick law postulates that for an ideal thin walled, dry sphere, the pressure 
within the sphere (P) is equal to the force needed to flatten its surface (F), divided by the 
applanation area (A), that is P=F/A (Garcia-Feijoo et al. 2015). Goldmann tonometry is 
accepted as the standard instrument and all current tonometers are calibrated against it 
(Stuckey 2004).   
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The Goldmann tonometer is used as an accessory to a slit lamp biomicroscrope, although there 
is a portable handheld version called the Perkins tonometer. (An anaesthetic and fluorescein 
stain are instilled in the tear film before a bi-prism probe is rested on the centre of the cornea 
(Figure 1.14-3). The tonometer is adjusted to obtain a view of a horizontal “S” shape which is 
achieved when 3.06mm of the central cornea has been applanated. The Perkins tonometer 
yields IOP measurements that are closely comparable with Goldmann applanation tonometry 
(Arora et al. 2014). Portable electronic applanation is also available and recognised under 
names such as Tono-pen.  
 
  
FIGURE 1.14-2 Photograph to demonstrate Goldmann applanation tonometry. 
 
Non-contact tonometry uses air as the applanation force. At the point of flattening 3.06mm 
diameter of the cornea, a weak laser beam generated from the side, is reflected into a sensor 
located on the other side of the eye. The force at the moment of applanation is recorded and 
the value displayed in millimetres of mercury (Stamper 2011). Non-contact tonometry is often 
used for screening purposes as it does not use anaesthetic or a stain. The measurement 
achieved by non-contact tonometry gives a snapshot of IOP (Stamper 2011). Non-contact 
tonometers are table mounted or handheld.  
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Rebound tonometry has two co-axial coils which are used first to propel a lightweight 
magnetized probe toward the cornea and then to detect its deceleration when it bounces back 
off the cornea (Garcia-Feijoo et al. 2015). Among all variables linked to the probe’s 
movement, the inverse of the deceleration velocity correlates best with IOP (Martinez-de-la-
Casa et al. 2005). Rebound tonometry does not require topical anaesthesia or a stain. Icare 
products are the only instrument to date that use rebound tonometry and variability has been 
shown in its accuracy. (Chalkidou et al. 2016). However, the benefits are that is a handheld 
portable device that can be used in adults and children of all ages.  
Other types of tonometry that are known are the dynamic contour tonometry (DCT) and 
Ocular Response Analyser (ORA). These are not routinely used in community optometric 
practice and will not be covered in this thesis. Two devices used to monitor 24-hour IOP and 
not in optometry practice will also not be reviewed. These are the Triggerfish Contact Lens 
Sensor and the Implandata EyeMate.  
 
1.14.3 REVIEW OF TONOMETRY TECHNIQUES 
Accurate intraocular pressure (IOP) measurement has an important role in diagnosis and 
follow-up of patients with glaucoma (Kouchaki et al. 2017). A meta-analysis review of the 
agreement of tonometers with Goldmann tonometry showed that non-contact tonometry 
showed the least amount of variability with Goldmann; this included handheld non-contact 
instruments. Results showed that approximately two-thirds of measurements from non-contact 
tonometers were within 2.0mmHg of Goldmann tonometry measurements (Cook et al. 2012). 
This also implies that on average one third of intraocular pressure measurements are not 
reliable, by the 2.0mmHg criterion. Using data from the Blue Mountains Eye Study, Turner et 
al. (2013) showed that 34% of individuals with ocular hypertension (OHT) would be missed 
using a tonometer that underestimated IOP by 1.0mmHg and approximately 3% of the 
population would be falsely diagnosed if screening tests occur using a tonometer that over-
read by 1.0mmHg. Cook et al. (2012) also reported that reliability between tonometers was 
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substantial but variability between repeat measurements was non-negligible. Thus, suggesting 
that consistent use of the same tonometer during clinical follow-up is arguably almost as 
important as the choice of tonometer (Cook et al. 2012).  
NICE (2017) reviewed the accuracy of tonometers for diagnostic test accuracy and 
reassessment. They reported that “when assessing the evidence from a diagnosis and 
reassessment perspective, all the evidence was of low to very low quality based largely on the 
uncertainty around the sensitivity estimates, all of which failed to reach the pre-specified 
threshold for consideration of a non-contact test used in the diagnosis and reassessment 
context”. NICE (2017) recommend the use of Goldmann applanation tonometry for suspect 
glaucoma cases.  
Efforts to achieve accuracy for intraocular pressure measurement are paramount for correct 
diagnosis but accuracy is also important for self-monitoring of intraocular pressure which may 
become a regular regime for patients who are suspect or diagnosed with glaucoma.   
 
1.14.4 PACHYMETRY 
Central corneal thickness is measured using a technique called pachymetry. Pachymetry 
methods use slit-lamp based devices, optical/laser based pachymetry, ultrasound or optical 
coherence topography methods.  
Goldmann tonometry is effective for an average corneal thickness of 520µm measured by 
pachymetry (Iester et al. 2009). Central corneal thickness has been shown to vary between 
races; Caucasian, Chinese, Hispanic and Filipino eyes have comparable CCT values compared 
to a Black population in which they are significantly thinner (Aghaian et al. 2004). Central 
corneal thickness has shown to be associated in glaucoma progression in patients with higher 
baseline IOP compared to those with lower baseline IOP (European Glaucoma Prevention 
Study et al. 2007). 
Goldmann tonometry measurements are often corrected for CCT and published formulae are 
available, however conversion is not recommended (Ehlers et al. 1975; Doughty and Zaman 
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2000). Available formulae to correct IOP measurements have not demonstrated an 
improvement for the accuracy of prediction models for development of glaucoma (Brandt et 
al. 2012; Medeiros &Weinreb 2012). Non-contact tonometers also give corrected IOP values. 
Rebound tonometry measurements have been shown to be overestimated in eyes with thicker 
corneas and underestimated in eyes with thin corneas (Brusini et al. 2006).  
 
1.14.5  ASSESSMENT OF THE OPTIC NERVE 
Glaucoma is an optic neuropathy and it is therefore paramount that the optic nerve is assessed.  
To characterise optic nerve damage, optometrists are practiced at assessing the cup-to-disc 
ratio and neuro-retinal rim (Varma et al. 1992a). Both parameters are dependent on the size of 
the optic nerve. An increase in optic nerve head cupping is a sign of loss of neuro-retinal rim 
tissue, and perhaps the most specific sign of glaucomatous optic neuropathy (Anderson 1983). 
A glaucomatous optic nerve head is shown in Figure 1.14-4. More recently, the disc damage 
likelihood scale (DDLS) has been devised for assessment of the optic nerve (Spaeth et al. 
2002). This is a technique which is based on the neuro-retinal rim width for a given disc 
diameter (Henderer 2006).     
Optometrists regularly examine the optic nerve using a direct ophthalmoscope or indirect 
ophthalmoscopy. Fundus biomicroscopy is preferred to direct ophthalmoscopy because 
assessment of size of the cup-to-disc ratio (CDR) is more accurate under stereoscopic 
conditions (Mwanza et al. 2017; Varma et al. 1992b; Watkins et al. 2003).  However, 
comparison of serial stereoscopic optic disc photographs are considered the gold standard for 
assessing glaucoma progression (Mwanza et al. 2017 Kass et al. 2002; Leske et al. 1999; 
Medeiros & Weinreb 2009; Nicolela et al. 2003).  
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FIGURE 1.14-3 Pictorial image of a normal optic nerve head (top 
image) and a glaucomatous optic nerve head. in the top image, the 
neuroretinal rim has a normal shape in that its widest part is the 
inferior region, followed by the superior region and the nasal region, 
followed by the temporal region (ISNT). in the lower picture, the 
glaucomatous optic nerve has a neuroretinal rim which is thinner and 
the optic cup is larger and the cup is deeper.  
 
 
 
 
 
 
 
1.14.6 ASSESSMENT OF THE RETINAL NERVE FIBRE 
LAYER 
There is a topographical relationship between the location of glaucomatous visual field loss 
and RNFL damage in glaucoma eyes (Hoffmann et al. 2006). The thickness of RNFL also 
been shown to be different between ocular hypertensive, glaucomatous and normal eyes 
(Bowd et al. 2001; Hammel et al. 2017; Miki et al. 2014; Weinreb et al. 1995). The RNFL can 
be assessed with slit-lamp biomicroscopy, fundus photography or imaging modalities 
(Blumenthal & Weinreb 2001).  
 
1.14.7 IMAGING 
Technology has allowed for development of imaging that can quantify the structure of the 
retina and optic nerve. Automated imaging technologies are readily used in adjunction to an 
ophthalmologists/optometrists’ assessment (Banister 2016). Clinical biomicroscopic 
examinations of the optic nerve yield a true view and may reveal glaucomatous features that 
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are not visible with computer-generated images but similarly the imaging techniques now give 
clinicians information not visible on direct observation. Examples of imaging instruments are: 
Confocal scanning laser ophthalmoscopy, which is commercially available as Heidelberg 
retina tomograph (HRT); it includes two classification algorithms (the Moorfields regression 
analysis (MRA) (Wollstein et al. 1998) and the glaucoma probability score (GPS) (Coops et 
al. 2006). Scanning laser polarimetry (Glaucoma Diagnostics (GDx) (Garas et al. 2012) or 
spectral-domain optical coherence tomography (OCT) (Sehi & Iverson 2013) techniques are 
used readily to assess the retinal nerve fibre layer.  
 
 ASSESSING THE VISUAL FIELD 
Perimetry is the term used for measurement of a person's field of vision. Many perimeters 
record visual light sensitivity in terms of the decibel (dB), which is a unit to quantify retinal 
light sensitivity (Rudnicka & Edgar 2007). Perimetry evaluates the retina and the neural 
pathways responsible for relaying information from the retinal to the higher centres of the 
brain (Henson 2000). Examination strategies can broadly be divided into kinetic and static. 
Static tests can be divided into threshold and suprathreshold (Henson 2000).   
 
1.15.1 KINETIC EXAMINATION STRATEGIES 
For kinetic examinations, the examiner selects a stimulus of a given size and intensity and 
moves it from outside the visual field towards its centre, noting the position at which it first 
becomes visible (Henson 2000). This is repeated along a series of different meridians and the 
points at which the stimulus first became visible are then joined together by a line which is 
called an isopter (Henson 2000). A depression or loss within the visual field (scotoma) is 
detected by continuing to move the stimulus towards the centre of the visual field after it has 
first been detected (Henson 2000). The whole process can be repeated with stimuli of differing 
size and/or intensity, to build up a map of the patient’s visual field (Henson 2000). Kinetic 
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perimetry is normally conducted with a bowl perimeter or tangent screen, such as the 
Goldmann bowl perimetry and the Bjerrum tangent screen (Henson 2000).   
 
1.15.2 STATIC EXAMINATION STRATEGIES 
Automated perimetry has been the clinical standard of care since the mid-1980s (Heijl et al. 
2012). Suprathreshold tests are when stimuli are presented at an intensity that is calculated to 
be slightly higher than the patient’s threshold and it is recorded whether the stimuli are seen 
(Henson 2003). The suprathreshold examination strategy has largely been developed as a 
screening/case finding procedure for conditions such as glaucoma (Henson 2000). The 
threshold strategy is technique in which the stimulus threshold is estimated at a series of 
different locations (Henson 2000). Automated perimetry may use a static target (standard 
automated perimetry) or a technique called frequency doubling technique (FDT). FDT is 
based on the frequency-doubling illusion which occurs when a sinusoidal grating at a low 
spatial frequency, flickers at a high temporal frequency (Jung et al. 2017). 
 
 SUMMARY 
This section has provided information on the classification of glaucoma and its epidemiology. 
Pathogenesis, screening and treatment measures have also been reviewed with focus on 
POAG, NTG and OHT. There is ambiguity in knowledge of the pathogenesis of glaucoma. 
Age related changes occur in IOP but it is not known if there are people who always have 
slightly higher IOP than the average and therefore more at risk of optic nerve change. 
Normative values of average intraocular pressure in younger adults are not known, nor is it 
known if those with a family history have higher average measurements. It is also not known 
how many years prior to glaucoma diagnosis, that IOP and the optic nerve begin to change. 
The literature reviewed thus far reports that there are people who may be more at risk of POAG 
but is unable to provide information how early changes are detectable in those who are at risk. 
Chapter 1 has been an introductory review of literature to form a rationale for a formal 
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literature review on the risk factors of POAG. The literature review will be the basis for the 
aims and objectives of this thesis.  
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 LITERATURE REVIEW 
 AIMS OF LITERATURE REVIEW 
The introductory chapter has provided an overview of the eye and the structures involved in 
glaucoma. The aims for this literature review are to investigate the risk factors for primary 
open angle glaucoma. The literature will be critically appraised using the Critical Appraisal 
Tools by CASP (2017).   
 
 LITERATURE SEARCH 
The literature searches for this thesis were conducted from November 2012 to November 2017 
using PubMed, Cochrane Library and Google-scholar databases. Ophthalmology and 
optometry text books were used for background reading. Publications written in English were 
reviewed from 1967. Alerts were set using the terms open angle glaucoma, pathogenesis and 
intraocular pressure for Google and Mendeley. The “related citations” option in PubMed was 
also used to capture additional articles. The search strategy used the following terms: 
• Open angle glaucoma and risk factors 
• Open angle glaucoma and intraocular pressure 
• Ocular hypertension and intraocular pressure 
• Intraocular pressure and normal 
• Open angle glaucoma and family history 
• Open angle glaucoma and pathogenesis 
• Open angle glaucoma and visual field 
• Open angle glaucoma and optic nerve 
• NICE Guideline and glaucoma 
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 RESULTS OF THE LITERATURE SEARCH 
Pubmed and googlescholar presented approximately 4000 research papers on glaucoma and 
risk factors. These were screened and refined to approximately 650 papers. The literature was 
screened by the suitability of the title and abstract. Key epidemiological studies, NICE 
guidelines and the European Glaucoma Society were also used to search for papers. Studies 
that were based in the Far East were not included as there is an indication that the prevalence 
of glaucoma is different in Asia as compared to Europe and the Americas (Chan et al. 2015).  
 
 RISK FACTORS FOR PRIMARY OPEN ANGLE 
GLAUCOMA 
Literature has shown that the key risk factors associated with POAG are age, gender, race, 
family history, myopia, IOP, corneal biomechanics and systemic factors. These will each be 
reviewed in turn.  
 
2.4.1 AGE 
Observation studies and randomised controlled trials give evidence for the contribution of 
increasing age in the incidence and prevalence of glaucoma (Leske et al. 1995; Ekström 2012; 
Gordon et al. 2002; Le et al. 2003; Mukesh et al. 2002; Miglior et al. 2007).  
Three population studies have shown an increase in incidence of POAG with age. A five-year 
study based in Australia reported that there was an incremental change in incidence of OAG 
from 0.2% at the ages of 40-49 years to 5.4% at ages 80 and over (Le et al. 2003; Mukesh et 
al. 2002). This study did not report any specific race differences in the participants. A specific 
definition for OAG was also not given and therefore it is assumed that open angle glaucoma 
due to secondary causes (e.g. pigment dispersion syndrome or pseudo exfoliation) may have 
been included in this study (Figure 1.6-2). Similar results were reported by the Rotterdam 
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Study (Dielemans et al. 1994). This was a five-year prospective cohort study investigating the 
prevalence of POAG. Increasing age changed prevalence from 0.2% at the ages of 55-59 years 
to 3.3% at ages 85-80 years. A longer, 20-year population study based in Sweden (Ekstrom 
2012) used diagnostic criteria published by Foster (2002) and distinguished POAG and 
secondary OAG in their analyses. However, the increase risks in OAG with age were reported 
collectively for both groups. It was reported that participants from 70 years and older 
experienced a 1.21-3.22 (95% CI) increased risk compared with those under the age of 70 
years (Ekstrom 2012). The Barbados Eye Study (Leske et al. 1995) was a population based 
study for pre-dominantly Black participants between the ages of 40 and 84 years. The study 
found that 7% of the group had OAG and this group were of an older age; the mean age of the 
group without OAG was 57.8 + 11.8 years and the mean of the OAG group was 69.2 + 10.4 
years.  
A randomised control trial was conducted by the European Glaucoma Prediction Study 
(EGPS) (Miglior et al. 2007). Participants with IOP greater than 22.0mmHg in one eye were 
placed on a double-masked placebo trial to research conversion to OAG. The EGPS study also 
found that age was “significantly predictive” for the development of OAG. Interestingly, 
considering current NICE guidelines, referral for consideration of treatment would be 
considered only if IOP was 24.0mmHg or greater if the optic nerve and visual fields were 
healthy.  
A meta-analysis of 46 observational studies (Rudnicka et al. 2006) reported that although 
black populations had the highest OAG prevalence at all ages, the increase in prevalence of 
OAG with age was highest in White populations.  
Changes at the trabecular meshwork and retina are two of the suggested reasons why the risk 
of glaucoma may increase with age.  
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2.4.1.1 TRABECULAR MESHWORK 
Morphologic studies have shown that trabecular meshwork dysfunction may result in an 
increase in intraocular pressure and thereby increase the risk of glaucoma (Chhunchha et al. 
2017). The reasons for these changes may be that a natural decrease of the cellularity of the 
trabecular meshwork with age results in a decrease in outflow (Alvarado et al. 1980; Grierson 
& Howes 1987) or pathological alterations (Gabelt & Kaufman 2005).  
 
2.4.1.2 RETINA 
Ageing shows an accumulative change in the structure of the retinal layers. People of 
increasing age show a loss in retinal vessel density and thinning of the retinal nerve fibre layer 
and ganglion cell and inner plexiform layer (Wei et al. 2017; Hammel et al. 2017). In contrast 
to the reduction in the inner retinal layers, thickening of the outer plexiform layer and 
photoreceptor layer have been reported (Wei et al. 2017) with increasing age. The rate of 
change in the retinal layers has been reported to be faster in glaucoma subjects (Hammel et al. 
2017).  
 
2.4.2 GENDER 
Literature on the risk of POAG being different for males and females showed varying results. 
The Beaver Dam Eye Study (Klein et al. 1992) was a population study that did not find a 
gender difference with the prevalence of OAG. Rudnicka et al. (2006) reported from their 
meta-analysis that OAG is more common in men than in women across all racial groups but 
included only two studies in their analysis for this. Kapetanakis et al. (2016) and Chan et al. 
(2016) reviewed POAG cases and both reported that age-adjusted prevalence of POAG is 
higher in males compared with females and that this remains consistent across all ethnic 
groups.  
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2.4.3 RACE 
A population based prevalence study of POAG in Baltimore, estimated the prevalence to be 
up to five times higher in the Black race as compared to White (Tielsch 1991). Kapetanakis et 
al. (2016) summarised in their systematic review that Black populations have a higher 
prevalence of POAG from early middle life. An evidence-based review of population studies 
reported that being of Black race if not an independent risk factor but the Black race have 
thinner corneas, greater cup-to-disc ratios and higher IOP; it is these factors that may increase 
the risk of POAG (Friedman et al. 2004). 
A recent case-control study conducted with a South African population, reported that 
participants with a higher proportion of genetic African ancestry had a thinner CCT and 
African ancestry also had a higher IOP in POAG participants (Bonnemaijer et al. 2017). But 
the study also found that as the proportion of ancestry got stronger, the difference in CCT 
between POAG and controls lessened. The authors reported that knowing the strength of the 
racial link is important (Bonnemaijer et al. 2017). This study had defined inclusion criteria 
and POAG diagnostic criteria.  
The prevalence of POAG with race changes with age. Age-specific increase in POAG are 
higher amongst White and Hispanic populations in later life, followed by Asians and lowest 
in the Black population (Rudnicka et al. 2006; Kapetanakis et al. 2016).  
 
2.4.4 FAMILY HISTORY OF PRIMARY OPEN GLAUCOMA 
This section will review the risk of POAG with a positive family history. Hereditary forms of 
glaucoma can arise from environmental, gene-environment, and also gene-gene interactions 
(Doucette et al. 2015). Inheritance can also be as a Mendelian trait; this has been discussed in 
section 1.11. Kass and Becker (1978) reported a correlation between family history and 
glaucoma; based on their observations, researchers suggested that the most effective method 
of glaucoma detection was to check family members (Samples 2010). Prevalence studies have 
shown the association between POAG and a positive family history.  
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Rosenthal and Perkins (1985) conducted a 10 to 12 year follow up of 101 participants with a 
family history of POAG. Confirmed POAG had developed in 3% of the group, while an 
additional 6% were diagnosed as suspect POAG.  
The Baltimore Eye Survey (Tielsch et al. 1991) was a cluster sample survey of 5000 
participants (2500 White participants and 2500 Black participants). The ages of the 
participants subjects were 40 years and greater.  POAG was diagnosed by optic nerve and 
visual field assessment but IOP was not included as part of the diagnostic criteria (Sommer 
1996). The age-adjusted association between POAG and family history was shown to be 
stronger when the affected relative was a sibling (OR 3.7 95% CI 2.1-6.5), rather than a parent 
(OR 2.2 95% CI 1.1-4.4) or child (OR 1.1 95% CI 0.3-4.9) (Tielsch et al. 1994). These results 
suggest that a polygenic or multifactorial influence contributes to the expression of POAG 
(Lichter 1994). The Baltimore Eye Survey may have included secondary glaucoma cases 
within its sample. This study is based on a single observation whereas a clinical diagnosis 
basis a diagnosis on structural change of the optic nerve and/or functional change of the visual 
field.  
The absolute and relative risk of primary open glaucoma of first degree relatives was assessed 
through a population-based study in Rotterdam (Wolfs et al. 1998). The minimum age of the 
glaucoma cohort was 44 years. The results were for lifetime risk of elevated pressure in those 
participants with a family history of glaucoma was reported to be 6.3 (95% CI 2.1-19.2). 
Lifetime risk of enlarged CDR was 3.8 (95% CI 2.3-6.1). The study concluded that the lifetime 
risk of glaucoma at 80 years was 22.0% for relatives of participants with glaucoma compared 
to 2.3% of the controls (OR 9.2 95% CI 1.2-7.3).  (Wolfs et al. 1998).  An enlarged cup to 
disc ratio was the earliest feature of change reported in those with a family history of glaucoma 
(Wolfs et al. 1998).   
A case-control study carried out to compare the differences between POAG participants and 
controls in Caucasians over the age of 40 years, found that a family history of glaucoma in 
first degree relatives had an OR of 7.67 (95% CI 3.25-18.1) (Charliat et al. 1994). The risk 
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factors were determined by means of a questionnaire and therefore may not have been accurate 
or confirmed.  
The Glaucoma Inheritance Study based in Tasmania (Green et al. 2007) was ethnically 
homogenous. POAG was found in 60% of the participants who had a family member: 38.6% 
had a first-degree relative affected, 6.5% had a second-degree relative affected, 6.1% had a 
third-degree relative affected, and 8.4% had a fourth-degree relative affected (Green et al. 
2007). The odds ratio for having a participant with POAG to have a positive family history 
was stated to be and 4.1 (95% CI 3.2–5.2) (Green et al. 2007). A similarly designed study was 
the Nottingham Family Glaucoma Screening Study (Sung et al. 2006). This study found the 
prevalence of OAG (POAG, NTG and OHT) to be 11.8% in siblings (Sung et al. 2006). These 
results are similar for those found for siblings in the Rotterdam Study and the Baltimore Eye 
Survey.   
A positive family history of POAG is not a simple risk factor (Boland & Quigley 2007). More 
often, cases of POAG are a combined effect of genetics and environmental risk factors (Fingert 
2011). This section has reviewed the population studies for the prevalence of POAG in family 
members and will discuss the difference in optic nerve and intraocular pressure in family 
members under each individual section.  
 
2.4.5 REFRACTIVE ERROR 
A systematic review on the risk factors of glaucoma that can be assessed in a routine eye 
examination presented that myopia is associated with POAG (Hollands et al. 2013). Moderate 
myopia was defined as 3 to 6 dioptres, high myopia was defined as 6 to 8 dioptres, and 
pathologic myopia is defined was greater than 8 dioptres (Hollands et al. 2013). This review 
considered minimal studies but found four studies that reported that at a threshold of 3.0 
diopters the prevalence of glaucoma was 6.0% (OR 2:1 95% CI 1.3-3.4). Hollands et al. (2013) 
also reported that compared to other all other risk factors of glaucoma, one study had reported 
high myopia to have the strongest odds ratio (OR 5.7 95% CI 3.1-11). Findings from a meta-
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analysis also reported myopia to double the risk of OAG in comparison to individuals without: 
pooled OR were 2:46 (95% CI 1.9-3.2) for high myopia (greater than 3 dioptres) and 1.77 
(95% CI 1.4-2.2) for low myopia (up to 3 dioptres) (Marcus et al. 2011). The standard 
deviations in the latter meta-analysis were narrowly spread compared to a wide range of risks; 
(Poostchi et al. 2012) report that this variation in the risk of glaucoma in individuals may 
reflect true differences between study populations. Poostchi et al. (2012) performed a 
regression analysis of the cross-sectional studies selected by Marcus et al. (2011) and found a 
50% increase in risk between those with low and high myopia (OR 1.5 95% CI 1.0-2.3).  
A large Swedish population study with participants aged between 57 years and 79 years 
reported that glaucoma was more prevalent in myopic eyes with lower IOP (Grodum et al. 
2001). Interestingly, the inclusion criteria included localised narrowing of the optic disc rim, 
vertically elongated cupping, localised RNFL defects and IOP over 25.0mmHg. This study 
was also based on undiagnosed glaucoma from a direct assessment rather than detection of 
change.  
The susceptibility of POAG in people with myopia has also been reported in other population 
studies such as the Blue Mountains Eye Study (Mitchell et al 1999) and the Barbados Eye 
Study (Wu et al 1999). However, the OHTS (Gordon et al. 2002) did not find myopia to be a 
baseline predictive factor for POAG development.  
 
2.4.6 INTRAOCULAR PRESSURE  
Increased intraocular pressure was previously considered to be a diagnostic feature of POAG, 
but this is now best described as a modifiable risk factor (Sommer 1989). It is the only risk 
factor that is modifiable with medication or surgery (Morrison et al. 1998). With current NICE 
guidelines (NICE 2017), IOP at 24.0mmHg is the level required for referral for assessment if 
there is no other pathological change.  
Literature readily shows that the level of IOP is a risk factor for POAG incidence, prevalence 
and progression (Boland & Quigley 2007). The literature on IOP will be considered in three 
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parts: the risk of POAG with higher baseline IOP; the progression of POAG with treated IOP 
and lastly IOP asymmetry and diurnal variation.  
 
2.4.6.1 RISK OF PRIMARY OPEN ANGLE GLAUCOMA AND INTRAOCULAR 
PRESSURE 
The Rotterdam study showed that a higher level of baseline IOP led to a higher risk of incident 
OAG in a pre-dominantly white population over the age of 55 years (de Voogd et al. 2005). 
The Ocular Hypertension Study (OHTS) was a multicentre-randomised control trial on the 
use of IOP lowering drops for the prevention of POAG (Gordon et al. 2002). The number of 
participants that developed glaucoma had increased with higher IOP levels. The results 
showed that 17% of the control group that progressed to develop POAG had a mean IOP of 
22.2mmHg; 12% had a mean IOP of 24.9mmHg and 36% had an IOP of 27.9mmHg; all these 
participants were reported to have a central corneal thickness of 555µm or less.  
 
2.4.6.2  GLAUCOMA PROGRESSION AND INTRAOCULAR PRESSURE 
The progression of open angle glaucomas (including secondary causes) have been investigated 
through four multi-centred randomised clinical trials (Coleman & Miglior 2008). These trials 
are the Collaborative Normal Tension Glaucoma Study (CNTGS 1998), the Advanced 
Glaucoma Intervention Study (AGIS) (Gaasterland et al. 2000), the Early Manifest Glaucoma 
Trial (EMGT) (Leske et al. 1999) and the Collaborative Initial Glaucoma Treatment Study 
(CIGITS) (Musch et al. 1999). All participants on these trials had OAG. Coleman and Miglior 
(2008) suggest that these studies report predictive factors rather than prognostic factors as 
factors associated with endpoints or outcomes were not eliminated. These trials were 
conducted prior to 2008 when glaucoma specialists held a symposium to discuss glaucoma 
endpoints and outcomes (Weinreb & Kaufman 2009). Endpoint and outcome measures should 
be considered with optic nerve parameters and/or visual field indices (Coleman & Miglior 
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2008). These endpoints are objective and do not reflect the impact of the changes on quality 
of life (Hartmann & Rhee 2006; Vandenbroeck et al. 2011).  
The CIGITS (Musch et al. 1999) had a participant group of newly diagnosed glaucoma 
patients. Most of these participants had POAG. Visual field change was monitored in two 
groups; one group treated with medication and a second through surgery. Each group had an 
initial IOP of approximately 27.0mmHg which was reduced to 14.0 to 18.0mmHg. Over a 
period of five years, little change had been noted on visual field outcome (Musch et al. 1999). 
The CIGITS lowered IOP by 50 % and report that as there was a substantial reduction, it may 
take longer to show any functional change (Musch et al. 1999). It has also been a suggestion 
that a 30% reduction in IOP can also be effective in decreasing the rate of visual field loss 
(Anderson 2003; Heijl et al 2002). The Early Manifest Glaucoma Treatment Study (EMGTS) 
lowered IOP by an average of 25% in a sample that contained participants with baseline 
pressures of up to 29.0mmHg. The EMGTS demonstrated that IOP-lowering treatment 
significantly delayed disease progression in patients with normal tension glaucoma and in 
those with higher IOP (Heijl 2002). 
A major outcome for the AGIS was the stability or progression of visual fields as related to 
IOP control after the initial intervention (AGIS Investigators. 2000; Nouri-Mahdavi et al. 
2004). The participants who had an IOP of less than 18.0mmHg for all visits over the first six 
years were least likely to show worsening. A lower mean IOP during the 18 months after the 
initial intervention also predicted a better functional outcome (AGIS Investigators. 2000; 
Nouri-Mahdavi et al. 2004).  
Caprioli (2007) stated that the benefits of IOP reduction have been considered using 
prospective, randomised, long-term studies, a comparison of medical versus surgical and 
treatment versus no treatment. These study designs have shown that the progression of 
glaucoma is reduced with robust IOP reduction (Caprioli 2007). 
This review will now follow on to discuss the risks of IOP asymmetry and fluctuation.  
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2.4.6.3 INTRAOCULAR PRESSURE ASSYMETRY  AND FLUCTUATION 
IOP measurements can fluctuate. This fluctuation may also be asymmetric. The term “short-
term IOP fluctuation” can indicate what occurs over hours or days and “long-term IOP 
fluctuation” to indicate what occurs over months to years (Caprioli 2007). Caprioli (2007) 
states that “IOP investigation is best suited to standard deviation as it is less affected by 
outliers and takes the number of measurements into account”. Asymmetry between eyes with 
IOP measurements in normal tension glaucoma has been shown to lead to greater optic nerve 
head damage; the eye with the higher IOP has the greater damage (Collaborative Normal-
Tension Glaucoma Study Group 1998).  
The Advanced Glaucoma Intervention Study (Nouri-Mahdavi et al. 2004) used stability or 
progression of visual fields as an outcome to measure predictive measures for OAG. The study 
used single method long term evaluation and point-wise regression analysis. It was suggested 
that the most consistent predictors for visual field progression were older age and inter-visit 
IOP fluctuation. The odds for visual field progression increased by approximately 30% for 
each 1.0mmHg increase in IOP fluctuation and 5-year increment in age (Nouri-Mahdavi et al. 
2004). Lee et al (2007) conducted a retrospective analysis of data from 150 subjects over the 
age of 18 years with POAG, NTG, OHT and glaucoma suspects. Their records were 
investigated for a variation between intraocular pressure and glaucoma progression over a 
period of 12 years (minimum 5 years). This study showed through multivariate analysis, that 
with each 1.0mmHg increase in standard deviation of IOP, glaucoma progression was 4.2 
times more likely (Lee et al. 2007). The results of that analysis supported the AGIS data 
(Gaasterland et al. 2000) with suggestion that IOP variation between visits was a significant 
predicator of disease progression.  
 
2.4.7 CORNEAL THICKNESS 
Corneal thickness has also been implicated as an independent risk factor for the development 
of glaucoma (Sng et al. 2016). The OHTS demonstrated that thinner central corneal thickness 
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(CCT) may be an important predictive factor for the development of POAG in both univariate 
and multivariate models (Gordon et al. 2002). In participants who had ocular hypertension 
that went on to develop POAG, mean CCT was reported to be 553µm + 38.8µm compared to 
573.4µm + 37.8µm to the control group that did not have OHT. It was discussed in Section 
2.4.3, that literature has reported a higher prevalence of POAG in the Black population. The 
OHTS supported the evidence by Friedman et al. (2004) in reporting that the Black 
participants in the study had thinner CCT and larger baseline vertical CDR from baseline and 
that when multivariate analyses adjusted for these factors race was no longer a statistically 
significant predictor (Gordon et al. 2002).  
CCT has not only been implicated as a risk factor for development of visual field loss among 
patients diagnosed with OHT but it has also been suggested that it may constitute as a risk 
factor for progression of visual field loss amongst patients with pre-perimetric glaucoma 
(Medeiros et al. 2003). 
Corneal hysteresis was described in Section 1.2.1. The risk factor of a lower corneal hysteresis 
measurement and an increased risk of glaucoma progression have been inconclusive. Studies 
have shown that there is a difference in corneal hysteresis and POAG but it is not known if 
this is due to ageing or if the association is a cause or an effect (Medeiros et al. 2013; Congdon 
et al. 2006; Moraes et al. 2012; Khawaja et al. 2014).   
 
2.4.8 OPTIC NERVE HEAD 
Section 1.10 has reviewed that common features of glaucoma are loss of retinal ganglion cells, 
thinning of the retinal nerve fibre layer, and cupping of the optic disc (Jonas et al. 2017). 
Structural changes to these features are used to detect and monitor progression of glaucoma 
(Seth et al. 2017).  
The European Glaucoma Prevention Study (EGPS Group et al. 2007), reported that larger 
vertical CDR and larger vertical CDR asymmetry, were statistically significant predictive 
factors for development of OAG over a 5-year period. These results were determined from a 
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double-masked trial from OHT participants. The Visual Impairment Project (Le et al. 2003) 
assessed potential risk factors for the development of OAG in Australia for subjects aged forty 
years and over. A CDR greater than 0.7 was associated with a greater risk of development of 
possible OAG. However, the study methodology implies that only those with a CDR of 0.7 or 
greater were assessed at baseline and 5-year follow for detection of change.  
The EPGS also presented results that showed that RNFL changes with OCT assessment were 
more predictive of changes using a risk calculator than other techniques such as the GDx or 
HRT (Colombo et al. 2016) (Section 1.14.6). Differences at the RNFL have also been 
suggested in normal subjects with a first degree relative of POAG when compared to those 
without a family history. RNFL thinning was detected in normal looking discs on comparison 
of forty subjects with the family history (Karti et al. 2017). This study would require longer 
follow up to understand whether the changes were an early indicator of glaucoma (Karti et al. 
2017).  
Optic disc diameter was found to be a risk factor for POAG in two population studies 
involving both European-derived (Healey & Mitchell 1999) and African-derived persons 
(Quigley et al 1999). The Blue Mountains study, involved over 3000 subjects and compared 
optic disc size in the eyes of those classified as normal to those with open-angle glaucoma, 
ocular hypertension, or pseudo-exfoliation syndrome (Healey et al 1997). The mean optic disc 
diameter in glaucomatous eyes was significantly larger than in normal eyes (Healey et al 
1997). It was also reported with this study that there was linear relationship between vertical 
CDR and vertical disc diameter (Crowston et al. 2004) 
Ageing changes of the optic nerve have been reported. The Beaver Dam Study concluded from 
a 5 and 15 year follow up study of normal eyes, that an incremental change in vertical cup-to-
disc ratio were associated with an increase in IOP (Klein et al. 1997; Klein et al. 2006). The 
risk factor of this change being pathological for the optic nerve has been investigated through 
alterations at the lamina cribrosa. In vivo imaging, albeit in an animal study, showed pressure 
variations from baseline normal levels caused changes of neural tissues (Tran et al. 2017). 
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Biomechanical models of the eye have hypothesised that IOP-related stress is dependent on 
the individual and pathophysiologic levels could cause changes in cell synthesis and tissue 
microarchitecture. This would result in mechanical failure of the structures of the optic nerve 
and retinal ganglion cell death (Bellezza et al. 2000; Rebolleda et al. 2017).  
 
2.4.9 SYSTEMIC CONDITIONS AND POAG 
Systemic factors have been shown to be associated with the prevalence of POAG but they are 
not independent risk factors. The Blue Mountains study considered the prevalence of POAG 
in a population of Australians aged from 49 years to 96 years and suggested that there is an 
association with diabetes. POAG and OHT prevalence was increased in participants with 
diabetes when compared to those without (Mitchell et al. 1996). Also for those participants 
receiving glaucoma treatment, IOP was reported to be consistently higher in those with 
diabetes (Mitchell et al. 1996). These results have been contradicted by other population 
studies (Tielsch et al. 1991). However, a recent meta-analysis concluded from a review of 
thirteen studies that there is a strong association between diabetes and intraocular pressure 
(Zhou et al. 2014). A similar meta-analysis considering blood pressure and POAG suggested 
that hypertension was associated with increased IOP but only a possibility in the development 
of glaucoma (Zhao et al. 2014). These meta-analyses have included studies from all countries 
whereas this review has concentrated on studies in Europe, Americas and Australia.  
The UK Biobank considered the associations of systematic factors with Goldmann-correlated 
IOP and corneal compensated IOP in a British cohort (Chan et al. 2016). The study reported 
that diabetes was related to corneal biomechanical properties and systolic blood pressure with 
a higher IOP (Chan et al. 2016). 
Vascular factors have been implicated as risk factors in glaucoma. Examples of these are 
ocular blood flow, ocular perfusion pressure and retinal calibre changes (Mitchell et al. 2005; 
Tielsch et al. 1995; Chen et al. 2016; Flammer et al. 2002). The literature on ocular blood flow 
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is varied as studies have investigated it using different techniques and at different stages of 
glaucoma (Flammer et al. 2002). 
 
 SUMMARY OF LITERATURE REVIEW 
This literature review has discussed the risk factors implicated in POAG. The incidence and 
prevalence of POAG increase with age. With advancing age, intraocular pressure has also 
been shown to increase together with increases in vertical cup to disc ratio and thinning of the 
RNFL. The literature also reports that there is an age specific increase in POAG with the 
Caucasian race but a higher prevalence in the Black population from early middle life. The 
male race has a higher prevalence. Myopia is also a risk factor for glaucoma. A family history 
of glaucoma is strong risk factor of POAG with the odds ratio decreasing from first to fourth 
degree relative. The literature reviewed has also shown that the research on the risk factors of 
POAG has largely been based on population studies or treatment studies. All the studies have 
been on a population age of 40 years and above.   
The designation “glaucoma” is reserved for people with damage to the optic nerve (Jampel 
2017). POAG changes are not rapid in progression and the processes underlying the subtleties 
of change in glaucoma have begun to be investigated; one example the use of biomechanics 
(Rebolleda et al. 2017). These types of studies are beginning to highlight that not enough is 
known about how these changes are happening and when and why certain individuals are 
susceptible to changes. However, the literature in this review present studies that have 
considered what is changing and who is at risk.  
A prevalence of 3% to 4% of POAG has been reported in a population aged 48 years or more 
(Mitchell et al. 1996; Leske et al. 1994). Yet, the literature does not clearly provide 
information on the glaucomatous changes in adults younger than the age of 40 years. 
Appreciating that glaucomatous changes are gradual, could there be early detectable changes 
in those people that are susceptible to glaucoma with known risk factors? The earliest 
detectable changes are important for screening for the presence of glaucoma in the community 
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or in a primary eye care setting is increasing. The rationale for early detection is that vision 
loss from glaucoma can be reduced by treatment to lower IOP and that glaucoma is largely 
asymptomatic until there is noticeable damage to the optic nerve (Jampel 2017).  
This thesis highlights that research is needed to understand the process of glaucoma in those 
at risk in the years preceding glaucomatous change. This aims for the research for this thesis 
will be presented in Chapter 3.  
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 HYPOTHESES AND THESIS AIMS 
 OVERVIEW 
The literature review discusses the importance of early detection of primary open angle 
glaucoma (Chapter 2). There is strong evidence that the risk of developing glaucoma is raised 
with a positive family history. There are also other factors that place groups of people at risk; 
examples being those with myopia, male gender and Black race. There is an importance to 
research the groups of people who are at risk of glaucoma as we do not have knowledge on 
how these groups present at an earlier age. The questions that have been raised from the 
literature review are: 
• Are people at risk of glaucoma, anatomically predisposed? The increased risk of 
glaucoma changes with an increased vertical cup to disc ratio have been reviewed. Is 
it possible that people are born with this difference? 
• Does vertical cup to disc ratio change before the start of glaucoma changes or does it 
change after due to progression of the condition? 
• Is intraocular pressure slightly higher for those at risk of glaucoma but still within a 
normal range prior to glaucoma changes? Could slightly higher IOP cause an 
increased burden, increasing the risk of glaucomatous changes?  
• If intraocular pressure is not slightly higher for those at risk throughout life, could 
there be an earlier detection point for when it starts to increase? Is it possible that 
intraocular pressure could be measured higher than average up to ten years, six years 
or three years before glaucomatous changes?  
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 THESIS AIMS 
The introduction and literature review have raised several questions, answers to which would 
aid an understanding of the process of glaucomatous change. The aims of this thesis are to 
investigate glaucomatous change through investigating: 
1. People at risk of primary open angle glaucoma due to a family history; and/or 
2. People who have primary open angle glaucoma and investigating how they 
differed from control populations many years before they developed changes.   
 
Knowledge of the risk factors of glaucoma and its progression has been collected from 
population studies or clinical trials that have on average a follow up period of five to eight 
years (Broman et al. 2008). Studies have found that baseline IOP, a larger baseline vertical 
CDR and older age at baseline are all factors which are more likely to cause visual field 
deterioration over the next eight to nine years (Lee et al. 2014; Leske et al. 2008; Lichter et al. 
2001; Gordon et al. 2007). However, the baseline values for glaucoma studies are often set 
above an IOP of 21.0mmHg and a vertical CDR is 0.7 as confirmed glaucoma participants are 
being sampled. It would not be ethical to monitor a confirmed glaucoma participant in a 
prospective study without suitable treatment. This may be why there is gap in the literature on 
the changes that have occurred with IOP and vertical CDR prior to these factors being termed 
baseline. To consider changes prospectively in patients who have a risk of developing 
glaucoma as a longitudinal study would be difficult to bring to fruition due to the sample size 
that would be required and time scale. However, retrospective analyses of data have 
successfully been used in past glaucoma studies (Rossetti et al. 2010; Oliver et al. 2002; 
Kobelt-Nguyen et al. 1998). With consideration of this, and with supervisory discussion and 
input, the investigations for this thesis were planned through two retrospective studies. 
The aims of this thesis are to consider the differences in people with confirmed glaucoma 
and/or people who at risk of glaucoma due to a family history. This will be done by 
investigating if patients that have got confirmed glaucoma changes (requiring treatment) had 
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normal intraocular pressure and optic nerve, ten years prior to diagnosis. If differences against 
a control group are found, then this raises the possibility of monitoring earlier and screening 
earlier for changes for earlier intervention. The aims of this thesis are not to answer these 
questions but to initially ask if there are there detectable differences up to ten years prior to 
diagnosis.  
 
 AIMS AND OUTCOME MEASURES. 
The aims of the research reported in this thesis are to investigate whether there are differences 
in intraocular pressure or optic disc cupping in young populations who do not have glaucoma; 
that either have the risk factor of family history of glaucoma or in later years go on to develop 
glaucoma. 
 
3.3.1 AIM FOR STUDY 1 
3.3.1.1 PRIMARY  AIM FOR STUDY 1 
The primary aim for Study 1 is to investigate intraocular pressure values in patients with a 
family history of glaucoma and those without a family history of glaucoma.  
 
3.3.1.2 PRIMARY  OUTCOME MEASURE FOR STUDY 1  
The primary outcome measure for Study 1 is to establish whether intraocular pressure values 
in patients with a family history of glaucoma is significantly higher than in patients without a 
family history of glaucoma.  
 
3.3.1.3 SECONDARY  AIM FOR STUDY 1 
The secondary aim for Study 1 is to compare optic nerve cup to disc ratio measurements in 
patients with a family history of glaucoma to those without.  
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3.3.1.4 SECONDARY  OUTCOME MEASURE FOR STUDY 1 
The secondary outcome measure for Study 1 is to establish whether the optic nerve cup to disc 
ratio measurements in patients with a family history of glaucoma is significantly larger than 
in patients without a family history of glaucoma.  
 
3.3.2 AIM FOR STUDY 2 
The aim of Study 2 is to investigate if the risk factors for primary open angle glaucoma are 
present many years before glaucoma develops.   
 
3.3.2.1 PRIMARY  AIM FOR STUDY 2 
The primary aim for Study 2 is to investigate intraocular pressure values in patients with 
primary open glaucoma, ten years prior to their diagnosis.  
 
3.3.2.2 PRIMARY  OUTCOME MEASURE FOR STUDY 2  
The primary outcome measure for Study 2 is to establish whether intraocular pressure values 
in patients with primary open angle glaucoma are significantly higher ten years prior to 
diagnosis when compared to a pair-matched control group.  
 
3.3.2.3 SECONDARY  AIM FOR STUDY 2 
The secondary aim of Study 2 is to investigate optic nerve cup to disc ratio measurements in 
patients with primary open glaucoma, ten years prior to their diagnosis.  
 
3.3.2.4 SECONDARY  OUTCOME MEASURE FOR STUDY 2 
The secondary outcome measure for Study 2 is to establish whether the optic nerve cup to disc 
ratio measurements in patients with primary open angle glaucoma is significantly larger ten 
years prior to diagnosis when compared to a pair-matched control group.   
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 STUDY 1 DESIGN AND METHODS 
 STUDY 1 OBJECTIVES 
The objectives for Study 1 are: 
• To retrospectively collate intraocular pressure readings from anonymised records 
from participants aged between 18 years and 40 years. 
• To create a frequency distribution curve for intraocular pressure measurements for 
participants between 18 years and 40 years.  
• To compare intraocular pressure readings from those participants that reported a 
family history of glaucoma with those that did not.  
• To compare the recorded vertical optic nerve head cup to disc ratio in participants that 
had a family history with those that did not.  
 STUDY 1 DESIGN 
Study 1 is an exploratory study for risk factors of primary open angle glaucoma in two groups 
of adults aged between 18 years and 40 years. From the two groups, one is to have a family 
history of glaucoma and the other shall not. To conduct this research a cross-sectional study 
was designed. Cross-sectional studies are like a snapshot, measuring both exposure and 
outcome at one-time point (Grimes & Schulz 2002). The advantage of cross-sectional studies 
are that participants are not deliberately exposed, treated, or not treated and hence there may 
be fewer ethical difficulties. This type of study can also be relatively inexpensive (Mann 
2003). A sample size calculation was not conducted as there are no previous studies that have 
provided adequate information for determining an appropriate effect size.  
 
 ETHICAL APPROVAL 
Ethical approval was requested and granted from three separate committees; the Faculty 
Research Ethics Panel of Anglia Ruskin University, London South Bank University and the 
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Institute of Optometry. The process for ethical approval took approximately 12 months. The 
chair of London South Bank University ethics committee stated that ‘the sharing of data and 
open access to data is an evolving research and ethical area’ and the application for this study 
was thoroughly considered in view of data protection and anonymisation prior to being given 
approval. The study did not apply for NHS ethical approval and did not use any NHS patient 
data. The study adhered to the tenets of the Declaration of Helsinki. The ethics application, 
information sheet, consent form and approvals letter are shown in Appendices 1 to 6 (Sections 
12 to 17).  
 
4.3.1 INCLUSION AND EXCLUSION CRITERIA 
To aid recruitment and obtain an expansive sample of cases, this study attempted to have broad 
inclusion criteria. The inclusion criteria required that the anonymised records included the 
required variables listed in Section 4.4. Important exclusion criteria were; refractive surgery, 
corneal pathology, pigment dispersion syndrome, pseudo-exfoliation and glaucoma.  
 
4.3.2 PATIENT INFORMATION SHEET AND CONSENT 
The Information Commissioner’s Office (ICO) guidelines (ICO 2017) for procedures for data 
anonymization were studied and complied with.  The anonymised data used in this study were 
not “processed in such a way that substantial damage or substantial distress was likely to be, 
caused to any data subject” (ICO 2017). The ICO (2017) advise that patient consent is not 
needed for anonymised data or pseudonymised data to be extracted for research. This was 
confirmed by email correspondence. However, each participating optometric practice had 
written policies on display advising their patients that anonymised data from their clinical 
records may be used for audits and research purposes. The ethics committees were informed 
that Anglia Ruskin University Data Protection Register entry listed research as one of the 
purposes for which data are held. The University Eye Clinic also had a policy in place that 
required each patient to read and sign a consent document if they agreed for their data to be 
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used for research purposes. Every record at the University Eye Clinic had a letter of consent 
associated with it; with consent being reconfirmed at each eye examination. The author also 
created a participant information and consent form which were written and approved by the 
ethics committees (Appendices 2 & 3). This was to safeguard ethical practice in the event of 
the possibility that records needed to be used prior to the date of the policies being in place.  
 DATA COLLECTION 
The study was designed to collect retrospective data from participants who were under 40 
years of age at the time of their eye examination. The data were selected as forming two 
groups: those with a family history of glaucoma and those with no family history of glaucoma. 
The University Eye Clinic at Anglia Ruskin University and a community optometric practice 
in Bedfordshire were the two sites chosen for data collection. The investigator was employed 
at both practices.   
Each eligible anonymised clinical record was used to extract the following data: 
1. Sex – coded as male or female.  
2. Age - recorded numerically in years as age at time of examination. Only the year of birth 
was known as all identifiable data had been anonymised.   
3. Vision/visual acuity - converted to LogMAR. Recorded numerically for right and left eye.   
4. Refractive error – converted to spherical equivalent refraction. Recorded numerically for 
right and left eye.  
5. Family history of glaucoma – coded as yes or no and, if yes, by which family member and 
by which type of glaucoma (if known).  
6. Intraocular pressure measurement- recorded in mmHg. Recorded numerically for right and 
left eye.  
7. Optic nerve head assessment – Vertical cup to disc ratio. Recorded numerically for right 
and left eye.  
8. Visual field assessment. Recorded numerically for right and left eye. Coded to yes or no if 
an assessment was made. Details of the assessment were summarised as full or defective.  
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 DATA ANONYMISATION 
Study 1 employed a two-stage process for data anonymisation. The researchers involved were 
the investigator and one of the doctorate supervisors. Both researchers were members of the 
clinical team who routinely have access in their work to clinical records and who are aware of 
the need to maintain patient confidentiality and to follow the guidelines on confidentiality of 
the General Optical Council (General Optical Council 2016). 
In the first stage of data collection, the investigator searched the clinical database for eligible 
records. The University Eye Clinic and the community practice each used an electronic patient 
database. The support services for the database companies were asked to produce a database 
of all cases seen between the ages of 18 years to 40 years over a 2-year time-period. They 
were also asked to create a separate list of cases between the ages of 18 years to 40 years if 
the database listed them to have a family history of glaucoma. Clinic records were then 
reviewed and anonymised data were extracted if the patient was between the age of 18 years 
and under 40 years and an IOP measurement had been taken. Weekly clinic lists were also 
reviewed and all records under the age of 40 years were assessed for suitability. The 
anonymised data (Section 4.3) were extracted and recorded onto a spreadsheet. Photographs 
were not extracted. The data extracted did not include any personal identifying information 
such as name, address and date of birth. At this stage, each anonymised dataset was identified 
by the clinic reference number. Once the spreadsheet was complete, the investigator passed 
this to the assigned doctorate supervisor. The supervisor randomly assigned a unique research 
number to each dataset and deleted the clinic reference number and randomly re-ordered the 
data in the spreadsheet. For example, the dataset that was in row 3 might now be in row 250. 
This second level anonymised spreadsheet was then passed to the investigator for analysis. It 
included 265 rows of data of the type illustrated in Table 4.5-1. It was implausible that the 
researcher would know from which patient each dataset originated.  
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TABLE 4.5-1 Example of the table used for data extraction for Study 1. 
 
 LIMITATIONS 
Prior to the ethics committee application, the initial thoughts for this study were that it could 
be conducted at several community optometry practices as the data were to be extracted 
anonymously. London South Bank University Ethics Committee advised that data could only 
be extracted from case records with consent, and records could not be searched in a practice 
in which the investigator was not employed as they held identifiable details. The investigator 
was employed at both centres that were used for data collection. Although both centres were 
busy with patient flow, it is not currently commonplace practise to routinely measure IOP in 
patients under the age of 40 years. An assumption was made that the University Eye Clinic 
would hold a large percentage of patients who were young adults and that IOP would more 
likely be measured for teaching of clinical skills. However, it is necessary for a teaching clinic 
to advise when to make appropriate clinical decisions for clinical assessments. The optometry 
practice in Bedfordshire demographically had an older patient base, although measurement of 
IOP on all adult patients above the age of 18 years was routinely performed. Challenges were 
faced in finding records of participants between the ages of 18 years and 40 years in whom 
IOP had been measured and in finding participants who had a positive family history of 
glaucoma. These may have been the result of the study being restricted to two study sites and 
the demographics of the population at each site. Participants between the ages of 18 to 40 
years may not have first generation family members with glaucoma as the incidence is lower 
in younger ages. Therefore, data were also collected from cases that had a family history of 
glaucoma via second-generation family members. It has been suggested that epidemiology 
studies that include only first-degree relatives may underestimate the familial/genetic nature 
of glaucoma (Green et al. 2007). The current study had the advantage of collecting 
0 34 0.0 0.1 0.75 0.75 12 NCT 14 NCT 0.2 0.2 N N
0 21 0.0 0.2 -3 -3 14 NCT 16 NCT 0.3 0.1 N Y
1 21 0.1 0.0 0.01 0.01 13 NCT 13 NCT 0.2 0.2 Y Y
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retrospective data from a “real world” situation, but it is also a recognised limitation of 
retrospective studies that they generate a lot of “missed data” (Anthonisen 2009).  
 SUMMARY 
This chapter has detailed the study design and methodology for Study 1. The next chapter will 
review the data collected and show their results after analyses. 
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 STUDY 1 RESULTS 
 STUDY 1 OVERVIEW 
This chapter presents the descriptive results and statistical analysis for Study 1. Results were 
conducted on intraocular pressure (IOP) values and vertical cup to disc ratio (CDR) 
assessments. 
 DESCRIPTIVE STATISTICS 
Intraocular pressure measurements were documented from 272 cases. Approximately 5000 
records were reviewed from both sites. The summary data collected from these records are 
presented in Table 5.2-1. 
The number of the anonymised case records that did not report a family history of glaucoma 
were 169. This group has been named ‘F0’. There were 41 anonymised case records reported 
with a first-degree relative who had a family history of glaucoma. This group has been named 
‘F1’. A second degree relative second-degree relative (grandparent or uncle/aunt) was 
recorded in 62 of the records. This group has been named ‘F2’. Records that had documented 
both a first-degree relative as well as other relatives were recorded only in the first-degree 
relative category. The confidence intervals of the means were calculated at 95% and an effect 
size index was calculated using Cohen’s D formula (Sections 5.4.1.1& 5.5.1.1). 
From the 272 data entries for IOP, 95 were measured with non-contact tonometry (NCT), 138 
with Rebound (Icare) tonometry (RBT) and 1 with Perkins applanation tonometry. On 38 
records, the technique used to measure the IOP was not recorded. RBT was used on 55.0% of 
the patients without a family history compared to 44.9% with. NCT was used on 67.3% of the 
patients with a family history compared to 32.7% without a family history. Applanation 
tonometry was used to measure IOP on one case of a participant with a family history of 
glaucoma.
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TABLE 5.2-1 Summary of descriptive statistics for Study 1. ‘F1’ is family history of glaucoma with first degree relative. ‘F2’ is family history of glaucoma with second- degree relative. ‘F0’ is negative family 
history.  all ages are in years. ‘R’ is right eye, ‘L’ is left eye, ‘VA’ is visual acuity, SER is spherical equivalent refraction, IOP is intraocular pressure, CDR is cup-disc ratio. ‘S.D.’ is standard deviation, IQR 
is interquartile range and ‘Min’ and ’Max’, minimum and maximum results respectively.  
 
 
 
 
  
Mean S.D. Min Max Mean S.D. Min Max Mean S.D. Min Max Mean S.D. Min Max Median IQR Min Max
F1, n = 17 33.1 6.6 20 40 -0.1 0.6 -0.1 0.1 -1.7 2.8 2.1 -6.8 16.3 2.5 12.0 20.0 0.4 0.3 0.1 0.7
F2, n = 31 29.4 7.6 19 40 -0.1 0.1 -0.2 0.1 -1.5 2.4 1.6 -7.6 15.5 3.2 10.0 21.0 0.4 0.2 0.0 0.6
F0, n = 62 27.1 6.8 18 40 -0.1 0.1 -0.2 0.2 -1.3 2.3 4.3 -7.9 14.6 2.8 9.0 21.0 0.3 0.2 0.1 0.7
F1, n = 24 33.1 7.2 18 40 -0.2 0.2 -0.2 1.0 -1.0 2.4 3.9 -7.0 14.6 3.7 7.0 22.0 0.2 0.1 0.0 0.5
F2, n = 31 30.8 6.8 19 39 -0.1 0.9 -0.2 0.2 -1.5 2.3 1.5 -8.8 14.2 3.5 9.0 22.0 0.4 0.3 0.1 0.8
F0, n = 107 27.6 7.4 18 40 -0.1 0.1 -0.2 0.5 -1.4 3.0 5.0 -17.9 14.7 3.1 8.0 22.0 0.3 0.2 0.0 0.8
Mean S.D. Min Max Mean S.D. Min Max Mean S.D. Min Max Mean S.D. Min Max Median IQR Min Max
F1, n = 17 33.1 6.6 20 40 -0.1 0.1 -0.2 0.3 -1.7 2.8 2.3 -6.4 16.0 3.1 11.0 21.0 0.3 0.2 0.0 0.5
F2, n = 31 29.4 7.6 19 40 -0.1 0.1 -0.2 0.2 -1.4 2.8 4.5 -8.8 14.8 3.6 9.0 24.0 0.3 0.2 0.1 0.7
F0, n = 62 27.1 6.8 18 40 -0.1 0.8 -0.2 0.3 -1.3 2.5 4.4 -9.6 14.2 2.6 8.0 20.0 0.3 0.3 0.1 0.7
F1, n = 24 33.1 7.2 18 40 -0.1 0.1 -0.2 0.6 -0.8 2.5 4.0 -8.3 14.4 3.4 8.0 22.0 0.2 0.2 0.1 0.7
F2, n = 31 30.8 6.8 19 39 -0.1 0.1 -0.2 0.1 -1.1 2.6 4.5 -9.0 13.7 3.8 8.0 23.0 0.3 0.3 0.1 0.7
F0 n = 107 27.6 7.4 18 40 -0.1 0.1 -0.2 0.4 -1.2 2.9 4.8 -18.4 14.3 3.2 6.0 21.0 0.3 0.3 0.1 0.8
ONH (R)
ONH (L)
Male 110
Female 162
VA (L)
SER (R)
SER (L)
IOP (R)
IOP (L)
GENDER NUMBER
FAMILY 
HISTORY
AGE VA (R)
AGE
Male 110
Female 162
GENDER NUMBER
FAMILY 
HISTORY
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 FREQUENCY DISTRIBUTION CHARTS FOR 
INTRAOCULAR PRESSURE 
Four frequency distribution graphs below show the distribution of IOP measurements for right 
and left eyes; firstly, for the group of cases which did not have a family history and secondly 
for the complete group of cases with a family history (includes those with a first degree relative 
and those without a first degree relative but with a second-degree relative). These frequency 
distribution graphs were created with the aid of a statistical package (SPSS). Data have been 
tabulated using Microsoft Excel. A frequency distribution chart gives a simple graphical way 
of depicting a complete set of observations (Altman 1991) and can provide evidence of 
parametric distribution of data by inspection. This was also confirmed with a Shapiro-Wilk 
test for normality using SPSS. The values obtained for the Shapiro-Wilk test for each eye have 
been added under each figure. 
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FIGURE 5.3-1 Frequency distribution for right eye intraocular pressure in subjects without a family history 
of glaucoma. Shapiro-Wilk test: p= 0.155.  
 
 
FIGURE 5.3-2 Frequency distribution for left eye intraocular pressure in subjects without a family history 
of glaucoma. Shapiro-Wilk test: p= 0.272 
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FIGURE 5.3-3 Frequency distribution for right eye intraocular pressure in subjects with a family history of 
glaucoma (F1 and F2). Shapiro-Wilk test: p= 0.100 
 
 
 
FIGURE 5.3-4 Frequency distribution for left eye intraocular pressure in subjects with a family history of 
glaucoma (F1 and F2). Shapiro-Wilk test: p= 0.058 
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 STATISTICAL ANALYSIS FOR INTRAOCULAR 
PRESSURE.  
Frequency distribution graphs and the Shapiro-Wilk test demonstrated that the IOP 
measurements collected for this study were normally distributed. Parametric statistical 
analyses were therefore justified and an independent samples t-test was used. There were 169 
cases in the group that did not have a family history of glaucoma (group F0). The mean IOP 
for this group was 14.6 mmHg (95% CI 14.2 - 15.1mmHg) for the right eye and 14.2mmHg 
(95% CI 13.8 - 14.7mmHg) for the left eye.  
The total number of cases with a family history of glaucoma was 103 (groups F1 + F2). The 
mean IOP for all the cases with a family history of glaucoma (groups F1 + F2) were 15.0 
mmHg (95% CI 14.4 - 15.7mmHg) for the right eye and 14.6mmHg for the left eye (95% CI 
13.9 - 15.3mmHg). These data were further subdivided and for the 41 cases in the group that 
had only reported a first-degree relative with glaucoma (group F1) the mean IOP was 15.5 
mmHg for the right eye (95% CI 14.5-16.4mmHg) and 15.2mmHg (95% CI 14.2-16.2mmHg) 
for the left eye.  
An independent samples t-test was conducted to compare the mean intraocular pressure 
between groups F0 and F1, and for groups F0 and F1+F2. The descriptive and comparative 
statistics for these measurements are shown in Table.5.4-1. 
 
Table 5.4-1 Descriptive and comparative statistics for intraocular pressure measurements. ‘F1’ is 
family history of glaucoma with first degree relative. ‘F2’ is family history of glaucoma with a 
second-degree relative. ‘N’ is total number. IOP values in mmHg. ‘S.D’ is standard deviation and 
CI is confidence interval. R is right eye and L is left eye. The ‘p’ values shown in row F1* are 
calculated with comparing this group with F0 only 
 
 
Mean S.D. CI (95%) p Mean S.D. CI (95%) p
169 14.6 3.0 14.2-15.1 - 14.2 3.0 13.8-14.7 -
41 15.5 3.2 14.5-16.4 0.224* 15.2 3.2 14.2-16.2 0.097*
103 15.0 3.4 14.4-15.7 0.300 14.6 3.6 13.9-15.3 0.4
GROUP/VARIABLE
F0
F1
F1 & F2
IOP (R) IOP (L)
N
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The intraocular pressure measurements in the group without a family history (group F0) 
compared to those with a family history of a first degree relative (group F1) did not show a 
significant statistical difference between means (RIOP; t(208) = -1.3, p=0.224: LIOP; t(208) 
= -1.7, p=0.097).   
The intraocular pressure measurements in the group without a family history (group F0) 
compared to those with a family history of a first degree relative and second degree relative 
(groups F1 and F2) also did not show a statistically significant difference between means 
(RIOP; t(270) = -1.0, p=0.353:(LIOP;t(270) = -0.88, p=0.398).  
 
5.4.1.1 EFFECT SIZE 
An online statistical calculator was used to confirm the effect size of each group (F0, F1 and 
F2). (Effect size calculator for Cohen’s d: https://www.cem.org/effect-size-calculator 2017).  
 
EQUATION 2 COHEN’S D EQUATION FOR STUDY 1 INTRAOCULAR PRESSURE 
Cohen's d = (M2 - M1) ⁄ SDpooled  
 
The values using the above equation for the right eye are shown below: 
Comparing F0 effect to F1 = M = Mean value. M2 is 15.5 (F1), M1 is the 14.6 (F0) and SDpooled 
is 3.0. Cohen’s D = 0.3 
Comparing F) to F1 + F2 = M= Mean value. M2 is 15.0 (F1 & F2), M1 is the 14.6 (F0) and 
SDpooled is 3.2. Cohen’s D = 0.13 
The values obtained for Cohen’s d for the groups compared were all below 0.3 which indicates 
that the size of the effect is small.   
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 OPTIC NERVE HEAD/CUP TO DISC RATIO 
The secondary aims for this study also included an analysis of the vertical cup to disc ratio 
measurements between the group of cases that had a family history of glaucoma and those that 
did not. For this analysis, the group of cases with the family history of glaucoma included both 
first and second-degree relatives (groups F1 and F2). A statistical package (SPSS) was used 
to confirm if the data for the CDR had a normal distribution. Both the Kolmogorov-Smirnov 
and Shapiro-Wilk tests were statistically significant (p<0.05). This confirms that the data 
collected were not normally distributed and non-parametric testing should be used.  
The data collected for optic nerve/cup to disc ratios have been presented using box plots. The 
medians for each group were 0.3 at the 50th percentile,   
 
FIGURE 5.5-1 Box plot to present the range of cup to disc ratio measurements in a group of cases with a 
family history of glaucoma and a group of cases with a negative family history of glaucoma. The Y axis 
presents the cup to disc ratio values. The median is marked by the horizontal line inside each box. The top 
and bottom ends of the box represent the interquartile range. The whiskers (lines outside of the box) 
represent the lower and upper quartiles. The dots above the top whiskers present the outliers and the 
uppermost measurements. 
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5.5.1 STATISTICAL ANALYSIS FOR OPTIC NERVE/CUP TO 
DISC RATIO IN GROUPS WITH A FAMILY HISTORY 
(FIRST DEGREE AND SECOND-DEGREE RELATIVE) AND 
NO FAMILY HISTORY.  
A Mann-Whitney U test indicated that the optic nerve/cup disc ratio for the group with a 
family history of glaucoma was not significantly different from that in the group without a 
family history of glaucoma. The median value in each group was 0.3 (50th percentile) and did 
not show a statistically significant difference between the two groups (Mann-Whitney U= RE 
(8618.0) LE (8584.0) (Z = R -.14: L -.19), p R = 0.890 L 0.848).   
Table 5.5-1 Descriptive and comparative statistics for optic nerve head/cup to disc ratio measurements. ‘F1’ 
is family history of glaucoma with first degree relative. ‘F2’ is family history of glaucoma with second- degree 
relative. ‘n’ is total number. R is right eye. L is left eye. The ‘p’ values shown in row F1* are calculated with 
comparing this group with F0 only.  
 
 
5.5.1.1 EFFECT SIZE 
SPSS was used to calculate the effect size using the results from the Mann Whitney U test. 
The effect size η was calculated using the equation listed in Equation 3, where Z is the value 
given of the calculated Z test from SPSS and N is total number of all cases. The effect size 
between the two groups of family history and no family history were each 0.0001, showing 
no effect.   
 
EQUATION 3 EFFECT SIZE CALCULATION FOR STUDY 1 OPTIC NERVE CUP TO DISC RATIO 
𝜂2 =  
𝑍2
𝑁−1
  where N = 271 and Z = -0.138 (REONH) and -0.192 (LEONH) 
 
      
Median p Median p
169 0.30 - 0.30 -
103 0.30 0.890 0.30 0.848F1 & F2
GROUP/VARIABLE
F0
N (L)
ONH/CDR (R) ONH/CDR (L)
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 SUMMARY OF RESULTS FOR STUDY 1 
This chapter has presented a summary of the data collected for intraocular pressure and the 
optic nerve/cup to disc ratio measurements for a group of cases which had a family history of 
glaucoma and a group which did not. The aims and objectives presented for this study were 
achieved. A total of 272 cases were reviewed with an age range of 18 years to 40 years. The 
mean values of the intraocular pressure and the median values of the cup to disc ratio between 
the two groups were not statistically significantly different. These results will be discussed in 
the Chapter 6.   
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 DISCUSSION FOR STUDY 1 
 OVERVIEW OF DISCUSSION 
This chapter will briefly review the results for Study 1, relate them to the literature, and discuss 
their implications.   
 REVIEW OF RESULTS 
Study 1 collected data from 272 anonymised cases (Table 5.2-1). Group F0 (n=169) did not have 
a family history of glaucoma. Group F1 (n=41) had a first degree relative with glaucoma and 
Group F2 (n=62) had a second-degree relative with glaucoma. The age range of all the cases 
were between 18 years and 40 years.  
The intraocular pressure values were normally distributed and parametric testing was 
conducted. The mean intraocular pressure values in the right eye for group F0 was 14.6 mmHg 
(SD 3.0) and for the left eye 14.2 mmHg (SD 3.0). The combined mean IOP for groups F1 
and F2 was 15.0mmHg (SD 3.4) for the right eye and 14.6mmHg (SD 3.6) for the left eye.  
Statistical analysis was used to compare the mean intraocular pressure values in groups F0 
and F1. The second analysis was carried out to compare the means of the group F0 and the 
combined group of F1 and F2 together. An independent samples t-test showed that the means 
were not significantly different for either comparison. The 95% confidence intervals were 
calculated and an effect size index calculation performed using Cohen’s D equation. This 
revealed only a small effect for the comparisons between each group with a family history of 
glaucoma (F1; n=41 and F1 & F2; n=103) and the groups with no reported family history of 
glaucoma (F0 n=169) (Section 5.4.1.1).   
The data collected for vertical cup to disc ratios were not normally distributed for group F0 or 
for the combined group (F1 & F2); therefore, non-parametric testing was used. For each group, 
the median vertical CDR value was 0.3. An effect size calculation revealed a very small effect 
size in groups F1 and F2 together (Section 5.5.1.1).  
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 COMPARISION TO CURRENT LITERATURE FOR 
STUDY 1 
To aid recruitment and obtain a broad sample of cases, Study 1 attempted to have broad 
inclusion criteria; exclusion criteria included corneal pathology, pigment dispersion syndrome 
and pseudo-exfoliation. As far as could be ascertained, all cases with corneal pathology were 
excluded; however, it has not always been routine practice for optometrists to use slit lamp 
examination for assessment of the anterior eye. Optometry practice has had an evolving role 
in eyecare delivery over the last two decades (Harris 2014; Harper et al. 2016). Optometrists 
are encouraged to discuss evidence and research in practice (Bullock et al. 2014; Harris 2014), 
develop clinical skills and work in conjunction with general practitioners and 
ophthalmologists (Harris 2014). The role of optometrists working within the hospital eye 
service is also changing and glaucoma has a leading extended role service provided by 
optometrists (Harper et al. 2016). 
The initial research proposal for this study indicated that the race of the participants was also 
to be collected if available. It was soon apparent that these data were not being collected by 
the practices involved in the study. Anglia Ruskin University reported their student 
demographic to be 62% White, 11% Black, 11% Asian and less than 5% for Chinese, Arab 
and other ethnicities combined (ARU 2016). Central Bedfordshire census data reported its 
demographics as: White British 89.7% and Non-White British as 10.3% (Bedfordshire 
Council 2016).    
Many of the participants in this study had a myopic refractive error. This may not be 
representative of the general population as people with refractive errors are most likely to 
consult optometrists. One of the reasons for this may be that a university eye clinic was used 
to collect data; a greater prevalence of myopia than would be expected in a general population 
was also found in first year undergraduate students at another UK university (Logan et al. 
2005). 
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6.3.1 COMPARISION TO CURRENT LITERATURE: 
INTRAOCULAR PRESSURE 
The literature reviewed in Chapter 2 has shown that larger epidemiological studies on POAG 
have all concentrated on participants over the age of 40 years. It was necessary to consider the 
literature on intraocular pressure for younger adults for this discussion. A search was 
conducted using the terms “normal intraocular pressure” and “adult” on PubMed. The search 
was specified for studies on humans aged between 18 years and 40 years and for studies 
written in English from years 1967 to 2017. The result was approximately 400 papers. The 
literature search did not find any studies designed exclusively for measuring the normal range 
of IOP in young adults. Thus, all abstracts were considered to see which may have measured 
IOP in adults of age 18 year to 40 years. The intraocular pressures presented in Table 6.3-1 
are from papers that have measured intraocular pressure in normal eyes for other research 
reasons. The studies were European, Australian and American studies which presented IOP in 
eyes without ocular pathology. Asian studies were not included as changes with intraocular 
pressure with age are reported to be different (Nomura et al. 2002) and the pathogenesis of 
glaucoma may have a different process as optic neuropathy has been reported at lower levels 
of IOP than in Europeans (Shiose et al. 1991).   
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TABLE 6.3-1 Summary of clinical studies to show intraocular pressure measurements in young adults. 
STUDY COUNTRY AGE SUMMARY 
Hacopian et al. 
2017 
US 33.8 years 
+/- 12.8 
years 
Tonopen XL 
Males 13.89 +/- 2.58 mmHg 
Females 13.02 +/- 2.61 mmHg 
 
Najmanova et 
al.2016 
Czech 19-25 years Non-contact tonometry 
Baseline 15.0 mmHg pre-exercise 
 
Huang & 
Rosenfield 2015 
US 23-28 years Handheld Tonopen 
14 healthy subjects. 
IOP pre-exercise 14.6 mmHg 
 
Parissinen et 
al.,2012 
Finland 29.2 to 37.4 
years 
Mean 34.5 
year +/- 1.57 
years 
Goldmann Applanation Tonometry 
(Myopic Rx) 
Males 16.23 +/- 2.83 mmHg 
Females 16.39+/-2.8 mmHg 
Read & Collins 
2011 
Australia Mean age 25 
+/- 4 years 
Goldmann Applanation Tonometry 
50% had a myopic prescription 
16.52 +/- 2.21 years 
Loewen et al 
2010 
US Age range 
19.6 to 24.7 
years 
Non-Contact Tonometry 
Hyperopia.  9 subjects 
IOP average diurnal sitting 
15.3 +/- 1.2 mmHg 
Emmetropia 21.5 +/- 1.9. 32 subjects 
IOP average diurnal sitting 
16.2 +/- 1.8 mmHg 
Myopia 21.8 +/- 1.8 34 subjects 
IOP average diurnal supine 
17.6+/- 2.1 mmHg 
 
Leydolt et al 
2008 
Austria Age range 
19-29 years 
Perkins Applanation Tonometry 
Mean IOP 14.0 mmHg 
Range 11-17 mmHg 
 
Morgan et al. 
2008 
Australia Mean age 
22.7 years 
SD 15.9 
Goldmann Applanation Tonometry 
Mean IOP at baseline 14.9 S.D. 3.9 mmHg 
Exclusion criteria not clear – could have 
included participants with corneal issues 
 
Gonzalez et al 
2006 
Portugal Mean age 
22.3 (2.94) 
18–30 
Age differences in central and peripheral 
intraocular pressure using a rebound 
tonometer (Icare) 
Central IOP measure used 
Mean 15.3 (S.D. 2.9) Range 8 to 23. 
Theelan et al 
(2004) 
Netherlands Mean age 21 
Range 
19 – 25 
Study on neck tie – results chosen of those 
with neck tie open at slit lamp as most 
close to normal practice 
Tonopen 
Mean IOP readings were 16.9 mmHg 
(S.D. 2.3). 
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Epidemiological studies (Section 1.2) have shown mean IOP to be approximately 16.0mmHg 
with a standard deviation of 3.0 (Colton & Ederer 1980; European Glaucoma Society 2017). 
More recent research from a UK bio data bank, states that the mean IOP in a Caucasian 
population (mean age of 57 years) to be 15.7mmHg (Chan et al. 2016). The IOP measured for 
this study ranged between 13.7mmHg and 16.3mmHg. These reflect the values presented 
within Table 6.3-1.  
There was no statistically significant difference in mean intraocular pressure between the two 
groups for this study: family history of glaucoma and no family history. When the comparison 
was limited to between those with no family history of glaucoma and those with a first-degree 
relative with glaucoma then the difference in mean intraocular pressure was again not 
statistically different between groups. The age range studied may have been too low to identify 
sufficient cases with a first degree relative with glaucoma. It should also be considered that 
optometrists may not document family history of glaucoma if beyond first degree relative. It 
is often the case that patients are not aware of the details of family conditions. It has been 
shown that in diagnosed glaucoma patients, 50% can be unaware of a positive family history 
(McNaught et al. 2000). Furthermore, if patients are aware of a positive history, optometrists 
do not confirm diagnoses with family members; it is also possible that family members may 
consider ocular hypertension to be the same as glaucoma (Gordon et al. 2007). Patients with 
a diagnosis of ocular hypertension have intraocular pressures at 24.0mmHg or higher but 
normal optic nerve and visual fields. Ocular hypertension can be treated with pressure 
lowering drops to prevent conversion to POAG (NICE 2017).   
Wolfs et al. (1998) demonstrated that siblings of glaucoma patients had significantly higher 
intraocular pressures and cup-disc ratios than siblings of controls (OR 14.7 95% CI 1.7-130.0). 
The age range of the cases in the current study would make it unlikely that a case would have 
a sibling with POAG, NTG or OHT unless this were a sibling with congenital or juvenile 
glaucoma (Marx-Gross et al. 2017). It was also reported that the lifetime risk of elevated IOP 
in first degree relatives of patients with glaucoma compared with relatives of controls had a 
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risk ratio of 6.3 (Wolfs et al.1998). A large familial study of POAG showed that within 59.5% 
of patients with primary open angle glaucoma, 38.6% had a first- degree relative, 6.5% had a 
second-degree relative, 6.1% had a third-degree relative and 8.4% had a fourth-degree relative 
(Green et al. 2007). This study highlights the importance of history taking in optometric 
practice and gathering information on family history. The reasons for this are that the odds 
ratio of a person with POAG having a positive family history have been shown to be 4.1 (95% 
CI 3.2–5.2) (Green et al. 2007).  
The techniques used to measure intraocular pressure in this study were almost exclusively 
either non-contact tonometry (NCT) or rebound (RB) tonometry. 35% had IOP measured with 
NCT, 51% had IOP measured with RB, less than 1% had applanation tonometry and 14% did 
not have the measurement technique recorded. An assumption was made for the current study 
that the calibration of the instrument was accurate at time of IOP measurement. Optometry 
students may not be practiced with tonometry and may repeat measurements; conversely 
qualified optometrists may rely on single IOP measurements rather than an advised average. 
It is possible also that with all subjects (possibly more if a student is conducting the 
examination) a higher IOP was measured in the first eye as subjects are more likely to squeeze 
their eyes in apprehension leading to an artefactual rise in IOP (Dabasia et al. 2016).   
A systematic review showed that as compared to Goldmann applanation tonometry, the 
proportion of NCT and handheld applanation tonometers to measure within 2.0mmHg of 
Goldmann measurements are about 60% (Cook et al. 2012). A study of IOP measurements 
with RB in children with glaucoma concluded that “normal” IOP readings are likely to be 
accurate with RB but higher readings can be overestimated (Dahlmann-Noor et al. 2013). IOP 
in children has been said to reach adult levels from the age of 12 years (Bresson-Dumont. 
2009). A more recent study which compared rebound tonometry with applanation tonometry 
in children found that the IOP amongst 214 eyes with an age range of 7 years to17 years (mean 
12.0 years) resulted in a mean IOP of 17.5mmHg with RB and 16.2mmHg with GAT 
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(Grigorian et al. 2012). The study by Grigorian et al. (2012) supports previous studies which 
reported that RB can measure higher than GAT in children (Dahlman-Noor. 2013).  
Although the mean IOPs were not statistically significant between groups in this study, the 
mean values are higher in the group with a family history than without. The right eye values 
for the groups were F0=14.6mmHg, F1 & F2=15.0mmHg and F1=15.5mmHg. The intraocular 
pressure values for the left eye show symmetry with the right eye: F0=14.2mmHg, F1 & 
F2=14.6mmHg and F1=15.2mmHg. In particular, the intraocular pressure was approximately 
1.0mmHg higher in the group with a first-degree family history compared to those with no 
family history. Intraocular pressure asymmetry has been shown to be a risk factor for having 
POAG (OR 2.14) (Williams et al. 2013). The cases presented in Study 1 did not show 
asymmetry even though the range of asymmetry has been said to be more represented with 
NCT than GAT (Vernon & Jones 1991).  
 
6.3.2 COMPARISON TO CURRENT LITERATURE: OPTIC 
NERVE/CUP TO DISC RATIO 
One of the main clinical indicators for differentiation between normal and glaucomatous optic 
nerve heads is an increase in vertical CDR over time (Jonas et al. 1999; Mwanza et al. 2017) 
and therefore it is paramount that accurate baseline clinical assessments are recorded. 
However, the data collected and analysed for optic nerve/cup to disc ratio in Study 1 were 
obtained in busy primary care clinics in patients of ages where glaucoma prevalence is very 
low. Therefore, it is likely that the measurements were not recorded with the same attention 
to detail as would occur in, for example, a hospital glaucoma clinic. The median values for 
the vertical CDR in each group (with and without a family history of glaucoma) were identical 
and there was no statistically significant difference between medians. Vertical CDRs have 
been observed to be 0.34 + 0.25 measured in 419 optic nerve heads in normal subjects with 
fundus photography (Jonas et al. 1988). Consideration of change in CDR over an 11 year 
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follow up study of optic nerve topography in healthy volunteers reported the median for CDR 
to be 0.3 both at baseline and after 11 years (See et al. 2009).  
The vertical CDR measurement is important to measure as a larger vertical CDR has been 
shown to be a risk factor of open angle glaucoma (OR 1.34 95% CI 1.14-1.58) (Miglior et al. 
2007). The records assessed in the current study did not indicate consistently whether the optic 
disc was viewed with direct or indirect methods. Direct and monocular examination of the 
optic nerve has long been known to be a sub-optimal method for viewing or describing optic 
nerve features as they are not accurate enough to detect small changes (Odberg & Riise 1985). 
Estimation of the optic nerve using cup to disc parameters is a complex process and subjective 
assessment can differ between clinicians (Tielsch et al. 1988). However, Harper & Reeves 
(2000) reported optic nerve assessment with direct ophthalmoscopy can achieve comparable 
sensitivities and specificities compared with stereophotographic assessment. Although the cup 
to disc ratio has historically been an indicator in glaucoma (Armaly 1967; Armaly & Sayegh. 
1969), a more recent recommendation is to observe the neuroretinal rim (Hoskins et al. 1975; 
Bengtssson 1976). The current study has isolated one assessment of the optic nerve but “it is 
the ‘global’ view of the disc (including the inter-eye comparison) which is used in 
discriminating normal and glaucomatous discs, rather than individual features in isolation” 
(Harper & Reeves 2000). For future studies, we are now further aided by fundus imaging to 
make an objective assessment of a complete optic nerve.  
 
 STRENGTHS AND LIMITATIONS 
6.4.1 STRENGTHS 
This study has assessed intraocular pressure measurements in 272 cases of normal eyes in 
adults aged 18 years to 40 years. A review of the literature showed that, to date, this topic has 
not been investigated in isolation. The data were sourced from two established and reputable 
 
88 
optometric practices and there has been consistency in the tonometers used for intraocular 
pressure measurement at each study site.  
 
6.4.2 LIMITATIONS 
This study was unable to collect a large sample of data which may have been due to 
demographics, the age of the subjects being too young for them to have family who have 
developed glaucoma, and deficiencies in the details of family history documented on history 
taking.  
The data collected for optic nerve assessment show consistency for the median values obtained 
when compared with published research. However, the CDR observations for this study were 
not confirmed using fundus photography or other imaging sources; although there would have 
been verification of student observations from the University Eye Clinic from qualified 
optometrists.  
 
 CONCLUSIONS 
Study 1 has presented intraocular pressure and optic nerve/cup to disc ratios for two groups of 
cases; a group with a family history of glaucoma and a second group without. The study found 
that the differences in mean intraocular pressure measurements were not statistically 
significant different. The optic nerve vertical CDR measurements presented identical median 
values in each group with no statistically significantly differences between groups.   
These results have initiated a gap in knowledge about intraocular pressure in younger adults. 
Optometrist make a clinical decision as to when to measure intraocular pressure and this may 
be worth more consideration if a young adult has strong risk factors such as family history, 
and other risks such as myopia and large vertical cup to disc ratio. Patients at the age of 18 
years may not yet have family who have developed glaucoma at that age; measurements only 
on those who are known at risk may miss a large spectrum of cases. The mean intraocular 
pressure values for the group with a family history, particularly those with a first-degree 
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relative family history, were higher albeit not statistically significant. The standard deviation 
of the mean IOP measurements were also higher in the family history groups which has been 
suggested to provide more information for IOP fluctuation than isolated measurements 
(Caprioli & Coleman 2008; Caprioli 2007). Further research would be beneficial with a larger 
sample. This study would also provide further information as a prospective study with 
potential of other measurements such as CCT and OCT.   
The following chapter will present the second study for this thesis. There is knowledge still to 
be investigated about intraocular pressure as Study 1 has leaves a question mark as to whether 
a difference would have been significant with a larger sample size. There have been challenges 
faced obtaining intraocular pressure results in young adults. For this reason, Study 2 will 
approach investigating possible early signs of glaucoma in a more direct way. Study 2 will 
conduct a retrospective study of historical clinical records in people who subsequently went 
on to develop glaucoma.  
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 STUDY 2 DESIGN AND METHODS 
 STUDY 2 OBJECTIVES 
The objectives for Study 2 are to: 
• retrospectively collate intraocular pressure readings from anonymised records of 
patients who subsequently developed primary open angle glaucoma and matched 
control. 
• retrospectively collate vertical optic nerve head cup to disc ratio from anonymised 
records of patients who subsequently developed primary open angle glaucoma and 
their matched controls.   
• statistically analyse the mean intraocular pressure measurements between two groups 
of cases: the group who subsequently develop glaucoma (pre-diagnosed glaucoma) 
and their case-matched controls.  
• statistically analyse the vertical optic nerve cup to disc ratio between two groups of 
cases: the group who subsequently develop glaucoma (pre-diagnosed glaucoma) and 
their case-matched controls. 
 
 STUDY 2 DESIGN 
Study 2 is an exploratory study for risk factors of primary open angle glaucoma in adults up 
to ten years prior to diagnosis. A review of clinical assessments from an outcome group of 
primary open angle glaucoma (POAG) normal tension glaucoma (NTG), pre-perimetric 
glaucoma (PPG) suspect glaucoma and ocular hypertension (OHT) cases over a period of ten 
years preceding diagnosis were compared against group-matched case controls. Data 
collection was conducted by matching an outcome case with a control case. The outcome 
group were labelled the PG group (pre-diagnosed glaucoma) and the matched case controls 
were called the CC group (case-control). Although there was individual matching of 
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individuals (on a paired basis), the purpose of this was to ensure that there were two groups 
that were approximately matched in mean age, gender and refractive error. Case control 
studies are often the design of first choice for observational research and aetiological studies, 
showing advantages in speed and efficiency (Knoll et al. 2008; Rosendaal 2001). Controls 
were chosen using a technique called density sampling. Density sampling involves using 
controls that are sampled concurrently with each case; each time a new glaucoma case was 
selected, a control was selected from the population at that point in time (Knoll et al. 2008). 
A sample size calculation was not conducted as there are no previous studies that would 
provide adequate information for determining an appropriate effect size.  
 
 ETHICS APPLICATION 
Ethical approval was requested and granted by the NHS, London South Bank University and 
the Institute of Optometry. The study adhered to the tenets of the Declaration of Helsinki. The 
process of NHS approval spanned a 12-month period. The application for this study was 
discussed at length with the research optometry lead and with the support officer at the 
Research Management and Governance office at Cambridge and Peterborough Clinical 
Commissioning Group (CCG) prior to submission. NHS approval was achieved through 
proportionate review from NHS Grampian in April 2015 (Appendices 7 to 15). Following 
NHS approval, a Research and Development application was made to the local CCG. 
Following their approval, an ethics application was made to London South Bank University 
and the Institute of Optometry and approved in May 2015. Individual applications were then 
made to eight different CCGs for a National Institute of Health Research passport (NIHR 
2015). This process needed a degree of perseverance and patience as each CCG group had a 
separate process and not every CCG had a research and governance officer. The research 
passport consists of a letter of access for research and a letter of assurance from the regional 
Research Management and Governance office. These letters were given as confirmation that 
the regional CCG gives approval for this research to be conducted in that area. The letter of 
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assurance and access were supplied to the community optometry practice in that region. 
(Sections 24 & 25). An annual NHS research review report was submitted in April 2016 and 
April 2017.  
 
 INCLUSION AND EXCLUSION CRITERIA 
The inclusion and exclusion criteria that were used for selecting case records are listed below. 
These are referred to in Section 7.5.  
Table 7.4-1 Study 1 Inclusion criteria 
INCLUSION CRITERIA 
 
GROUP: PRE-DIAGNOSED GLAUCOMA 
(PG) 
GROUP: CASE-MATCHED 
CONTROLS (CC) 
Diagnosis of POAG, NTG, OH, Pre-perimetric or 
suspect glaucoma and receiving glaucoma 
medication prescribed by an ophthalmologist. 
Patients who have had surgical intervention to 
lower IOP are not eligible.  
No diagnosis of POAG and no 
suspicion of any variant of glaucoma or 
ocular hypertension. Patients who have 
had surgical intervention to lower IOP 
are not eligible. 
The patient will have been seen at the same 
practice for a minimum of 10 years prior to 
diagnosis of POAG.  
If there are breaks in clinical records these should 
be no more than 4 years.  
The patient will have been seen at the 
same practice for a minimum of 10 
years.  
If there are breaks in clinical records 
these should be no more than 4 years. 
May or may not have a family history of 
glaucoma (if so, the type and relation will be 
documented). 
No recorded family history of 
glaucoma.  
Intraocular pressure readings available for 10 
years prior to glaucoma diagnosis. 
Intraocular pressure readings available 
for all 10 years. 
Visual field tests at least twice within the 10- year 
history prior to IOP treatment.  
Visual field tests at least twice within 
the 10-year history.   
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Table 7.4-2 Study 1 Exclusion Criteria  
GROUP: PRE-DIAGNOSED GLAUCOMA (PD) 
 
Other pathology likely to affect the visual field. 
Examples: Toxoplasmosis, optic nerve head drusen, retinal detachment, congenital visual 
field defect, photocoagulation for diabetes, angle closure glaucoma, strokes or other lesions 
affecting the visual pathway, secondary glaucomas, wet AMD if affects the visual field. 
Exclude any patients who have had refractive surgery or other corneal surgery. 
 
 DATA COLLECTION 
This study involved the collection of anonymised retrospective clinical data from cases of 
POAG, NTG, PPG, suspect glaucoma, OHT and matched controls from optometric practices. 
The optometry practices were identified in London and the East of England. Only those 
practices that were known to the investigators to be established over 15 years were 
approached; this was to ensure that they would hold case records for longer than a 10-year 
period.   
Identified optometric practices were approached and the study design was discussed and 
supported with written information. If the practice felt they could participate, written 
information and a practice consent form was completed (Sections 20&21). To maintain 
anonymity and ease of data extraction, recruitment was limited to optometric practices that 
could print or photocopy patient records after anonymising all identifying information. A total 
of 15 optometric practices were identified and 8 CCGs were contacted. Introductory 
conversations by telephone were also made to give information on the study. This was often 
with the practice manager so then follow up meetings were made with the practice manager 
and the lead optometrist. From the 15 practices, 4 did not did not return email or telephone 
contact. There were 3 of the practices who were visited twice to discuss the study and give 
support for finding cases but they were unable to commit. Even though these 7 practices did 
not take part, a prior application was made to their CCG so the study could be discussed with 
them. Recruitment was made of 6 practices; 4 practices were able to provide data for this 
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study. The minimum number of emails and telephone calls prior to collection of data were 
between 10 and 30 per practice. 
For each of the 6 practices that consented to the study, regular contact was made.  An initial 
email was sent to each practice with introduction of the study. A spreadsheet was created for 
the practices with the exclusion and inclusion criteria so the team could keep a record of any 
suitable cases. The communication with the practices was ongoing. It was found that the best 
way of ensuring significant numbers of records was to make regular contact by telephone calls 
and emails to encourage then to continue to seek records and to offer support. For the 4 
practices that could provide data, regular weekly contact was kept up over the course of 18 
months.  
Optometric practices were keen to help but often records were not available for 10 years 
preceding diagnosis. The main reason for this included not having cases that spanned 10 years 
prior to diagnosis. This was due to the case records not preceding 10 years to diagnosis but 
also due to practices having had a transition to electronic clinical records and papers records 
being archived. There were also cases that were excluded even though they had records 
spanning 10 years for patients seen prior to the age of 40, intraocular pressure measurements 
were not always recorded.  
The optometry practices used their databases to select cases of subjects being treated for 
POAG, NTG, PPG or OH glaucoma. The record was reviewed to check if that case had 
historical records tracking 10 years for that case prior to diagnosis. Specific eligibility criteria 
are listed in section 7.4-1 and 7.4-2. Cases were excluded if there was any suspicion that 
changes in IOP and or/ optic nerve or visual fields were caused by any reason other than from 
POAG, NTG, PPG or OH. A control case was matched to the outcome case by gender, age 
and spherical equivalent refraction (SER) (within +/-2 dioptres). Each case record was 
photocopied and all identifiable data were anonymised with a black permanent marker.  These 
records were then passed on to one of the doctorate supervisors to check anonymisation before 
being given to the investigator for data extraction.  
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It took approximately 18 months for collection of data. During this time, the investigator was 
working in any way possible to encourage and assist the practices. Suggestions were given for 
sourcing cases from the electronic database. A spreadsheet log with matching criteria was also 
devised for the practices to help log any identifiable patients. Each consented practice was 
asked to provide a minimum of 6 cases for the pre-diagnosis group (POAG, NTG, PPG, OH) 
and a further 6 cases as controls.  
The optometric practices searched case records for subjects that had been attending the 
practice for eye examinations for 10 years prior to their glaucoma diagnosis and start of 
treatment. Practices also checked historical records for patients as they were booked in.  Any 
suitable records were photocopied for one eye examination following diagnosis and all 
examinations for 10 years prior to diagnosis. The case records, together with any evidence of 
confirmed diagnosis for the glaucoma patient and visual field plots and fundus images were 
photocopied and anonymised of any identifiable data. The supervisor reviewed the record for 
anonymization and passed it on to the investigator. If the record met the selection criteria, the 
data listed above were extracted and the investigator asked the practice to find a control record 
with matching gender, race (if known) age and refractive error. The same system was used for 
double checking anonymisation before the control record was given to the investigator. The 
photocopies of anonymised records were destroyed as soon as the data were extracted onto 
the spreadsheet. 
 
7.5.1 DATA EXTRACTION 
The data for each anonymised record preceding confirmation of glaucoma diagnosis was 
extracted. To ensure that all data was accurately being collected prior to diagnosis, the 
practices were asked to photocopy the record for one entry from beginning treatment. Any 
correspondence from the hospital was also requested to be photocopied. The data collected 
was in order of, gender month and year of birth, age at eye examination, details of family 
history of glaucoma, visual acuity, refractive error, intraocular pressure, tonometer details, 
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vertical cup to disc ratio, visual field records and extra information. Each of these details were 
recorded for each eye. An Excel data sheet was used to record this data. The inputted data 
were regularly checked for inaccuracies.  
 
7.5.2 DATA CLEANING 
This study was dependent on 10 years retrospective clinical data for 182 cases. The study 
involved the collection of many records and it was essential that the collected data were 
scrutinised and inspected for errors. It was also important to interpret clinical notations 
correctly for each practice. The process of reviewing anonymised paper records was an 
ongoing and time-consuming task but necessary to ensure that all clinical data were transferred 
correctly. Every column had to be checked for errors and cross checked with the paper records.  
Any uncertain clinical notations were checked with the practice and if there was any 
uncertainty, the data were not recorded. No interpretation was made on the case records and 
every case was treated with complete neutrality. 
 
7.5.3 DATA ANALYSES 
The statistical package SPSS was used for the statistical analyses of the results and figures. 
The tables were created using Excel. Analyses were data from the eye which was either 
diagnosed first; if both eyes were diagnosed at the same time, a decision was made from the 
notes as to which eye was the more affected. This determination was from either a higher 
pressure, greater change in CDR over time or larger CDR or visual field change. If the records 
indicated that one eye was weaker due to poorer development at childhood (amblyopia) than 
the non-amblyopic eye was chosen. This criterion allowed a decision to be made on every 
case. The same eye was chosen for the control case.  
The statistical analyses performed on the data included initial statistical testing for normative 
distribution for intraocular pressure measurements and optic nerve head cup to disc ratio 
assessments. T-test analyses were performed on the variables used to match the groups. 
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Correlation and one-tailed parametric t-tests were used for analyses of the intraocular pressure 
measurements collected. Correlation and non-parametric Mann Whitney U tests were used for 
analyses for optic nerve head/cup to disc ratio assessments. Visual field data were tabulated 
but not statistically analysed.    
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 STUDY 2 RESULTS  
 OVERVIEW OF DATA 
For each section in this chapter, the data for the pre-glaucoma (PG) group cases will be 
presented first, followed by the case matched controls (CC).  
The results for Study 2 are based on a total of 182 anonymous case records supplied from four 
community optometric clinics (92 PG cases and 90 CC cases) (Table 8.1-1). Inititally,184 
records were collected but with further screening, 2 cases were excluded as they were cases 
of a secondary form of open angle glaucoma. For each record, data were extracted over a 10-
year period for the right and left eye, resulting in a minimum of 4 visit entries and a maximum 
of 11 visit entries (average 5) for each PG case and a minimum of 3 and maximum of 11 
(average 4) visit entries for each control case. Once data collection had been completed, the 
cases were reviewed and one eye per PG case was selected as specified in Section 7.5.1. 
Analyses were conducted on data from the eye which was either diagnosed first; if both eyes 
were diagnosed at the same time, a decision was made from the notes as to which eye was the 
more affected. 
 
Table 8.1-1 Number and category of cases obtained from each optometric practice.  
GROUP Practice 1 Practice 2 Practice2 Practice 4 Total 
Controls 41 13 16 20 90 
Primary Open Angle Glaucoma 24 11 17 20 72 
Normal Tension Glaucoma 4 5 2 2 13 
Ocular Hypertension 2 0 0 1 3 
Glaucoma Suspect 2 0 2 0 4 
Total Records 73 29 37 43 182 
 
 
 
99 
 DESCRIPTIVE DATA 
The anonymised case records for this study were collected in order of a PG case first; 
following which a CC case was matched individually for gender, age and refractive error 
(Tables 8.2-1 & 8.2-2). Data were extracted from the records over a retrospective span of 10 
years detailing the variables listed in Section 7.4. The inclusion criteria for the study were that 
the subjects were seen at regular intervals at the practice over a 10-year period (with no more 
than four years of gaps between intervals). The earliest recorded year for a case record was 
1982 and the latest was 2016.   
 
TABLE 8.2-1 Descriptive data for gender and chosen eye 
 
 
Table 8.2-2 Descriptive statistics for all Pre-Diagnosis and Case-Matched Control Cases.  
Central measure was mean and Measure of spread was standard deviation for all variables except ONH. 
The ONH measurements were not normally distributed and therefore their central measure was median 
and spread was interquartile range. Age in years, SER (spherical equivalent refraction, Visual Acuity as 
LogMAR, Intraocular Pressure in mmHg and Optic Nerve/Cup to Disc Ratio. Min=Minimum. 
Max=Maximum.   
 
 
 
63.3% 36.7% 57.1% 42.9%
65.7% 34.3% 56.9% 43.1%
FEMALE
RIGHT 
EYE
LEFT 
EYE
Pre-Diagnosis
Case-matched Control
GROUP MALE
Pre-Diagnosis 64.9 10.4 30.0 88.0
Case-matched 65.1 10.6 30.0 88.0
Pre-Diagnosis -0.8 3.5 -12.8 7.8
Case-matched -0.8 3.3 -11.1 12.0
Pre-Diagnosis 0.1 0.1 -0.2 1.0
Case-matched 0.1 0.1 -0.2 0.6
Pre-Diagnosis 18.9 4.5 9.0 36.0
Case-matched 14.9 3.2 7.0 25.0
Pre-Diagnosis 0.5 0.3 0.1 1.0
Case-matched 0.3 0.2 0.0 0.9
CENTRAL 
MEASURE
VARIABLE GROUP
MEASURE O F 
SPREAD
MIN MAX
Age/Years
SER
Visual Acuity
IOP
ONH
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8.2.1 PRE-GLAUCOMA GROUP 
Table 8.1-1 presents the number of cases collected for the subtypes of glaucoma. The records 
were extracted from the visit preceding the start of treatment for the PG case and where 
possible this was confirmed from the case notes and a correspondence letter from an 
ophthalmologist (anonymised) (Table 8.2-3). This visit was taken as the baseline visit. 
Records were then extracted 10 years prior to this. The total number of PG cases were 92. The 
majority of cases had POAG (n=72), followed by NTG (n=13). A small number of cases were 
collected for both glaucoma suspect patients on treatment (n=4) and OHT on treatment (n=3) 
(Table 8.1-1). The number of cases referred for glaucoma assessment by the community 
optometrist and discharged and re-referred were documented. Details were also compiled for 
the number of years that cases were monitored by the ophthalmologist before a confirmed 
diagnosis and treatment was started. Cataract surgery had been performed on 6 of the PG cases 
during over the 10- year duration (Table 8.2-3). 
Table 8.2-1 show that 63.3% of the PG Group were male and 36.7% were female. 57.1% of 
the data were for the right eye and 42.9% for the left eye. The PG Group had a minimum age 
of 30 years and a maximum age of 88 years. The mean age was 65 years and the standard 
deviation was 10.4 years. The mean spherical refraction equivalent for the relevant eye were 
-0.8 DS and the range was -12.8 DS to +7.8 DS.  The mean visual acuity for the relevant eye 
were log Mar 0.1 and the range was -0.2 to 1.00 (Table 8.2-2). The mean number of days over 
which the clinical records spanned for the PG group were 3918 (10.7 years).  
 
8.2.2 CASE-MATCHED CONTROL GROUP 
There were 90 cases of matched controls. These matched the PG group for gender, age and 
spherical equivalent refraction (Table 8.2-4). Unpaired T-test analysis was used to confirm 
that there was not a significance difference in means between the matched groups, thereby 
verifying that the groups were matched. Every effort was made to match each PG case to a 
CC case at the same practice; 9 controls could not be matched from the same practice and 
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these were matched by request from one of the other recruited practices. There were 2 of the 
control cases included in the study which had been referred to the Hospital Eye Service for 
raised intraocular pressure and optic nerve head assessment but were discharged. Cataract 
surgery has been performed on 12 of the cases in the CC group (Table 8.2-3). 
Table 8.2-2 shows that 56.9% of the data for the CC group were for the right eye and 43.1% 
for the left eye.  The group had a minimum age of 30 years and a maximum age of 88 years.   
The mean age was 65 years and the standard deviation was 10.6 years. 66.4 % of the group 
were male and 33.6% were female. The mean spherical refraction equivalent for the relevant 
eye was -1.0 DS and the range was -11.1 to +12.0 DS. The mean visual acuity for the relevant 
eye was LogMAR 0.1. The mean number of days over which the clinical records spanned for 
the CC group were 3894 (10.7 years).  
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TABLE 8.2-3 Information extracted from case records 
 
 
TABLE 8.2-4 Descriptive and comparative statistics. “SER” is spherical equivalent data. “S.D.” is standard deviation. “p” values calculated from unpaired t-test. 
 
 
P1 P2 P3 P4
Controls 12
Referred for raised IOP. Discharged with increased corneal thickness. Referred 
for optic nerve appearance. Discharged with diagnosis of physiological cupping. 
0 0 0 0
Primary Open Angle Glaucoma 4 Referred 2009 for OAG. Discharged. Re-referred 2011.
5 cases for 2 years.               
5 cases for 3 years.
2 cases for 4 years.
2 cases for 5 years.
1 case  for 9 years. 
11 1 3 13
Normal Tension Glaucoma 1
Discharged twice (2001 & 2007). Re-referred again in 2012.                                           
Referred 2006 for OAG. Discharged. Re-referred 2008
2 cases for 2 years
1 case for 3 years.
4 1 0 2
Ocular Hypertensive on Treatment 1 Referred in 1988 - monitored and discharged. Re-referred in 2008. 1 case for 2 years. 2 0 0 0
Glaucoma Suspect on Treatment 0
1 case for 5 years. 
1 case for 6 years
2 0 0 0
Case Cataract Surgery Case notes on Referrals Monitored by ophthalmologist
 Consultant Letter
Mean S.D. Mean S.D. p
Age 65.1 10.6 64.9 10.4 0.7
Visual Acuity 0.1 0.1 0.1 0.1 0.6
SER -1.0 3.5 -0.8 3.3 0.2
Group/Variable
CONTROL PRE-DIAGNOSIS
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 ANALYSIS 
The historical data were collected to analyse three specific variables: intraocular pressure, 
optic nerve head and visual fields. These variables may change with the progression of 
glaucoma. The results collected for each of these variables will be considered in turn.  
 
8.3.1 INTRAOCULAR PRESSURE 
The equipment used to measure intraocular pressure was tabulated from the last observed 
measurement for each case per group (Table 8.3-1). For each group, the most common method 
for measuring intraocular pressure was non-contact tonometry, followed by rebound 
tonometry (Icare), and lastly by Goldmann applanation tonometry.  
 
TABLE 8.3-1 Methods of tonometry used at the last observed measurement per group. All values shown as 
percentage.  
EQUIPMENT PRE-DIAGNOSIS CASE-MATCHED CONTROL 
Pulsair Non-Contact Tonometry 42.2 48.5 
ICare Rebound 30.1 38.7 
Perkins Applanation Tonometry 9.6 7.5 
Desktop Non-Contact Tonometry 7.3 0 
A O Reichart Non-Contact Tonometry 7.2 4.3 
Goldmann Applanation Tonometry 3.6 1.1 
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8.3.2 PRE-DIAGNOSIS GROUP 
The frequency distribution charts show that the data for intraocular pressure for the PG group 
closely approximated a normal distribution. (Figure 8.3-1). The intraocular pressure for the 
PG group had a minimum measurement of 9.0mmHg and a maximum of 36.0mmHg.  The 
mean intraocular pressure was 18.9 mmHg with a standard deviation of 4.4  
 
  
FIGURE 8.3-1 Frequency distribution for intraocular pressure in the Pre-Diagnosis Group. 
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 CASE-MATCHED CONTROL GROUP 
The frequency distribution chart show that the data for intraocular pressure were of a normal 
distribution (Figure 8.4-1). The intraocular pressure for the CC group had a minimum 
measurement of 7.0mmHg and a maximum of 25.0mmHg. The mean intraocular pressure was 
14.8mmHg with a standard deviation of 3.3.  
        
 
FIGURE 8.4-1 Frequency distribution for intraocular pressure in the Case-Matched Control group. 
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FIGURE 8.4-2 Box plots to present intraocular pressure distribution in the Pre-Diagnosis Group and Case-
Matched Control Group. The Y axis presents the intraocular pressure values in mmHg. The mean is marked 
by the horizontal line inside each box. The lower whiskers (lines outside of the box) represent the lowest 
measurements. The stars above the top whiskers present the outliers and the highest measurements.  
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8.4.1 CORRELATION FOR INTRAOCULAR PRESSURE 
 
 
FIGURE 8.4-3 Scatterplot to show correlation of intraocular pressure over time in days in groups Pre-
Diagnosis Glaucoma and Case-Matched Controls. 
  
A scatterplot and correlation was presented to observe the relationship and change in IOP over 
time between the PG group and the CC group. The first correlation was conducted for the CC 
group. The results of the correlation indicated that time explained 0.66% of the variance in 
intraocular pressure for the CC group (R2 = 0.0066), F (1,563), p=0.74). An R value was also 
calculated using an online tool for the CC group and found to be 0.08. The second correlation 
was conducted for the PG group. The results of this correlation indicated that time explained 
2.1% of the variance in intraocular pressure for the PG group (R2 = 0.021), F (1,765), 
p=<0.001). The R value for the PG group was 0.14.  
CASE-MATCHED CONTROLS 
R=0.08 
PRE-DIAGNOSIS: R=0.14 
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8.4.2 COMPARISON OF INTRAOCULAR PRESSURE BETWEEN 
THE PRE- GLAUCOMA GROUP AND THE CASE-
MATCHED CONTROL GROUP: 5 YEARS AND 10 YEARS 
BEFORE DIAGNOSIS.   
Parametric t-test analysis was used to consider the difference in IOP at specific time intervals. 
T-tests were used to determine whether IOP differed between the 2 groups at 5 years and 10 
years prior to diagnosis.  The data were restricted to a single measurement at or over years 5 
and under years 6 for both the PG group and the CC group.  The same procedure was carried 
out for each group for a single data point at year 8 or above and below year 11. All the entries 
were filtered for years equal to or greater than 5 years and no more than 6. The entries were 
screened and if there were 2 entries per case, the case which was closest in time to 5 years was 
kept; for example, if the same case had case records for year 5 and year 5.9, then year 5 was 
selected. The same process was used for cases between 8 and 10 years but on this occasion 
the cases closest to 10 years were selected.  
The data for 5 years are presented in Tables 8.4-1 and 8.4-2. The data for 10 years are 
presented in Tables 8.4-3 and 8.4-4 There were more cases for whom data entry points were 
available at 10 years than at 5 years. 
 
TABLE 8.4-1 Descriptive statistics for Pre-Diagnosis Glaucoma and Case-Matched Cases selected at 5 year 
assessment. “SER” is spherical equivalent refraction. “IOP” is intraocular pressure in mmHg “ONH” is 
optic nerve head cup to disc ratio. “S.D.” is standard deviation. “Min” in minimum and “Max” is maximum. 
The *values under ONH are median (below mean) and mode (below min).  
 
 
Pre-Diagnosis 58 65.8 9.0 41.0 82.0
Case-matched Control 46 65.8 9.4 38.0 80.0
Pre-Diagnosis 56 -1.0 3.4 -9.5 7.3
Case-matched Control 46 -0.4 3.3 -10.6 4.4
Pre-Diagnosis 57 0.1 0.1 -0.1 0.5
Case-matched Control 46 0.0 0.1 -0.1 0.5
Pre-Diagnosis 56 19.2 4.1 13.0 31.0
Case-matched Control 45 14.8 3.2 9.0 21.0
Pre-Diagnosis 48 0.4* 0.2 0.4*
Case-matched Control 38 0.3* 0.2 0.2*
Age/Years
MEAN S.D. MIN MAXVARIABLE GROUP
SER
Visual Acuity
IOP
ONH
NUMBER
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TABLE 8.4-2 Descriptive and comparative statistics for Pre-Diagnosis Glaucoma and Case-Matched Cases 
selected at 5 year assessment. “IOP” is intraocular pressure in mmHg.“SER” is spherical equivalent data. 
“S.D.” is standard deviation, “CI” is confidence intervals, “p” values calculated from unpaired t-test. 
 
 
TABLE 8.4-3 Descriptive statistics for pre-glaucoma group and case matched control cases selected at 10 
year assessment. “SER” is spherical equivalent refraction. “IOP” is intraocular pressure in mmHg. “ONH” 
is optic nerve head cup to disc ratio.  “S.D.” is standard deviation. “Min” in minimum and “Max” is 
maximum. 
 
 
TABLE 8.4-4 Descriptive and comparative statistics for Pre-Glaucoma Group and Case Matched Control 
Cases selected at 10 year assessment. “SER” is spherical equivalent data. “IOP” is intraocular pressure in 
mmHg “S.D.” is standard deviation, “CI” is confidence intervals, “p” values calculated from unpaired t-
test. 
 
 
8.4.2.1 COMPARISON OF INTRAOCULAR PRESSURE BETWEEN THE PRE- 
GLAUCOMA GROUP AND THE CASE-MATCHED CONTROL GROUP:  5 
YEARS AND 10 YEARS BEFORE DIAGNOSIS (EXCLUDING CATARACT 
CASES) 
The cases selected to determine whether IOP differed between the two groups at five years 
and ten years prior in Section 8.42 were screened for cases that had cataract surgery performed. 
These cases were removed and parametric T-test analyses were repeated (Tables 8.4-3 & 8.4-
4). 
 
Pre-Diagnosis 56 5.4 65.8 19.2 3.1 18.1-20.3
Case-Matched 45 5.4 65.8 14.8 4.1 13.9-15.7 P<0.00000001
Mean years prior 
to Diagnosis
Mean Age Mean IOP CI (95%)Group t-testNumber S.D IOP
Pre-Diagnosis 82 59.5 10.1 36.0 78.0
Case-matched Control 55 58.2 9.5 36.0 76.0
Pre-Diagnosis 81 -1.3 3.6 -11.9 7.0
Case-matched Control 55 1.1 3.6 -11.0 5.3
Pre-Diagnosis 82 0.0 0.1 0.0 1.0
Case-matched Control 54 0.0 0.1 0.0 0.0
Pre-Diagnosis 82 18.2 4.1 10.0 29.0
Case-matched Control 50 15.1 3.3 9.0 24.0
Pre-Diagnosis 64 0.5* 0.2 0.3*
Case-matched Control 37 0.3* 0.2 0.3*
VARIABLE GROUP NUMBER MEAN S.D. MIN MAX
Age/Years
SER/DS
Visual Acuity
IOP
ONH
Pre-Diagnosis 82 9.6 59.5 18.2 4.1 17.3-19.1
Case-Matched 55 9.8 58.2 15.1 3.3 14.1-16.1 P<0.000008
Mean years prior 
to Diagnosis
Mean Age Mean IOP CI (95%)Group t-testNumber S.D IOP
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TABLE 8.4-5 Descriptive and comparative statistics for Pre-Glaucoma and Case Matched Control Cases 
who had not had cataract surgery. Cases selected at 5 year assessment.”IOP” is intraocular pressure in 
mmHg “SER” is spherical equivalent data. “S.D.” is standard deviation. “p” values calculated from 
unpaired t-test. 
 
TABLE 8.4-6 Descriptive and comparative statistics for Pre-Glaucoma and Case Matched Control Cases 
who had not had cataract surgery. Cases selected at 10 year assessment. ”IOP” is intraocular pressure in 
mmHg “SER” is spherical equivalent data. “S.D.” is standard deviation. “p” values calculated from 
unpaired t-test. 
 
 
8.4.3 SECONDARY ANALYSIS FAMILY HISTORY OF 
GLAUCOMA 
Secondary analysis was conducted to look for differences in intraocular pressure at 5 years 
prior to diagnosis in all PG cases who had a direct family member (PGFHG) with glaucoma 
compared to those in the PG group without a family history (PGnFHG) of the condition. A 
correlation was calculated to observe the relationship and change in IOP over the last 5 years 
between these two subgroups from the PG cases. The results of the correlation indicated that 
time explained 0.8% of the variance in intraocular pressure for the PGnFHG group (R2 
=0.008). The second correlation was conducted for the PGFHG group. The results of this 
correlation indicated that time explained 0.7% of the variance in intraocular pressure for the 
PGFHG group (R2 = 0.007)  
 
8.4.3.1 SECONDARY  ANALYSIS 5-6 YEARS 
A t-test was conducted to compare mean IOP measurements in the PGFHG with PGnFHG at 
the time point 5 years. The mean intraocular pressure was not significantly different in the 
patients who had a family history of glaucoma and those that did not 5 years prior to diagnosis 
(p=0.80) (Table 8.4-5). 
Pre-Diagnosis 55 65.8 19.2 4.1
Case-matched 38 65.8 14.3 3.0
SD IOP
5.4
5.4
MEAN YEARS PRIOR TO 
DIAGNOSIS
MEAN IOPGROUP NUMBER
MEAN 
AGE
T-TEST
-
P<0.05
Pre-Diagnosis 82 59.5 18.2 4.1
Case-matched 47 58.2 15.0 3.4
SD IOP T-TEST
9.6 -
9.8 P<0.05
GROUP NUMBER
MEAN YEARS PRIOR TO 
DIAGNOSIS
MEAN 
AGE
MEAN IOP
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TABLE 8.4-7 Descriptive and comparative statistics for mean IOP in “PGFHG” (Pre-Diagnosis Group with 
a family history of glaucoma).and “PGFnHG” (Pre-Diagnosis Group without a family history of glaucoma) 
at 5 years prior to diagnosis. “IOP” is intraocular pressure in mmHg. “N” is number. “S.D” is standard 
deviation. “p” values calculated from unpaired t-test. 
 
 
8.4.3.2 SECONDARY  ANALYSIS  8-11 YEARS 
A t-test was conducted to compare IOP in the group of patients that had a family history of 
glaucoma and those that did not, specifically in the Group of patients that went on to develop 
glaucoma 10 years later. A t-test was conducted to compare IOP in the Group of patients that 
had a family history of glaucoma and those that did not, specifically in the Group of patients 
that went on to develop glaucoma 10 years later. The mean intraocular pressure was 
significantly different in the patients who had a family history of glaucoma and those that did 
not five years prior to diagnosis (p=0.04) (Table 8.4-6). 
TABLE 8.4-8 Descriptive and comparative statistics for mean IOP in “PGFHG” (Pre-Diagnosis Group with 
a family history of glaucoma).and “PGFnHG” (Pre-Diagnosis Group without a family history of glaucoma) 
at 10 years prior to diagnosis. “IOP” is intraocular pressure in mmHg. “N” is number. “S.D” is standard 
deviation. “p” values calculated from unpaired t-test 
 
 
 OPTIC NERVE HEAD 
Vertical CDR measurements were recorded from the PG Group and the CC Group. The details 
for these are described below. Frequency distribution and box plots were charted for each 
group (Figures 8-5 to 8-5.3). The frequency distribution charts confirm that the distribution 
for CDR in the PG group and the CC group were not of a normal distribution and therefore 
Mean S.D. p
27 20.2 4.9 -
29 18.3 3.0 0.8PGFnFHG
GROUP/VARIABLE
PGFHG
NUMBER
IOP
Mean S.D. p
33 19.3 4.2 -
49 17.4 3.8 0.04
GROUP/VARIABLE NUMBER
IOP
PGFHG
PGFnFHG
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non-parametric testing would be required. The Levene statistic was significant for the test of 
homogeneity (p<0.05) 
 
 
FIGURE 8-5 Frequency distribution for optic nerve/cup to disc ratio in the Pre-Diagnosis group. 
 
 
FIGURE 8.5-1 Frequency distribution for optic nerve/cup to disc ratio in the Case-Matched Control group. 
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FIGURE 8.5-2 Box plots to present optic nerve/cup to disc distribution in the Pre-Diagnosis group and Case-
Matched Control group. The Y axis presents cup to disc ratios. The mode by the horizontal line inside each 
box. The lower whiskers (lines outside of the box) represent the lowest measurements. The stars above the 
top whiskers present the outliers and the highest measurements. 
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 CORRELATION FOR OPTIC NERVE CUP TO DISC 
RATIO AND TIME.  
 
 
FIGURE 8.5-3 Scatterplot to show the correlation of optic nerve/cup to disc ratio over time in days 
A correlation was calculated to observe the relationship and change in cup to disc ratio over 
time between the PG group and the CC group. The correlation was conducted for the CC 
group. The results of the correlation indicated that time explained 1.0% of the variance in cup 
to disc ratio for the CC group (R2 = 0.001). The correlation was conducted for the PG group. 
The results of this correlation indicated that time explained 2.6% of the variance in intraocular 
pressure for the PG group (R2 = 0.026).  
 
 
CASE-MATCHED 
CONTROLS R=0.03 
PRE-DIAGNOSIS: R=0.16 
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8.6.1 ANALYSIS CUP TO DISC RATIO 
Optic nerve cup to disc ratios were tabulated for the first data entry for CDR for each case for 
groups PG and CC (Table 8.6-1) and tabulated for each data entry over 10 years.  
A non-parametric test was used to test for significance as the data were heteroscedastic (the 
standard deviation was greater in the PG group) (Spencer et al. 2017). The Levene statistic 
was significant for the test of homogeneity (p<0.05). The median optic nerve cup to disc ratio 
was significantly greater in the group PG (median 0.5 ± 0.2) group CC (0.3 ± 0.2) as per the 
Mann Whitney U test (p<0.05).  
 
TABLE 8.6-1 Descriptive and comparative statistics. “ONH/CDR” is optic nerve head/cup to disc ratio. “N” 
is number of data entries. “S.D” is standard deviation, “CI” is confidence intervals, “p” values calculated 
from Mann Whitney U test. 
 
 
8.6.2 ANALYSIS CUP TO DISC RATIO AT 5-6 YEARS 
The Mann Whitney U test was also used to determine whether the CD ratio in each Group 
significantly differed at five years prior to diagnosis. The cases were chosen with the same 
method as for the intraocular pressure analysis described in Section 8.4.2. The data were 
restricted for a single measurement at or over years 5 and 0 months and under years 6 and 0 
months for both the PG group and the CC group.  The descriptive data is presented at 5 years 
in Table 8.6-2. Five years before diagnosis the median CDR was statistically greater (Mann 
Whitney U test, p<0.05) in group PG (median 0.4 ± 0.2) than group CC (median 0.3 ± 0.2).  
TABLE 8.6-2 Descriptive and comparative statistics. Cup to disc ratio 5-6 years “ONH/CDR” is optic nerve 
head/cup to disc ratio. “N” is number of data entries. “S.D.” is standard deviation, “CI” is confidence 
intervals, “p” values calculated from Mann Whitney U Test. 
 
Median S.D. CI 95% p
661 0.5 0.2 0.3-0.4 -
467 0.3 0.2 0.5-0.5 <0.05
57 0.4 0.2 0.2
66 0.4 0.2 0.2
NUMBER
ONH/CDR
Visit 1 Pre-Diagnosis
Visit 1 Case-matched
Pre-Diagnosis
Case-matched
GROUP/VARIABLE
Median S.D. CI 95% p
48 0.4 0.2 0.4-0.5
38 0.3 0.2 0.3-0.4 <0.05
GROUP/VARIABLE NUMBER
ONH/CDR
Pre-Diagnosis
Case-matched Control
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8.6.3 ANALYSIS CUP TO DISC RATIO 8-11 YEARS 
The Mann Whitney U test was used to determine whether the CD ratio was different at ten 
years prior to diagnosis.  The data were restricted for a single measurement at or over years 8 
and 0 months and under years 11 and 0 months for both the PD group and the CC group.  The 
descriptive data are shown in Table 8.6-3. Ten years before diagnosis the median CDR was 
statistically significantly greater (Mann Whitney U test, p=<0.05) in group PG (median 0.5 ± 
0.2) than group CC (median 0.3 ± 0.2).  
 
TABLE 8.6-3 Descriptive and comparative statistics. Cup to disc ratio 8-11 years “ONH/CDR” is optic nerve 
head/cup to disc ratio. “N” is number of data entries. “S.D” is standard deviation. “p” values calculated 
from Mann Whitney U test. 
 
 
 VISUAL FIELDS 
The outcome of every visual field test was recorded from each case between the glaucoma and 
control Group.  The outcomes for each subgroup with the PG group and the CC group are 
shown in Table 8.7-1. The visual field instruments used were documented for each case 
although the data were not tabulated.  
 
8.7.1 PRE-DIAGNOSIS GROUP 
A full visual field was recorded in 58.9% of the PG group. 29.4% of the patients had no record 
of a visual field test. Approximately 9% of the clinical records had notes for the visual field 
plot to be reviewed; a suspicious visual field recorded was recorded in 2.3%. There was 1 case 
that had notes for visual fields to be repeated and 1 case that was having visual fields 
conducted at the hospital eye service. Figure 8.8-1 presents a pie-chart with the details of the 
visual field plot outcomes for the PG cases at their last visit prior to glaucoma diagnosis.  
Median S.D. CI 95% p
64 0.5 0.2 0.4-0.5
37 0.3 0.2 0.3-0.4 <0.05
GROUP/VARIABLE NUMBER
ONH/CDR
Pre-Diagnosis
Case-matched Control
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8.7.2 CASE-MATCHED CONTROL GROUP 
64.4% had a full visual field recorded. 29.2% of the patients had no record of a visual field 
test. 6.4% had notes to review the visual field plot (Table 8.7-1) presents a pie-chart with the 
details of the visual field plot outcomes for the CC group cases at their last visit.  
 
TABLE 8.7-1 Outcome of visual field assessments for all cases. Values in percentage. 
Description Pre-Diagnosis Group 
%age 
Case-matched Control Group 
%age 
Full visual field 58.9 64.4 
Suspect  2.3 0 
Review visual field 9.3 6.4 
Visual fields at hospital 0.1 0 
No record of assessment 29.4 29.2 
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FIGURE 8.7-1 pie chart to show visual field plots Pre Diagnosis Group:                           Figure 8.7-2 Pie chart to show visual field plots case-measured control at last visit prior 
at last visit prior to diagnosis      to diagnosis  
     
TABLE 8.7-2. Visual field outcomes calculated from last visit prior to diagnosis 
Visual field outcome from last 
visit prior to diagnosis 
Pre-Diagnosis Group Case-matched control group 
Full 40.0 66.9 
Suspect/See Plot 35.2 0 
Repeated 1.1 8.6 
At hospital eye service 1.1 0 
Not recorded 22.2 24.5 
41%
35%
1%1%
22%
Visual Field Outcome/Pre-Diagnosed 
Full
Suspect/See Plot
Repeated
At hospital eye service
Not recorded
67%0%
9%
0%
24%
Visual Field Outcome/Case-Matched 
Controls
Full
Suspect/See Plot
Repeated
At hospital eye service
Not recorded
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 SUMMARY OF RESULTS FOR STUDY 2 
This chapter has presented a summary of the data collected for intraocular pressure, optic 
nerve/cup to disc ratio measurements and visual field outcomes for two groups of cases 
(groups PG and CC). A total of 182 cases were reviewed. Both groups data were observed 
over a period of ten years. Statistical analyses were conducted using correlation and a 
comparison on mean and median values. The results for intraocular pressure measurements 
demonstrated that mean values for the PG group were statistically significantly greater at five 
years and up to ten years prior to diagnosis when compared to the CC group. Similarly, median 
optic nerve cup to disc ratio values were statistically significantly greater at five and ten years 
prior to diagnoses in the PG group. Visual field outcomes were tabulated to review the 
outcomes for all the cases and for the last visit prior to confirmed diagnosis. These results will 
be discussed in Chapter 9.   
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 DISCUSSION FOR STUDY 2 
 OVERVIEW FOR DISCUSSION  
This chapter will review and discuss the results for the ten years clinical data found for a group 
of subjects that were subsequently diagnosed with glaucoma (Chapter 8). The discussion will 
review the results on intraocular pressure followed by a discussion on the optic nerve head/cup 
to disc ratio findings and the visual fields data. A summary will be provided at the end of the 
chapter followed by a general discussions and conclusions chapter.  
 
 REVIEW OF RESULTS FOR STUDY 2 
9.2.1 STUDY DESIGN 
Study 2 involved individual matching of case records (on a paired basis). This type of study 
design is beneficial for efficiency by forcing the case and control samples to have similar 
distributions across confounding variables (Rose & Laan 2009). The limitations to the 
recruitment of the cohorts for this study are selection bias and misclassification. Selection bias 
can occur if the controls differ in an unknown way from the pool of controls (Keogh & Cox 
2014). In this study, attempts were made to collect each paired glaucoma and control case 
from the same practice to control for some demographic biases. This approach was mostly 
successful, with only four control cases needed to be matched from other practices. The 
matched cases being registered at the same optometry practice does not confirm that the cases 
are demographically from the same area. It is not unknown for subjects to travel out of their 
area to see a recommended optometrist.  
The data for Study 2, as in Study 1, were real world data and collected in routine community 
optometry practices. The clinical measurements were not measured or recorded for research 
purposes. The four practices that were used all had established practitioners who had achieved 
further optometry training. This had an advantage for extraction of data as there was some 
consistency with records and familiarity. There is also a control of measurement error in two 
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ways; repeatability of the same observer and between observers (Coggon et al. 2003). All the 
community practices used had more than one optometrist and therefore it is likely that over 
the time span that the case records were used, there would have been on occasions different 
optometrists assessing the participant, albeit the same practice. 
Almost two thirds of the PG group were male. This supports the results reported in the 
literature review (Section 2.4.2) for males to have a higher prevalence of POAG. Tham et al. 
(2014) also reported in a global prevalence report that men were more likely to have POAG 
than women (OR 1.36).  
 
 INTRAOCULAR PRESSURE 
9.3.1 TONOMETRY  
The equipment used to measure intraocular pressure was tabulated from the last observed 
measurement for the PG group and CC group. The results showed that the type of each 
instrument was similar in each group (Table 8.3-1). The most popular method of measuring 
IOP was with the Pulsair non-contact tonometry; followed by the Icare rebound instrument. 
Contact tonometry was used in 13.2% of the PG cases and in 8.6% of CC. Although contact 
tonometry is the current recommended guideline for IOP measurement before referral for 
OAG (NICE 2017), the cases have ranged in date from 1983 to 2016.  The span of years for 
the last observed measurement was from 1995 to 2016. These results agree with a national 
survey of diagnostic tests reported by UK community optometrists for the detection of OAG 
which reported non-contact tonometry methods to be the most popular (78%) and contact 
applanation being used 16% of the time (Myint et al. 2011).   
Consideration should be made to the time-span in which the intraocular pressure 
measurements were taken. The data have been collected over a span of 33 years. Tonometry 
equipment has developed and refined over that time so consideration is given that the more 
recent measurements may be more accurate.  
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9.3.1.1 SUMMARY  OF RESULTS FOR INTRAOCULAR PRESSURE IN THE PRE- 
GLAUCOMA GROUP AND IN THE CASE-MATCHED CONTROL GROUP 
The minimum IOP measurement in the PG group was 9.0mmHg and the maximum was 
36.0mmHg. The mean IOP was 18.9 mmHg with a standard deviation of 4.4. The minimum 
IOP measurement in the CC group was 7.0mmHg and the maximum was 25.0mmHg. The 
mean IOP was 14.9mmHg with a standard deviation of 3.3. The correlation results from group 
PG indicated that time explained 2.1% of the change in IOP as opposed to the CC group 
indication of 0.66%. The difference in intraocular pressure at specific time points was also 
considered between the groups PG and CC. At 5 years before diagnosis, the mean IOP was 
statistically significantly greater (unpaired t-test, p<0.00000001) in the PG Group (mean 19.2 
± 4.1) than the CC Group (mean 14.8 ± 3.1). At 10 years before diagnosis, the mean IOP was 
statistically significantly greater (unpaired t-test, p<0.000008) in the PG Group (mean 18.2 ± 
4.1) than the CC Group (mean 15.1 ± 3.3).  
Intraocular pressure was compared between the cases who had a family history of glaucoma 
(PGFHG) and those who did not have a family history of glaucoma (PGnFHG) at two-time 
intervals. At five years before diagnosis the mean IOP was not statistically different (unpaired 
t-test, p=0.8) in the group PGFHG (mean 20.2 ± 4.9) than group PGnFHG (mean 18.3 ± 3.0). 
At 10 years before diagnosis the mean IOP was statistically significantly different (unpaired 
t-test, p=0.044) in the group PGFHG (mean 19.3± 4.2) than group PGnFHG (mean 17.4 ± 
3.8).  
 
9.3.2 COMPARISON OF INTRAOCULAR PRESSURE RESULTS 
TO LITERATURE 
This study was reliant on the retrospective data and therefore there was little control on the 
quality of the data being extracted. The information that was controlled for was which eye was 
used for data analyses. Analyses were data from the eye which was either diagnosed first; if 
both eyes were diagnosed at the same time, a decision was made from the notes as to which 
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eye was the more affected (Section 7.5.3). The same eye was chosen for the control case. 
Research supports the view that the eye chosen for the case control could be either right or 
left, as symmetrical variation has been shown in IOP in untreated healthy individuals between 
ages 18 years to 74 years (Liu et al. 2005). The order of IOP measurement has been shown to 
be important. IOP measured in the first eye, whether the right or the left, is on average higher 
than the IOP measured in the fellow eye (Pekmezci et al. 2011; Chan et al. 2016). Optometrists 
are taught to measure and record investigations of the eye from right to left. However, as Study 
2 reported 56.9% measurements for the right eye and 43.1% for the left, this may have 
counteracted this difference. Recommendations from a predictive model for POAG in OHT 
patients evaluated using the “worse” eye or the means of right and left eyes and concluded 
that the latter is the more robust to measurement variability and error (The OHT Study Group 
and EGP Study Group. 2007). This study used the “worse” eye; taking the mean of the two 
eyes would not have been appropriate as often treatment can be initiated in both eyes to 
prevent progression in the worse eye is affected.  
Study 2 did not have a cut off for IOP measurements and the range extends to 36.0mmHg for 
group PG. This value was recorded for a participant at the time they were referred and 
diagnosed with POAG. Group CC had a maximum IOP value of 25.0mmHg. This entry was 
an isolated reading for the control case with all other measurements being below 21.0mmHg. 
The percentage of IOP entries that were recorded above 21.0mmHg were 29.7% for group PG 
and 5.1% for group CC. NICE guidelines recommend that all repeatable intraocular pressures 
over 21.0mmHg measured by applanation tonometry in people aged 18 years and over, should 
be assessed by a suitably trained healthcare professional (NICE 2017). In this study, relatively 
few of the PG cases were referred for IOP over 21.0mmHg; although this group did have a 
higher percentage of IOP measurements recorded by applanation tonometry than the group 
CC. The optometrists at each practice were monitoring these cases over many years and it is 
possible that PG cases had glaucomatous changes before referral was considered necessary. 
These results show that the optometrists who were monitoring these cases were vigilant in 
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assessing whether risk factors were changing into confirmed glaucomatous changes. This is 
evident through the extra visits and visual field assessments that the PG cases had. Literature 
supports that elevated intraocular pressure is a strong risk factor for glaucoma, but there are 
substantial numbers of people with elevated intraocular pressure who do not develop 
glaucoma even during lengthy follow-up (Weinreb & Khaw 2004; NICE 2017). Formal 
screening of glaucoma is not conducted in the UK and there is evidence that many cases of 
glaucoma may be undetected (Lawrenson 2012); Study 2 has suggested that optometrists may 
be informally screening all the time as is evident with the monitoring of the cases seen in this 
study. The 4 community clinics recruited were only asked to provide data on the confirmed 
glaucoma cases; there would therefore be many cases that they monitor just as closely who do 
not develop glaucoma. Table 8-2.3 gives evidence on the close monitoring of cases as there 
were cases that were re-referred to the hospital eye service but also several cases that were 
monitored by the hospital eye service. False referrals have been historically documented to 
occur to the hospital eye service (Salmon et al. 2007) but Study 2 has delivered information 
on the accuracy of optometry referrals. One of the commonest reasons why a patient was 
assessed as normal from referral was due to assessment of the optic disc (Salmon et al. 2007) 
but as imaging is regularly used in day to day optometry practice now, this may have 
improved.  
The mean intraocular pressure for the group PG was 18.9mmHg (S.D.4.4) (Chapter 8 & 
Section 9.22). Although the frequency distribution chart for the PG cases closely 
approximated a normal distribution, there is a slight skew towards higher IOP measurements 
(Figure 8.3-1).  This pattern of IOP has also been suggested in the Bedford Glaucoma Survey 
(Bankes et al. 1968; Harper & Reeves 1995) but these were single point IOP measurements 
as opposed to ten-year variation of IOP change. The normal distribution chart for group CC 
showed a steady rise in IOP to 15.0mmHg then a sharper fall (mean 14.9mmHg) (Figure 8.4-1). 
The percentage difference between the mean IOP for group PG and group CC was 27.5%.   
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The UK Glaucoma Treatment Study (Garway-Heath et al. 2015) recruited newly diagnosed 
participants with open angle glaucoma for a randomised control trial to investigate 
preservation of the visual field with an intraocular-pressure-lowering drug. Interestingly the 
participants recruited to this study had mean IOP of 19.6mmHg (S.D.4.6) and 20.1mmHg 
(S.D.4.8). These intraocular pressure measurements and standard deviations are comparable 
for the mean IOP and standard deviation for group PG (18.9 + S.D.4.5). The initial reduction 
from baseline IOP for the treatment group for the UK Glaucoma Treatment Study was 5.0 
mmHg (26%). This 5.0% difference is in line with the percentage difference between the mean 
IOP values between the PG and CC group. Hong et al (2007) conducted a nine-year 
retrospective study to associate long-term IOP fluctuation and visual field change. They found 
that standard deviation was more important even if IOP was less than 18.0mmHg. Caprioli 
(2007) also suggests that “standard deviation is a more robust measure, less affected by 
outliers, and takes the number of measurements into account”.  
There has been suggestion from the literature that IOP variability between visits may be more 
important than mean IOP (Singh & Sit 2011). Long-term IOP fluctuation (IOP peak minus 
IOP trough measured in a stated time-period) may have been represented from the correlation. 
Isolating the IOP measurements at specific time periods, may have the indicated the IOP peak 
(Sultan et al. 2009).  
There have been many studies showing that a reduction in IOP is in many cases an effective 
intervention at controlling the progression of POAG. The Early Manifest Glaucoma Trial 
(Heijl et al. 2002) demonstrated that progression of OAG may be controlled with a 25% 
reduction in IOP in patients with newly diagnosed OAG. This level of reduction has also been 
shown to be beneficial in patients with ocular hypertension. The Ocular Hypertension 
Treatment Study (OHTS) showed that a 20% reduction from baseline by topical medical 
therapy may delay or prevent the onset of POAG over the course of five years in individuals 
with elevated IOP (Kass et al. 2002). The implications of the results for this study when 
considered with the results of these and other studies are that they may be evidence to start 
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treatment earlier before structural and functional change becomes manifest. There are 
implications of starting treatment prematurely as glaucoma influences a patient’s quality of 
life (Quaranta et al. 2016), as there are implications of long term treatment, hospital visits and 
the anxiety of diagnosis or even mis-diagnoses; but this also must be balanced with the 
importance of timely glaucoma diagnosis for preserving vision (Quaranta et al. 2016; 
European Glaucoma Society 2017).  
The scatterplot (Figure 8.4-3) showed that there were differences in IOP over time between 
the two groups of PG and CC cases. The chart shows the distribution of IOP measurements 
for PG cases to be concentrated at higher IOP measures than CC cases. 
Inspection of the scatterplot shows that IOP for the case-control group stayed constant and 
appeared to plateau, if not lower after 10 years. The EPIC-Norfolk Eye Study (Foster et al. 
2011) and the UK Biobank Study (Chan et al. 2017) also found the same trend among women, 
however Study 2 had more male cases than female. Oestrogen use has been implicated with 
IOP and retinal ganglion cell protection, thereby reducing the risks of POAG (Newman-Casey 
et al. 2014). The relationship between age and IOP has not shown clear consistent relationships 
(Klein et al. 1992; Wu & Leske. 1997; Tomoyose et al. 2010; Wong et al. 2009). Consideration 
has been given to the fact that 12 of the cases from group CC had undergone cataract surgery 
compared to 6 of group PG. Cataract surgery has been demonstrated to reduce IOP in 
glaucoma as well as normal subjects (Shingleton et al. 2006). For this reason, the analyses 
were repeated at the 5-year interval and 10-year interval with all the cases who had had cataract 
surgery removed and the mean IOP difference remained to be statistically significantly 
different. (Section 8.4.2.1).  
The scatterplot also reveals that the trend over time in intraocular pressure for group PG shows 
long term change (Sit 2014). Intraocular pressure has a greater increase over time in the cases 
who go on to develop glaucoma. Downs (2015) aptly reports that the vulnerability of IOP may 
be underestimated if mean IOP is presented with snapshot measurements. Subtle changes in 
intraocular pressure, although keeping under 24.0mmHg (NICE 2017), may still be 
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contributory to optic nerve head alterations (Jiang et al. 2017). There are very few studies to 
date which have reviewed longitudinal change in IOP. One study that has done this is the 
Barbados Eye Study (Wu et al. 2006). This study reported on intraocular pressure change over 
9 years in non-glaucomatous African subjects. Over the 9 years, the mean IOP change was 
0.4mmHg (S.D. 4.0). The Barbados Eye Study also showed that over 9 years, from the 
participants who had an IOP of 21.0mmHg or less at baseline, 6.5% had an elevation of IOP 
after 9 years; 3.8% had subsequent IOP-lowering treatment and 2.7% developed OAG.  
The mean IOP for group PG was 18.2mmHg at 8-11 years prior to diagnosis; and 19.1mmHg 
at 5-6 year prior to diagnosis. In contrast, group CC had an IOP of 15.1mmHg at 8-11 years 
and 14.8mmHg at 5-6 years. These mean IOP differences between each group are statistically 
significantly different (p<0.000008). These results indicate that glaucomatous changes may 
be initiated much earlier than we have anticipated and corroborate with the results with Study 
1 that isolated intraocular pressure readings may provide very little information on their own 
but the pattern of change is important.  
 
9.3.3 SECONDARY ANALYSIS OF FAMILY HISTORY AT 5 AND 
10 YEARS  
Mean intraocular pressure in the cases who had a family history of glaucoma were found to 
be significantly higher to those that did not within group PG at 8-11 years prior to diagnosis 
but not at 5-6 years.  Interestingly, there were fewer data points for these sub groups at 5-6 
years compared to 8-11years. There may have been fewer if at this point the participants were 
beginning to be referred for second opinions to the hospital eye service. The reasons why a 
statistical difference in mean IOP was found at 8-11 years but not at 5-6 years are unclear. The 
results show that the mean IOP differences are unchanged between the two groups although 
both are higher. However, the standard deviation has decreased at 5-6 years from 3.8 to 3.0 in 
the group without a family history.   
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 OPTIC NERVE HEAD ASSESSMENT/CUP TO DISC 
RATIO 
9.4.1 SUMMARY OF RESULTS FOR OPTIC NERVE HEAD/CUP 
TO DISC RATIO  
The values for the whole data set showed the median value for group PG to be 0.5. 
Comparatively, these values were 0.3 for the median for group CC. The median CDR values 
for the first visit for each case were 0.3 in each group. Having substantially more entries for 
the whole data set may account for the change in median. However, a decrease in median for 
the control group may be accounted for by increasing accuracy if measurement techniques 
changed over the 10 years of the participants eye examinations. The Blue Mountains study 
found that in non-glaucomatous eyes, mean CDR increased 0.001 for every year of age and 
increased by 0.004 for each 1.0 mmHg increase in IOP (Healey et al. 1997). Thus, group CC 
would be expected to show little to no change, even accounting for age related axonal loss 
(Harwerth et al. 2008).  
 
9.4.1.1 SUMMARY  OF STATISTICAL ANALYSIS FOR THE PRE-DIAGNOSIS 
GROUP AND THE CASE-CONTROL GROUP FOR OPTIC NERVE 
HEAD/CUP TO DISC RATIO 
Statistical analysis with Mann Whitney U test showed that the median cup to disc ratio 
measured in group PG compared to the cases for group CC was significantly larger (p<0.05).  
The difference in cup to disc ratio at specific time points was also considered between groups 
PG and CC. The data were restricted to a single measurement at or over 5 years 0 months and 
under 6 years and 0 months for each group. The same was done for each group for a single 
data point at year 8 years and 0 months and under 11 years and 0 months. 
Five years before diagnosis the median CDR was significantly greater (Mann Whitney U test, 
p<0.05) in group PG (median 0.4 ± 0.2) than group CC (median 0.3 ± 0.2). 
  
129 
Ten years before diagnosis the median CDR was statistically significantly greater (Mann 
Whitney U test, p=<0.05) in group PG (median 0.5 ± 0.2) than group CC (median 0.3 ± 0.2).  
 
9.4.2  OPTIC NERVE/CUP TO DISC RATIO: COMPARISON TO 
CURRENT LITERATURE 
The results presented for median CDR values, when considered alongside the mean IOP 
values, concur with the Beaver Dam Eye Study (Klein et al. 1992). The Beaver Dam Eye 
Study found that amongst normal tension and open angle glaucoma subjects, vertical CD ratio 
was 0.5 with a mean IOP of 17.6mmHg. The values reported for the non-glaucoma group were 
CD ratio of 0.4 and mean IOP of 15.2mmHg. (Klein et al. 1992). The observations were made 
with a slit lamp microscope and accessory lens and photographs were taken. This is relevant 
as when screening for glaucoma, clinicians will readily use this procedure to screen and 
monitor for glaucoma changes (NICE 2017). Community optometry has evolved with not only 
its partnership with ophthalmology but also with the techniques used for assessments. Over 
the span of 15 years, optometry has progressed to having slit-lamp biomicroscopy as standard 
practice and many practices will use supplementary imaging with retinal photography or 
optical coherence topography. Historically, ophthalmologists used to have a higher 
interobserver agreement in estimating CDR for glaucomatous nerve damage when compared 
to optometrists (Abrams et al. 1994) but this may have changed positively (Roberts et al. 2015) 
as many optometrists are now part of glaucoma enhances schemes and monitoring services 
(Baker et al. 2016). 
The results show that the optic nerve assessment by CDR appear different in the PG group 
than the CC group. Observation of the frequency distribution charts present more data entries 
spread across a median of 0.3 to 0.9 whereas the CC group are concentrated between 0.3 and 
0.5. The correlation (Figure 8.5-3) does present a change over time. Thought has been given 
as to whether some cases may have had pathological changes and early glaucoma was not 
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being detected. However, these results suggest that the practitioners were monitoring subtle 
changes over the time and would therefore be less likely to miss pathology. This is supported 
also by observing the results of the CC group also had an increase in CDR over time, albeit it 
small. The median values of CDR from the first visit of each group suggest that the groups 
did not have distinct difference ten years prior to glaucoma diagnosis. Systemic risk factors of 
glaucoma should be considered as they may have some effect on the optic nerve. Evidence 
has been shown to suggest that localised ischemia affecting the papillomacular bundle of the 
neuronal tissue may cause thinning at the Bruchs membrane and result in associated VF loss 
(Park et al. 2011; Taniguchi et al. 2017). There are associations with these changes to be more 
likely in people with vascular dysregulation in conditions such as Raynaud’s syndrome (Park 
et al. 2011). Hypothetically there may be anatomical differences in the optic nerve cup of 
patients that could account for an added risk of mechanical or vascular possibly with or 
without an increase in IOP. Structural differences in the anatomy of the optic nerve such as 
the Bruch membrane have been indicated as new structural biomarkers associated with 
glaucoma (Taniguchi et al. 2017). Glaucoma research is advancing through consideration 
neuroprotection of the optic nerve and with analysis of the nerve with advancements of OCT. 
These techniques will broaden the scope of being able to detect early precursors of glaucoma 
(Sena & Lindsley 2013; Daneshvar & Nouri-Mahdavi 2017). 
Vertical cup to disc ratio has been recommended for observation of the optic nerve head 
(Garway-Heath et al.,1998) but being a retrospective study, the method of observation or 
accuracy was largely assumed. The structure of the optic nerve head and its examination have 
been reviewed in Section 1.14.5. Clinicians rely on descriptive data for the optic nerve as well 
as objective measurements. Descriptions such as the “ISNT” rule, optic disc size or cup 
position were not tabulated. The reasons for this are that there were different practitioners at 
the practices over the time span that the data were collected and the notes were recorded in 
various ways and not suitable for extraction and analyses. These details are also largely 
subjective (Tatham et al. 2015). The records also spanned several years and there were some 
records where descriptive words were used such as “normal” or WNL (within normal limits).  
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Comparison of CDR asymmetry was not used for this study as the details for the most affected 
eye were extracted; the most affected eye which would be suggestive of the one with the most 
acquired damage. Cup to disc ratio is a basis for further follow up for glaucoma suspects or 
those with risk factors but it is not used for screening purposes (Qiu et al. 2017). 
The mean refractive error for groups PG and CC was approximately -1.00DS; each group 
having a small amount of myopia. A systematic review and meta-analysis showed that 
glaucoma studies have described low myopia from -3.00DS and emmetropia up to -1.50DS 
(Marcus et al. 2011). With vertical CDR being shown to be 0.3 in normal eyes (Jonas et al. 
1988), the alteration over time for the PG cases are more likely due to a pathological alteration 
as opposed to any difficulties or abnormalities due to a myopia-related optic nerve (Chang & 
Singh 2013).  
 
 VISUAL FIELD ASSESSMENT 
9.5.1 SUMMARY OF DESCRIPTIVE DATA FOR VISUAL FIELD 
ASSESSMENT.  
Descriptive data were tabulated from the visual field results from each case for groups PG and 
CC. Table 8.7-1 presents the outcomes for visual field plots for each data entry. Table 8.7-2 
shows the outcomes tabulated for each group only from the last visit.    
For the PG group, less than 50 % had a full visual field recorded prior to diagnosis but as these 
records were not accessible it is unknown if they were glaucomatous. This could also not be 
determined for the fields that were recorded as “see plot” or “defect”. A small percentage of 
cases were being monitored at the hospital. In contrast, group CC had 66.9% with a full visual 
field recorded.  A quarter of cases in each group did not have a record of a visual field.  
 
9.5.1.1 VISUAL FIELD ANALYSIS: COMPARION TO CURRENT LITERATURE 
Visual field plots are often stored on the hard drive of the perimeter and it could be that there 
were plots that were asked to be reviewed by screening staff for anomalies such as false 
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positive results or lack of fixation. A quarter of cases for both groups did not have a visual 
field plot recorded. This may be as there were visual fields conducted but not recorded on the 
case record; or that a clinical decision was made not to perform perimetry for other reasons.   
Functional changes for glaucoma are thought to become evident once glaucoma has become 
manifest, yet there are no longitudinal studies comparing the value of assessing structural and 
functional progress at different states of glaucoma (Öhnell et al. 2017). The research described 
in this thesis was considering the subtleties in glaucoma changes which occur prior to 
diagnosis and therefore prior to visual field loss. Ideally, to meet the inclusion criteria, it was 
expected that there would have been record of every case to have had 2 visual field 
assessments over the 10 years.  
 
 STRENGTHS AND LIMITATIONS 
Study 2 presented a novel approach for considering the status of glaucoma patients 10 years 
prior to diagnosis. Using real clinical data has also shown the huge resource available in “real 
world” optometric data. The scope of this is expanding with many optometrists using 
advanced imaging such as OCT and routinely doing visual fields. Study 2 has also been 
successful in achieving a large sample size. With the support of four community optometrists, 
robust retrospective data were collected. As there was more than one practice, a broader and 
more representative sample of cases were collected than if one practice alone had been used. 
A challenge was finding practices that had had been observing patients over a considerable 
length of time. A great advantage to the data was that it spanned 33 years but a limitation that 
many records were hand-written which can require cautious examination. Although the cases 
were closely matched by group, the number of data entries per case differed and for this reason 
there was a difference in entry points for each group. Missing data is a limitation of 
retrospective data. Study 2 has benefits of using real data but also limitations that this research 
is relying on historical data of community clinical practices staffed by clinicians and not 
researchers. This means that we have variability in the use of equipment, limited visual field 
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data, and possibly optic nerve assessments made without dilation. Having awareness that some 
of these assessments were not made, there is the potential limitation that some of the PG group 
had glaucoma several years before diagnosis. Study 2 included data of patients who were being 
monitored by an ophthalmologist but not on treatment and this highlights the difficulty 
between a suspicion of glaucoma and confirmed glaucoma. This is discussed further in 
Chapter 10.  
 
 CONCLUSIONS 
Study 2 has presented data which shows that both IOP and optic nerve cup to disc ratio 
increase in value over a ten-year period in patients who subsequently progress to develop 
POAG. IOP is the only modifiable risk factor for glaucoma, yet its role in the development 
and progression of glaucoma are not well understood (Downs 2015). This discussion has 
presented mean IOP results in pre-diagnosed cases which are comparable to mean IOP data 
from recognised prevalence studies and randomised controlled trials, indicating further that 
changes in IOP increase the risk of glaucomatous optic nerve change. The reduction of 
intraocular pressure therapeutically, has been shown to slow the rate of glaucomatous change 
(Musch 1999; Anderson 2003). This study indicates that the mean IOP was higher over time 
in those that subsequently develop glaucoma, therefore there may be implications for starting 
treatment earlier for patients who have higher risks of glaucoma. Mean IOP measurements 
were also noted to be statistically higher in those that had a family history of glaucoma at ten 
years prior to diagnosis. The mean age recorded from all the cases was 65 years. The mean 
age observed for the specific cases at 10 years prior to diagnosis group PG was approximately 
60 years. These specific cases had a minimum age of 36 years and a maximum age of 78 years. 
Although it may not be usual to observe POAG in patients under 40 years, there is stronger 
suspicion that changes may be happening a lot earlier than expected. It may be these cases that 
are most instructive concerning the pattern of change. The increase in IOP over a ten-year 
duration for the PG cases corroborated with an increase in optic nerve CDR. The results of 
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Study 2 suggest that although visual field testing was being conducted, the details of these 
were difficult to interpret and this may be worth consideration if notes should be reviewed by 
other health professionals. Approximately 30% of the PG cases had a mean IOP over 
21.0mmHg. Current NICE guidelines advise that referral for investigation of POAG is to be 
made if IOP is measured at 24.0mmHg. The results from this study imply that optometrists 
should be monitoring closely the change of IOP over time and provide “results of all 
examinations and tests with referral” as advised by NICE (2017).  
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 GENERAL DISCUSSION AND 
CONCLUSIONS 
 GENERAL DISCUSSION 
This thesis describes two retrospective studies to investigate the risk factors of primary open 
glaucoma. Each study has reviewed measurements of intraocular pressure and cup to disc ratio 
assessments.  
Study 1 has reviewed intraocular pressure measurements in young adults aged between 18 
years and 40 years. As a known risk factor for glaucoma is family history, intraocular pressure 
measurements were collected between two groups; a group with a family history of glaucoma 
and a group without. Although firm conclusions cannot be drawn because the findings were 
not significant, the fact that there was a mean difference requires further investigation with 
larger sample sizes. The optic nerve cup to disc ratio measurements between each group did 
not show an observed difference. 
Study 2 collected retrospective data from case records of patients that subsequently went on 
to develop primary open angle glaucoma or be treated for ocular hypertension, pre-perimetric, 
normal tension or suspect glaucoma. The cases were approximately matched by age, gender 
and refractive error with a control case. The results demonstrated that there is a difference in 
correlation over time in the intraocular pressure measurements of patients that develop 
glaucoma. Mean intraocular pressure in the cases that subsequently went on to develop 
glaucoma compared to case-matched controls were shown to be significantly higher at 5-years 
and 10-year time points before diagnosis. Comparison of mean intraocular pressure for two 
subgroups (family history and no family history) amongst the cases that developed glaucoma 
were also significantly higher at 10 years prior to diagnosis. Optic nerve analysis for cup to 
disc ratio measurements also showed a correlation over time with the pre-diagnosed glaucoma 
group showing to have an increasing CD ratio when compared to case controls. The Mann 
Whitney U test showed that the median cup to disc ratios were significantly higher at 5 and 
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10-year time points. Information taken from case records for visual field plots presented that 
there were more recorded field plots prior to diagnosis but also highlighted that visual fields 
are not always being recorded and a minimum requirement or guideline may be needed with 
additional funding to upgrade the NHS sight test to include visual fields.  
Both Study 1 and 2 have provided supporting evidence that the pathogenesis of primary open 
angle glaucoma has many challenges as it is multifactorial. This agrees with the literature 
reviewed in Chapter 2. Rossetti et al. (p. 56) states that “the growing evidence about the wide 
variability in disease progression and outcomes between patients means that it is essential to 
study the risk factors that influence this variability. More knowledge in this field will help the 
clinician to identify the patients who require more care and might need a more aggressive 
treatment to achieve a better outcome” Spaeth (1993 p.63) was quoted in Section 1.5: “the 
most important characteristic of the glaucomatous process is change in the appearance of the 
disc from its former state”. The results from Study 1 and 2 have provided early evidence that 
the glaucomatous process may also be a change in the normal pattern of intraocular pressure. 
Patients’ often ask what “normal” intraocular pressure is and as optometrists we may answer 
what the normal range is for a given population (Colton & Ederer 1980). Optometrists are also 
aware that the risk of glaucoma increases with age as does intraocular pressure and thus 
standard practice can be to observe intraocular pressure after the age of 40 years. Yet few 
studies have investigated intraocular pressure measures in those with risk factors before the 
age of 40. Both Study 1 and 2 should be discussed with the issue of sampling. Study 1 used 
only one data entry point per case; Study 2 used one data entry point per visit. This may not 
represent the normal IOP for that given patient. In view of the increased diurnal variation in 
glaucoma, the odds of a low reading truly indicating normality (true negative) is also not that 
high (false negative). Study 1 and 2 each used purposeful sampling which has been described 
to be informationally representative (Sandelowski 2000). Study 1 and 2 reveal that even 
although IOP may within the normal range, in those at risk of glaucoma or who subsequently 
develop glaucoma the IOP may be higher than that in a control group; and this could be 
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causing subtle changes in structure. Whether these changes are a pre-cursor of glaucoma or 
might be related to subtle functional deficits that are not clinically detectable by community 
optometrists requires further research.  
The introductory chapter has reviewed the vascular and mechanical theories of glaucomatous 
change (Chapter 1). There are theories that suggest that an increase in IOP may cause 
compression of capillaries leading to impaired blood flow to the optic nerve head (vascular) 
or that an increase in intraocular pressure may alter the integrity of the lamina cribrosa 
(mechanical). The importance of developing knowledge of the precursors for glaucoma by the 
earliest detection come from acknowledging that the physical manifestations optometrists 
detect in practice may be at the end of a chain of events that can follow from an increase in 
IOP. Histological data shows that even at an early stage, the burden of increased IOP can cause 
changes in the lamina cribrosa in addition to loss of capillary vessels and axonal and glial cells 
(Evangelho et al. 2017). It is also worth briefly mentioning that animal studies have shown, 
sustained effects of raised intraocular pressure. Artificially raising IOP in a rat by injection at 
one week showed that fine processes of optic nerve astrocytes are damaged but with no 
damage to axons. However, despite lowering IOP to normal levels, at four weeks there was 
damage to all the astrocytes and the majority of axons (Dai et al. 2012). These examples of 
changes give further concern that Study 2 demonstrated a significant difference in mean IOP 
at ten years preceding diagnosis. It may be that knowledge of the earliest point of change in 
intraocular pressure or retinal structure may also be the earliest point of intervention if target 
IOP can be individualised (Rossetti et al. 2015). 
Technology is a supporting asset and the use of optical coherence tomography is rapidly 
changing the detail of information optometrists can collect at examinations. All this does 
suggest, that optometrists continue to keep accurate records and all information is relayed to 
ophthalmologists on referral. The case records that were reviewed in this study show the 
benefits of long term case records and the pattern that can be seen together with building up a 
relationship with a patient. Current NICE guidelines recommend that referral is necessary for 
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a measured intraocular pressure of 24.0mmHg with no other pathological changes. 
Considering the results of this thesis, the responsibility lies even more with optometrists to be 
monitoring for early detectable changes to prevent structural and functional optic nerve 
change. This will also aid in patients understanding of glaucoma and relaying this to family 
members. As with all things, learning takes time and these studies suggest that time is needed 
to learn and observe how an individual patients’ eyes may change. There is an informal risk 
analysis happening at each examination. The records from this study suggest optometrists do 
this all the time by annotating notes with words such as “suspect” or “monitor”. 
 
 STRENGTHS AND LIMITATIONS 
This thesis brings with its results a lot of information about optometry practice. Study 1 
showed that retrospective intraocular pressures measurements were difficult to collect in 
young adults. And Study 2 had difficulties too in sourcing data from cases of patients that had 
remained at the same practice for several years. The retail element of optometry brings with it 
competition and this means that patients do not stay registered at a single practice; this brings 
a challenge of being able to record observations over time and monitor change. In the wider 
scheme of public health, both optometry and patient education is needed about the regularity 
of eye examinations and if risk factors of glaucoma are present, the importance of monitoring 
change. It is interesting to consider whether full eye examination reports should be given to 
patients rather than optical prescription details alone. The results from this thesis also support 
the notion that optic nerve change occurs slowly over time in those that subsequently develop 
glaucoma. Optometrists are recognised as partners in eye health care by ophthalmologists and 
patients are best served by the two professions working together; certainly, prevention is better 
than cure for the growing older population together with the financial constraints of health 
care.  
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 RECOMMENDATIONS FOR FURTHER RESEARCH 
Further analyses of the data obtained in Study 2 could include requesting full visual field 
details from the practices, although this would be of limited use as only some of the practices 
routinely test visual fields on every adult. Further statistically analyses of the change in 
standard deviation over time would also provide interesting knowledge as to how intraocular 
changed in the PG and CC group. Analyses of data with further categorising of the cases for 
myopia would also be interesting.  
Future work arising from this thesis are recommendations to repeat Study 1 as a retrospective 
or prospective study. It may be possible to repeat Study 1 using non-independent optometric 
practices that have a protocol to routinely screen all adults. If these data are electronically 
available then it would be a way of access to gather extensive data on the proviso that there 
was a policy that the data could be used and no data protection acts were being breached. 
Study 1 would also be suitable to be conducted as a prospective study. It would be interesting 
to repeat Study 2 and to obtain OCT and full visual plots. A possible variation of this study 
could be to work with a hospital eye service and gather information on baseline visits prior to 
treatment and request previous data from community optometrists. These suggestions may not 
be feasible for the same obstacles that Study 2 encountered. Study 2 would be difficult to 
conduct as a prospective study due to an unknown longevity of conversion to POAG. But if 
further detail from a repeat retrospective study, than it would also be of interest to consider 
colour vision and contrast sensitivity and any perceived visual changes as these have been 
reported to be affected prior to development of localised nerve fibre bundle defects 
(Airaksinen & Drance 1985; Viswanathan et al. 1999). 
More generally, the research in this thesis has demonstrated the potential for research using 
optometric clinical records. The present research is not the first to use such an approach 
(Pointer 2001; Pointer 2011), and it needs to be noted that an optometric population is not the 
same as the general population (Pointer 2000). With improvements in standards of care of 
community optometry (e.g., many optometrists now have a higher qualification in glaucoma), 
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the quality of data in the clinical records of many practitioners is likely to have improved since 
the period surveyed in this research. The use of sophisticated imaging technologies (e.g., OCT, 
wide field scans) and hospital eye service standard visual field equipment in many practices 
further increases the potential for research of the type described in this thesis. With over 22 
million eye examinations carried out each year by community optometrists (Optical 
Confederation, 2015), there would appear to be a real potential for an “optometric biobank” 
approach to furthering the understanding of many ocular conditions. 
 
 CONCLUSIONS 
This thesis has achieved its aims to retrospectively investigate the differences in intraocular 
pressure and optic nerve cup to disc ratio in a group of cases that had a family history; together 
with analyses of how these measurements changed over a ten-year period in a group of 
participants that subsequently developed glaucoma. By “connecting the dots looking back”, 
this thesis has provided results demonstrating statistically significant differences in mean 
intraocular pressure measurements and optic nerve cup to disc ratios up to ten years prior to a 
diagnosis of glaucoma. The results indicate that there is further investigation needed to 
understand the subtleties of changes in the years leading up to a diagnosis of glaucoma and 
confirms the importance of monitoring change in the groups of people that have risk factors 
of primary open angle glaucoma. Further research would be needed to show if early 
intervention to lower intraocular pressure would be beneficial. This thesis has supported and 
provided evidence on the profusion of information accessible from clinical optometric records. 
The vital role that community optometrists hold in guarding the borders between pre-
glaucoma and glaucoma have also been brought to light. 
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